CuraCell Publishes Third and Final Clinical Report from CytoPLY™ Named-Patient Program, Demonstrating Tumour Responses Across Multiple Difficult-to-Treat Solid Tumours

Stockholm, Sweden - CuraCell TX AB (CuraCell) today announced the publication in Cytotherapy of the third and final scientific report emerging from its CytoPLY™ named-patient treatment program. The latest publication, “Targeting Intratumoral Heterogeneity in Pancreatic Cancer with Sequential TIL Infusions” adds pancreatic ductal adenocarcinoma (PDAC) to a growing body of clinical evidence supporting the potential of personalized tumour-infiltrating lymphocyte (TIL) therapy in heavily pretreated solid tumours. Together, the three publications summarize clinical observations from named-patient treatments performed using CytoPLY-derived therapies across multiple advanced cancers with limited treatment options. Across these patients, encouraging clinical activity was observed, including: • Two complete responses: metastatic prostate cancer (>5 years ongoing remission) and recurrent glioblastoma• Two partial responses: pancreatic cancer and renal cell carcinoma• Additional evidence of biological activity supporting continued development in refractory solid tumours The publications collectively demonstrate durable anti-tumour activity, long-term immune persistence, and the ability of personalized T-cell therapies to address challenges such as tumour heterogeneity and immune resistance in cancers traditionally considered difficult to treat with immunotherapy. The latest PDAC publication provides translational evidence that sequential TIL infusions can broaden anti-tumour immune responses and potentially address intratumoral heterogeneity, a major obstacle in pancreatic cancer treatment. The reported patient achieved a partial response accompanied by immunological findings supporting the biological activity of the infused T-cell products. “These three publications represent an important scientific milestone for CuraCell and provide a unique translational dataset generated from real-world named-patient treatments,” said Lucas Arruda, Chief Scientific Officer and co-author across the studies. “Across prostate cancer, glioblastoma and pancreatic cancer, we consistently observed evidence that transferred T cells can persist, infiltrate tumours, and contribute to clinically meaningful responses. Importantly, the pancreatic cancer study highlights how sequential TIL products may help overcome intratumoral heterogeneity, one of the key barriers limiting treatment success in solid tumours. Together, these findings strengthen the scientific rationale for advancing next-generation personalized cell therapies into broader clinical development.” Reflecting on the overall experience from the named-patient program, Martin Forster, Board Member and Clinical Advisor, commented: “While the patient numbers remain limited, the collective experience from the named-patient treatments provide important clinical insights. Across these heavily pretreated patients, we observed evidence of durable disease control and objective responses in tumour types where treatment options are often exhausted. Taken together, these findings support more formalised evaluation of personalised TIL therapies and suggest that meaningful clinical benefit may be achievable even in cancers traditionally considered resistant to immunotherapy.” Commenting specifically on the patient perspective, Forster added: “For patients with advanced cancers who have exhausted standard treatment options, even the possibility of durable disease control changes expectations. What stands out in these reports is not only the observation of tumour responses, but the duration of benefit in selected patients. This is ultimately the outcome that matters most - creating opportunities for longer survival and improved quality of life.” Building on these findings, CuraCell is advancing CytoPLY™ through CC-38, currently being evaluated in an ongoing Phase I/IIa clinical trial in colorectal and prostate cancer. About CuraCell CuraCell is developing next-generation personalized cellular immunotherapies designed to expand the impact of adoptive T-cell treatment across solid tumours with high unmet medical need. Scientific publications supporting this release: • Serial TIL infusions and PD-1 blockade drive long-term clonal persistence in prostate cancer • Tumor-infiltrating lymphocytes-derived CD8+ clonotypes infiltrate tumor tissue and mediate regression in glioblastoma  • Targeting Intratumoral Heterogeneity in Pancreatic Cancer with Sequential TIL Infusions  

Scandic expands with new franchise hotel in Köping

Scandic’s franchise portfolio continues to grow with a new hotel in Köping, located approximately 1.5 hours car drive from Stockholm. The city is home to Sweden’s second-largest inland port, a significant manufacturing industry, and is considered a regional hub. The hotel is strategically located close to both the city center and the popular Kristinelund Sportsfield.   Currently marketed under a different brand, the hotel is undergoing full renovation and is set to welcome Scandic guests in early 2027. It will feature 110 rooms, a restaurant, and meeting facilities for up to 150 participants.   “Scandic’s franchise model enables us to grow in smaller cities across the Nordics where we currently have no presence. At the same time, we offer a strong value proposition to potential franchise partners,” says Jens Mathiesen, President and CEO of Scandic Hotels Group.   “We are very pleased that Norlandia has chosen to partner with Scandic through a franchise agreement. We offer a strong commercial franchise package, including one of the Nordics’ largest loyalty programs and attractive corporate agreements. The fact that Norlandia is expanding its collaboration with us is proof of Scandic’s strength in growing together with our partners over time,” says Søren Nystrøm, Head of Scandic Franchise.   “We have worked with Scandic for many years across several of our other hotels, and are delighted to now also enter into a partnership with our newly renovated hotel in Köping,” says Morten A. Kahrs, CEO of Norlandia Hotel Group.  The hotel will become certified with the Nordic Swan Ecolabel, which is one of the toughest environmental certifications in the industry.   For more information, please contact:  Malin Selander, Communications Director, Scandic Hotels Group Email: malin.selander@scandichotels.com (christoffer.sjolin@scandichotels.com) Phone: +46 70 426 40 06 

Autoliv Strengthens Global Safety Innovation

The Innovation Center builds on more than 70 years of safety expertise rooted in Sweden, where Autoliv’s operations have played a pivotal role in advancing traffic safety on a global scale. Technologies developed here have been scaled worldwide and are today protecting road users across vehicle segments. With the Autoliv Innovation Center, Autoliv now takes the next step. By bringing research, system architecture, testing, prototyping and pilot production together in one environment, the center enables faster technical evaluation and shorter development cycles. Advanced digital tools are combined with physical labs and test environments to verify performance in realistic and measurable scenarios. A key foundation of the Innovation Center is Autoliv’s long‑standing triple‑helix approach, where industry, academia, and society collaborate to address complex safety challenges. The ambition is to create an arena for global cooperation that drives innovation across mobility and society, with the ultimate goal of Saving More Lives. “The Autoliv Innovation Center is a strategic development in how we advance safety going forward. By bringing the full innovation chain together, we can move faster from insight to real‑world impact and scale solutions globally. It is also the natural evolution of our long‑established operations in Vårgårda, building on decades of experience and capability. Sweden has played an important role in advancing traffic safety worldwide, and Vårgårda has been central to these accomplishments. What we are doing today is building on that heritage to accelerate the next generation of global safety innovation,” said Fabien Dumont, Executive Vice President & Chief Technology Officer, Autoliv. Over time, the operation in Vårgårda has been central to innovations for road safety including advanced motorcycle safety solutions, the development of Human Body Models (HBM) that improve injury assessment, Load Limit Management (LLM) technologies that enhance restraint performance, Pyrotechnic Safety Switch (PSS) solutions for electrical safety, and safety systems tailored for commercial vehicles. Autoliv’s safety solutions save approximately 40,000 lives and reduce around 600,000 injuries every year, a tangible demonstration of how innovation makes a real difference for society. With increased investment and an expanded platform for collaboration, the Autoliv Innovation Center is set to further accelerate the development of next‑generation safety solutions and help save even more lives in the future. Inquiries:  Media: media@autoliv.com Gabriella Etemad, Tel +46 70 612 64 24, Emelie Ericson, Tel +46 70 957 81 35 Investors & Analysts: ir@autoliv.com Anders Trapp, Tel +46 709 578 171 , Henrik Kaar, Tel +46 709 578 114 About Autoliv Autoliv, Inc. (NYSE: ALV; Nasdaq Stockholm: ALIV.sdb) is the worldwide leader in automotive safety systems. Through our group companies, we develop, manufacture and market protective systems, such as airbags, seatbelts, and steering wheels for all major automotive manufacturers in the world, as well as mobility safety solutions, such as commercial vehicles and electrical safety solutions. At Autoliv, we challenge and re-define the standards of mobility safety to sustainably deliver leading solutions. In 2025, our products saved approximately 40,000 lives and reduced around 600,000 injuries. We have operations in 25 countries, and we drive innovation, research, and development at our 13 technical centers. Our 64,000 employees are passionate about our vision of Saving More Lives and quality is at the heart of everything we do. Sales in 2025 amounted to $10.8 billion. For more information go to www.autoliv.com. Safe Harbor Statement This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements, including general economic conditions and fluctuations in the global automotive market. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any such statements in light of new information or future events, except as required by law.

Metso launches new primary crushers for unmatched safety and availability in mining

Metso is strengthening its prominent position as a crushing solutions supplier with the launch of three new primary crushers – Metso Primarok™, Metso Optirok™ and Metso Durarok™. Engineered to address the diverse needs of modern mining operations, these high-performance crushers offer superior capacity, safer maintenance, as well as the lowest capital expenditure and total cost of ownership across a wide range of primary crushing applications and ore types. “Mining operations today require crushing solutions that are not only powerful, but predictable, safe, and optimized for the specific application. At the same time, primary crushing as the first stage in concentrate processing lays the foundation for overall recovery efficiency,” says Olli-Pekka Oksanen, Senior Vice President, Crushing at Metso. “Built on proven technologies complemented with major new features, including, for example, data-driven services and performance solutions, the new crushers take performance, availability, and maintainability to a totally new level, resulting in lower total cost of ownership. Primarok offers the highest capacity of any gyratory on the market, while Optirok is designed to address high-capacity primary crushing in compact footprints. Durarok, on the other hand, is a robust solution for materials with variability and moisture constraints and demanding operating conditions,” explains Oksanen. Primary crushing solutions for every application · Metso Primarok™ – engineered for unmatched performance and highest availabilityBuilt on more than a century of experience in gyratory crushing, the Metso Primarok can handle the most demanding primary crushing applications with ease. Its optimized kinematics, refined chamber design and ability to accept large feed sizes drive high efficiency and stable performance. On top of this, it allows for quick and secure shutdowns, as every maintenance task has been streamlined to maximize efficiency and safety.  · Metso Optirok™ – high capacity crushing in a compact footprintAs an evolution of the primary jaw crusher, Metso [AR2.1]Optirok takes crushing to a completely new level in applications with limited space and height. It delivers unmatched productivity, integrated scalping and a high reduction ratio, efficiently processing large volumes of run of mine material while enduring hard rock and abrasive applications. Its innovative features simplify maintenance, improving safety and reducing downtime.  · Metso Durarok™ – robust, simplified sizer designed for maximum enduranceThe Metso Durarok primary sizer combines a simplified, heavy duty design with high performance and durability. Its crushing rolls are engineered to withstand the heaviest loads and generate high crushing forces while maintaining low wear rates. Durarok enables higher utilization and uptime compared to conventional solutions, helping reduce operating costs and increase capacity. It is well suited for handling sticky materials, soft to medium hard ores, and demanding mining applications. Metso’s complete offering and support for crushing operations Metso has delivered thousands of crushers to mining and aggregates customers around the world, building a wide installed base across applications and commodities. The new primary crushers further strengthen Metso’s comprehensive crushing portfolio, which also includes well established jaw, cone, impact and gyratory crushers, which are available as stationary, semi-mobile and mobile solutions. As a leading provider of minerals processing solutions and services, Metso’s offering also covers lifecycle services and upgrades, as well as data-driven services and performance based service models. Read more about the new Metso crushers on our website . Register for the webinar To find out more about the new primary crushers, we invite you to attend the webinar scheduled for June 17, 2026, at 18:00 – 19:30 EEST. You can access the webinar through the registration LINK . Save the date: Metso Summit virtual launch event  A new chapter in minerals processing is about to begin. Join our upcoming Metso Summit virtual launch event on September 10, 2026, to experience our latest revolutionary technologies. Be the first one to discover how these innovations support the entire flowsheet with improved efficiency, sustainability, and customer value. More details will be available soon on our website . Further information:  Vinicius Vilela, Vice President, Mining Crushers, Metso, tel. +1 262 290 7567, email: Vinicius.vilela(at)metso.com  Metso Media Desk, tel. +358 20 482 1930, email: media(at)metso.com Metso is a frontrunner in sustainable technologies, end-to-end solutions and services for the aggregates, minerals processing and metals refining industries globally. We improve our customers’ energy and water efficiency, increase their productivity, and reduce environmental risks with our product and service expertise. We are the partner for positive change.  Metso is headquartered in Espoo, Finland. At the end of 2025 Metso had close to 18,000 employees in around 50 countries, and sales in 2025 were about EUR 5.3 billion. Metso is listed on the Nasdaq Helsinki. metso.com 

EQT Real Estate expands its growing UK logistics footprint with acquisition of six assets across key distribution hubs

EQT Real Estate is pleased to announce that the EQT Real Estate Europe Logistics Value Fund V has acquired a portfolio of six logistics assets totaling approximately 1.6 million square feet across Leamington Spa, Didcot, Peterborough and Kettering from Tritax Big Box REIT plc. The assets are fully leased following completion of the lease at Leamington I and are occupied by a diversified tenant base across e-commerce, logistics, publishing, healthcare and consumer industries. Strategically located near major transport routes including the M40, A14, and A1(M) which connect cities including London, Birmingham and Edinburgh, the properties provide access to key UK population centers and established distribution networks. The portfolio consists of modern Grade A properties featuring high clear heights, large loading yards and strong sustainability credentials, with most assets holding Energy Performance Certificate (EPC) A ratings. The acquisition further expands EQT Real Estate’s UK logistics footprint  and complements its broader European logistics portfolio across key distribution corridors and consumption hubs. The investment aligns with EQT Real Estate’s strategy of investing in high-quality logistics assets in supply-constrained markets that are supported by resilient occupier demand and long-term rental growth potential. Jonathan Mackie, Managing Director at EQT Real Estate, said: “We continue to see attractive long-term opportunities in European logistics, supported by structural trends including the  growth of online retail, supply chain optimization and increasing demand for efficient distribution space close to major population centers. This acquisition expands our growing UK logistics footprint and complements our broader European logistics portfolio across established distribution markets.”  ContactEQT Press Officepress@eqtpartners.com

Alleima responds to growing global demand for nuclear power – inaugurates Tube Mill 2026 in Sandviken

Photo: Alleima, Göran Björkman, CEO and President Alleima on stageThe inauguration of Tube Mill 2026 is a direct response to the growing global interest in nuclear power. The expansion includes the upgrade and reopening of one of Alleima’s production facilities for steam generator tubes. The new facility increases Alleima’s production capacity by approximately 60%, and the order base is solid, extending well into the future. The entire project has been completed according to plan and will be operational during 2026. “The opening of Tube Mill 2026 marks an important milestone for Alleima. By upgrading and reopening our tube mill, we strengthen our ability to meet the growing demand within the nuclear segment, both for conventional nuclear power plants and for small modular reactors. This is a central part of our strategy and demonstrates that we are a leading supplier of high-technology products based on quality, reliability, and long-standing industry experience,” says Göran Björkman, CEO of Alleima. For more than 60 years, Alleima has supplied critical components to the nuclear industry worldwide. The company already has around 300 employees directly involved in its nuclear operations, a number that is now increasing by nearly 100 employees. In addition to conventional nuclear power, the company sees strong potential for SMRs. Recently, major technology companies have also begun to show interest in nuclear power for their data centers driven by the need for large amounts of stable and fossil-free electricity around the clock. Among those present at the event were several key players in the nuclear industry, including Doosan Enerbility, NuScale Power, Rolls-Royce SMR, and Westinghouse. “Today, we have customers from all over the world here in Sandviken. This demonstrates that we have established ourselves as a reliable, stable, and long-term partner, manufacturing world-leading products for extremely demanding environments. Strong and close collaboration with our customers is essential for us, and we are therefore very pleased to celebrate this together,” says Carl von Schantz, President of the Tube Division at Alleima. Alleima supplies fuel cladding tubes, steam generator tubes, and nuclear-grade components, and also conducts research on tubing for future cooling technologies. Sandviken, Sweden, June 3, 2026 Alleima AB (publ) Contact detailsFrida Adrian, Head of Investor Relationsfrida.adrian@alleima.com+46 (0) 70 930 93 24 Yvonne Edenholm, Press and Media Relations Manageryvonne.edenholm@alleima.com+46 (0) 72145 23 42 Related LinksFotos from the event About AlleimaAlleima, is a global manufacturer of high value-added products in advanced stainless steels andspecial alloys as well as solutions for industrial heating. Based on long-term customer partnerships and leading materials technology, we develop products for the most demanding applications and industries. Our offering includes products likeseamless steel tubes for the energy, chemical and aerospace industries, precision strip steel for white goods compressors, air conditioners and knife applications, based on more than 900 active alloy recipes. It also includes ultra-fine wires for medical and micro-electronic devices, industrial electric heating technology and coated strip steel for fuel cell technology for cars, trucks, and hydrogen production. Our fully integrated value chain, from R&D to end-product, ensures industry-leading technology, quality, sustainability, and circularity. Alleima, with headquarter in Sandviken, Sweden, had approximately 6,800 employees and revenues of about 19 billion SEK in about 80 countries in 2025. Alleima is listed on Nasdaq Stockholm under the ticker ‘ALLEI’. Learn more atwww.alleima.com 

Balder’s Norwegian joint venture company Anthon Eiendom has closed the deal with Olav Thon Eiendom AS

In March, Anthon B Nilsen AS and Fastighets AB Balder signed a letter of intent with Olav Thon Eiendom AS regarding the sale of all shares in Anthon Eiendom AS. Today, 3 June, the definitive agreement was signed and, subject to approval of the transaction by the Norwegian Competition Authority, Olav Thon Eiendom will take possession of the properties on 1 July. “Having developed high-quality properties in Oslo and the surrounding areas for more than 25 years, it is reassuring to know that ownership of the properties is now being transferred to a stable and professional owner such as Thon Eiendom. This ensures that the tenants will continue to receive the quality and service that we have always strived to deliver," says Peder Chr. Løvenskiold, CEO and one of the owners of Anthon Eiendom. “We have a clear ambition to further develop Thon as a leading property group in Norway and Scandinavia, and this transaction is fully aligned with our strategy of growing in markets where we see potential for strong long-term value creation. At the same time, it strengthens our position as one of the largest owners of office properties in the Greater Oslo area,” says Annette Hofgaard, Group Chief Real Estate Officer in the Thon Group. The parties' advisers in the transaction were Akershus Eiendom and Haavind for the sellers, while Thommessen and EY acted as advisers to the buyer. For further information, please contact:Annette Hofgaard, Olav Thon Eiendom AS, +47 926 97 630, annette.hofgaard@thon.noPeder Chr. Løvenskiold, Anthon B Nilsen AS, +47 908 60 783, pcl@anthoneiendom.noEva Jonasson, Media relations, Balder, +46 31 10 79 44, eva.jonasson@balder.se 

Volvo Cars reports rolling three-month sales for the period ending May 2026

The company's sales of electrified models – fully electric and plug-in hybrid models – accounted for 48 per cent of all cars sold during the three-month period. Fully electric cars comprised 23 per cent of all cars sold for the period, and plug-in hybrid models accounted for 25 per cent. The automotive industry, including the premium segment, continues to face intensifying headwinds across regions which reflected in the sales performance for the three-month period ending May 2026. Sales in China remain under pressure, as overall industry volumes continue to decline in double-digits for consecutive months. This is due to the highly competitive industry landscape and challenging macro environment. In the US, there are early signs of a recovery for both the industry and Volvo Cars, which is reflected in the gradual improvement in deliveries. However, the overall market still remains impacted by low customer sentiment and subdued demand for fully electric and plug-in hybrid cars post subsidy removal. “Despite all the external challenges, we continue to grow in Europe through electrification,” said Erik Severinson, Chief Commercial Officer at Volvo Cars. “Overall, deliveries of our fully electric cars grew for the eighth consecutive month driven by the strong demand for the EX30 and EX40 electric SUVs in Europe.  We have also seen sustained and strong increase in retail orders for our fully electric models in the region, which further reinforces our strategy to become a leader in premium electrification.” "Additionally, we are excited to receive overwhelmingly positive reviews of our new EX60 fully electric SUV from our customers and the media. Initial customer orders for the car have already surpassed our internal expectations. We are now gearing up to gradually ramp up the production of the car in the second half of the year.” March - May March - May y-o-y 2026 2025 Change (%) Electrified models 85,696 83,216 3% - Fully electric 41,435 37,502 10% - Plug-in hybrid 44,261 45,714 -3%Mild hybrids/ICE 93,284 106,224 -12%Total 178,980 189,440 -5.5%

Changes in UPM’s Group Executive Team: Joonas Rauramo appointed Executive Vice President, UPM Energy

UPM-Kymmene CorporationStock Exchange Release (Changes board/management/auditors)June 3, 2026 at 10:00 EEST Changes in UPM’s Group Executive Team: Joonas Rauramo appointed Executive Vice President, UPM Energy Joonas Rauramo has been appointed Executive Vice President, UPM Energy. He will be a member of UPM’s Group Executive Team and report to Massimo Reynaudo, President and CEO. He will assume his role on October 1, 2026 and will be based in Helsinki, Finland. Rauramo, born in 1983, will join UPM from Coolbrook Oy where he has served as CEO since 2022 and prior to that as Executive Vice President, Strategy & Industrial Partnerships. From 2007 to 2021, he held various roles at Fortum, most recently as Vice President, Wind and as Vice President, Solar & Wind Development. He serves as a board member at Korkia, and as a member of the IEA Technology and Innovation Advisory Board. Rauramo has Master of Science in Technology from Helsinki University of Technology and Master of Science in Economics from Aalto University School of Economics. He is a Finnish citizen. “I’m delighted to welcome Joonas to UPM. He brings extensive experience in power generation and industrial decarbonisation, as well as deep expertise in energy markets, project financing, M&A and building global partnerships. These are capabilities that are increasingly critical as demand for reliable, emission-free electricity continues to grow and the energy system undergoes profound transformation. With Joonas on board, we continue to develop our energy business further and contribute to the transition towards a sustainable and resilient energy future,” says Massimo Reynaudo. UPM, Media relationsMon-Fri 9:00–16:00 EESTtel. +358 40 588 3284media@upm.com UPMUPM is a material solutions company, renewing products and entire value chains with an extensive portfolio of renewable fibres, advanced materials, decarbonization solutions, and communication papers. Our performance in sustainability has been recognized by third parties, including EcoVadis and the Dow Jones Sustainability Indices. We operate globally and employ approximately 15,100 people worldwide, with annual sales of approximately €9.7 billion. Our shares are listed on Nasdaq Helsinki Ltd.UPM – we renew the everydayRead more: upm.com  Follow us onLinkedIn |YouTube |Instagram |#UPM #materialsolutions #WeRenewTheEveryday

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT MAY 2026

Zinzino group revenue increased with a total of 14 %, compared with the previous year. The revenue in May for Zinzino's sales markets increased by 14 % and amounted to SEK 312.2 (273.7) million. Faun Pharma's external sales amounted to SEK 3.9 (3.9) million. Overall, the Group increased revenues by 14 % to SEK 316.1 (277.6) million compared with the previous year. Accumulated revenue for January – May 2026 increased by 23 % to SEK 1,545.9 (1,254.0) million. Revenues were distributed as follows: Regions,MSEK 26-May 25-May Change YTD 2026 YTD 2025 ChangeThe Nordics 26.2 29.5 -11% 129.4 129.8 0%Central Europe 99.2 72.8 36% 464.4 333.9 39%East Europe 30.1 36.3 -17% 141.6 160.6 -12%South & West Europe 51.1 47.6 7% 258.5 216.4 19%The Baltics 9.2 11.3 -19% 48.1 48.6 -1%North America 66.6 46.1 44% 329.3 207.9 58%South America 3.6 0.8 350% 18.7 3.9 379%Asia-Pacific 24.1 27.4 -12% 117.2 118.4 -1%Africa 2.1 1.9 11% 10.5 8.4 25%Zinzino 312.2 273.7 14% 1,517.7 1,227.9 24%Faun Pharma 3.9 3.9 0% 28.2 26.1 8%Zinzino Group 316.1 277.6 14% 1,545.9 1,254.0 23% Countries in regions: -The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden -Central Europe: Austria, Germany, Switzerland -East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania -South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands -The Baltics: Estonia, Latvia, Lithuania -North America: Canada, USA, Mexico -South America: Peru, Colombia -Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea -Africa: South Africa For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, dag@zinzino.com  Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com Pictures for publication free of charge: marketing@zinzino.com Certified Adviser: Tapper Partners AB

Nobia appoints Jesper Gylling Olsen as CEO

Jesper Gylling Olsen is currently Executive Vice President at Nobia for HTH and has been employed by Nobia since 2019. Jesper Gylling Olsen succeeds Kristoffer Ljungfelt, who assumed the role of CEO having previously served as CFO and subsequently EVP for Nobia’s UK region."We are happy that Jesper Gylling Olsen has accepted the role of President and CEO of Nobia. Jesper brings impressive experience from the kitchen industry and has, within Nobia, successfully strengthened one of the Group's most significant businesses, delivering strong financial performance and high operational quality. Jesper will play a central role in the continued work to strengthen Nobia’s Nordic operations and realise the Company's priorities going forward. We also wish to thank Kristoffer for leading Nobia through a challenging period during which we first divested the UK business, and subsequently completed a new rights issue. Through Kristoffer’s efforts, we now have a focused Nordic Nobia ready for its next phase," says Jimmy Renström, Chairman of the Board of Nobia."I am proud and pleased that the Board has given me the opportunity to lead Nobia. Today, we have a clearer position in the Nordic kitchen market, with well-established brands and leading market positions. I have had the privilege of working with one of Nobia’s strong brands and look forward with confidence and great humility to driving the entire Group's continued focus on profitable growth," says Jesper Gylling Olsen, incoming President and CEO of Nobia. Jesper Gylling Olsen is Executive Vice President for HTH, one of Nobia’s strong brands, where he started working for the second time in 2019. During his time with Nobia, Jesper Gylling Olsen has been Head of International Brands (HTH and unoform), VP Director (HTH Kitchen), and Sales Director (HTH Kitchen). Before this, Jesper Gylling Olsen had more than 20 years’ experience from companies in the same market segment, with leading positions at e.g. JKE Design and Multiform/Ballingslöv. This information is information that Nobia is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person above, at 09:30 CET on 3 June 2026.

SSAB expands steel powder production capacity in Oxelösund

Additive manufacturing enables the development of stronger, lighter, and more advanced components, while reducing material waste and shortening lead times. The technology has evolved from primarily being used for prototypes and spare parts to becoming an important complement in industrial production, with increasing demand in sectors such as defense, automotive, and engineering. At the same time, additive manufacturing contributes to greater resilience in society and industry by enabling more flexible and local production, thereby reducing vulnerability in global supply chains. “By increasing SSAB’s manufacturing capabilities, we are strengthening our offering in steel powder for additive manufacturing and making the technology more accessible to our customers. We see growing demand for our powder products, which combine high performance with a lower climate impact throughout the value chain,” says Jesper Vang, Head of Powder Technology at SSAB. SSAB has developed its own high-strength steel powders optimized for additive manufacturing, based on 50 years of experience in high-performance steel products. This enables advanced designs with low weight and high strength. In some applications, steel powder can replace aluminum as a lightweight material. The powders can also be used without subsequent heat treatment, reducing risk, lead times, and costs. The facility is being expanded in cooperation with SMS group, whose technology meets SSAB’s high requirements for manufacturing equipment. Construction is planned to start in 2026, with production starting in the first quarter of 2028. The facility will have a capacity of 350 tonnes per year and employ around 20 people at full production. For further information, please contact:Charlotte Lindevall, Head of External Communications and Brand, charlotte.lindevall@ssab.com, phone: +46 703 44 59 73.

Cold Roads, Hot Marketing: How Iceland’s Clever ‘Hola’ Campaign Became a Global Masterclass in Public Relations

REYKJAVÍK – Infrastructure marketing is notoriously difficult to make exciting. Yet, a brilliant creative initiative out of Iceland has done the unthinkable: it turned pothole complaints into an award-winning, globally discussed marketing phenomenon.  The "¡Hola!" campaign, launched by the road-paving giant Colas Ísland in collaboration with advertising agency Pipar/TBWA, has caught the attention of international marketing circles after completely sweeping Iceland’s prestigious advertising awards (Lúðurinn) and winning Áran—the title for the most effective campaign of the year.  The Icelandic Context: A Brilliant Linguistic Twist Aired across Icelandic television, billboards, and digital media, the campaign capitalized on a genius linguistic coincidence. While the Spanish word "¡Hola!" is a cheerful greeting, phonetically it sounds identical to "hola", the Icelandic word for a pothole. Instead of hiding from public frustration regarding worn-down winter roads, Colas leaned directly into the problem. They introduced the world to Nicolas, a fictional, overly enthusiastic "pothole lover" who traveled across Iceland's rugged road networks, cheerfully saying "hello" (¡Hola!) to every crater he encountered on TV and social media.  Beyond the Screen: Driving Political and Civic Action What started as a humorous broadcast campaign quickly evolved into a massive public engagement project. The initiative featured several highly strategic pillars that turned viral laughs into real-world impact: · The Ruined Roads Guidebook (Ónýtuvegahandbókin): Colas published a comprehensive, tongue-in-cheek guidebook mapping out the worst road damage across the country, effectively pressure-testing local authorities to step up infrastructure budgets. · Interactive Civic Tracking: Icelandic drivers and cyclists were invited to actively participate by reporting road issues, transforming a public nuisance into a proactive community effort. · Humanizing the Crew: The ads cleverly shifted public perspective, turning road maintenance workers from an "inconvenience that causes traffic" into community heroes fixing the infrastructure. Why the International Marketing World is Watching International branding experts are pointing to the Icelandic campaign as a prime example of "flawpop" marketing—taking a company's most glaring industry challenge and turning it into their greatest asset. "Colas Iceland didn't just ask for patience; they created a shared cultural moment out of a universal frustration," noted an international creative director during an ad-industry review. "By using humor and local wordplay, they took the heat off their brand and put the focus on collaborative solutions." With its recent clean sweep at the 2026 Icelandic marketing awards, the "¡Hola!" campaign has proven that even the most mundane industries can achieve international creative acclaim. It stands as a reminder to companies worldwide that sometimes, the best way to fix a problem is to look it in the face and simply say hello. 

KONE Corporation’s Extraordinary General Meeting has approved the proposed resolutions related to the TK Elevator transaction

KONE Corporation, stock exchange release, June 3, 2026 at 11:45 a.m. EEST KONE Corporation’s Extraordinary General Meeting has approved the proposed resolutions related to the TK Elevator transaction KONE Corporation's Extraordinary General Meeting was held in Helsinki on June 3, 2026. The General Meeting approved the proposed resolutions related to the Transaction: an authorization to issue class B shares and the election of two new members to the Board of Directors. KONE Corporation ("KONE") announced on April 29, 2026 that KONE and Vertical Topco I S.A. (the "Seller") have entered into a share purchase agreement (the "Share Purchase Agreement"), pursuant to which KONE would acquire the entire issued share capital of Vertical Topco II S.A., which holds all of the assets of TK Elevator Group and is a wholly-owned direct subsidiary of the Seller (the "Transaction"). The rationale, details and terms of the Transaction are described in the stock exchange release concerning the Transaction published on April 29, 2026. Pursuant to the Share Purchase Agreement, the consideration to be paid by KONE to the Seller upon completion of the Transaction would consist of a combination of EUR 5 billion in cash (the "Cash Consideration") and a maximum share consideration of 270 million newly issued KONE class B shares (the "Share Consideration") as further described in the Transaction announcement of 29 April 2026. Both the Cash Consideration and the Share Consideration are subject to adjustments and will be finally determined in connection with completion of the Transaction, which is currently expected to take place at the earliest during the second quarter of 2027. Completion of the Transaction is subject to all conditions to completion under the Share Purchase Agreement and on the regulatory conditions to completion of the Transaction having been satisfied or waived. According to the Share Purchase Agreement, the Seller is from the date of completion of the Transaction entitled to appoint two of the members of the Board of Directors of KONE, one of whom would serve as co-vice chair. The Seller's board nomination right reduces to one director upon the ownership of the Seller in KONE, together with certain of its affiliates and direct and indirect shareholders, afforded by the class B shares received as Share Consideration as set out in the Share Purchase Agreement, falling below 15 per cent of the total shares in KONE, and terminates upon the ownership of the Seller in KONE, together with certain of its affiliates and direct and indirect shareholders, as set out in the Share Purchase Agreement, falling below 10 per cent of the total shares in KONE. Resolutions of the Extraordinary General Meeting on June 3, 2026 KONE Corporation’s General Meeting approved all resolutions as proposed in relation to the Transaction. The General Meeting authorized, in accordance with the proposal, the Board of Directors to resolve, on one or several occasions, upon the issuance of up to a maximum of 270,000,000 new class B shares in KONE in deviation from the shareholders' pre-emptive rights (directed share issue). The authorization may be used only for the issuance of the Share Consideration to the Seller in connection with the conveyance of all the shares in Vertical Topco II S.A. to KONE against the Share Consideration and the Cash Consideration, pursuant to the terms of the Share Purchase Agreement. The Board of Directors was authorized to decide on all other terms relating to the issuance of new class B shares in KONE pursuant to the authorization, including the issuance of class B shares against consideration in kind or set-off. The authorization is valid until June 3, 2031 and the authorization does not revoke the authorization to resolve upon a share issue granted to the Board of Directors by the Annual General Meeting held on March 5, 2026. Furthermore, as proposed, the General Meeting resolved to increase the number of members of the Board of Directors of KONE to ten (10), and elected Ranjan Sen and Bruno Schick as new members of the Board of Directors. The resolutions regarding increasing the number of members of the Board of Directors and election of the new members to the Board of Directors are conditional upon the completion of the Transaction, i.e., the resolutions will enter into force on the date on which completion of the Transaction occurs. The current eight (8) members of the Board of Directors elected by the Annual General Meeting on 5 March 2026, Banmali Agrawala, Matti Alahuhta, Susan Duinhoven, Marika Fredriksson, Anna Herlin, Antti Herlin, Jussi Herlin, and Timo Ihamuotila will continue in their positions until the conclusion of the next annual general meeting. For further information, please contact:Natalia Valtasaari, Head of Investor Relations, tel. +358 204 75 4705 Sender: KONE Corporation Niina VilskeSecretary to the Board Ilkka HaraCFO About KONE At KONE, our purpose is to shape the future of cities. As a global leader in the elevator and escalator industry, we move two billion people every day, making their journeys safe, convenient, and reliable with smart and sustainable People Flow®. In 2025, KONE had annual sales of EUR 11.2 billion, and at the end of the year over 60,000 employees in close to 70 countries. KONE class B shares are listed on the Nasdaq Helsinki Ltd. in Finland. www.kone.com

Fiskars Corporation increases bond maturing in 2028 by EUR 50 million

Fiskars CorporationStock Exchange ReleaseJune 3, 2026 at 12.30 p.m. EEST Fiskars Corporation increases bond maturing in 2028 by EUR 50 million On June 10, 2026, Fiskars Corporation will issue notes in an amount of EUR 50 million as a private placement (the "Notes") by way of a tap issue to its existing notes. The Notes will be further notes to its existing EUR 200 million 5.125 per cent senior unsecured sustainability-linked notes maturing in 2028 with ISIN FI4000561949. The issue price of the Notes is 101.611%. The proceeds from the issue of the Notes will be used to refinance existing indebtedness, balance the debt portfolio and for general corporate purposes. OP Corporate Bank plc acted as sole lead manager in the issue of the Notes. FISKARS CORPORATION Further information:Kaisa Vuorinen, VP, Group Treasury and Risk Management, tel. +358 50 327 9095 Fiskars Group in brief Fiskars Group (FSKRS, Nasdaq Helsinki) is the global home of design-driven brands for indoor and outdoor living. Since 1649, we have designed products of timeless, purposeful, and functional beauty, while driving innovation and sustainable growth. In 2025, Fiskars Group’s global net sales were EUR 1.1 billion, and we had approximately 6,600 employees. We have two Business Areas (BA), Vita and Fiskars. BA Vita offers products in the high-end homeware segment as well as fine branded jewelry. Its desirable brands include Georg Jensen, Royal Copenhagen, Wedgwood, Moomin Arabia, Iittala and Waterford. In 2025, BA Vita’s reported net sales were EUR 613 million, and it had approximately 5,000 employees. BA Fiskars offers functional innovations in the gardening and outdoor categories, in addition to the scissors and creating, as well as cooking categories. The brands include Fiskars and Gerber. In 2025, BA Fiskars’ net sales were EUR 522 million, and it had approximately 1,300 employees. Read more: fiskarsgroup.com Disclaimer The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into any such country or jurisdiction or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, any securities or other financial instruments in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. This communication does not constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the U.S. Securities Act of 1933 (the “Securities Act”), or under the securities laws of any state or other jurisdiction of the United States. The Notes may not be offered, sold, pledged or otherwise transferred directly or indirectly within the United States or to, or for the account or benefit of, U.S. Persons (as such term is defined in Regulation S under the Securities Act).

Corem achieves full letting at 1245 Broadway in New York – and repays construction loan

[1245 Broadway-kombinerad.jpg] Corem has now signed lease contracts for all spaces in the project property at 1245 Broadway in New York. The property is therefore fully leased. The final floor, comprising approximately 770 square meters, has been leased to an existing tenant in the building, which thereby expands its premises to a total of 2,140 square meters under a new five-year lease. The total annual contractual rental value for the property now amounts to approximately USD 20 million, and the occupancy rate stands at 100 percent. In connection with the completion of the project and the finalization of leasing, Corem has also fully repaid the construction loan of approximately USD 78.5 millon, that financed the development of the property. 1245 Broadway is an office property comprising approximately 17,500 square meters of leasable space, spread across 23 floors, located at the corner of Broadway and 31st Street in New York. The building is LEED Gold certified and offers modern office space with a high technical standard, including advanced solutions for air quality and touchless systems. The property was designed by Skidmore, Owings & Merrill and developed in collaboration with GDS Development Management (GDSNY). "We are very pleased to have now fully leased 1245 Broadway. It confirms the strength of the location, the quality of the product, and the demand for modern, sustainable office environments. At the same time, being able to repay the construction loan - which has been our most expensive loan in the portfolio - is an important milestone that further strengthens our financial position," says Sebastian Schlasberg, CEO of Property Operations at Corem. Corem Property Group AB (publ)FOR FURTHER INFORMATION, PLEASE CONTACTSebastian Schlasberg, CEO of Property Operations, +46 70 923 90 19, sebastian.schlasberg@corem.seEmelie Mörndal, Head of US operations, +46 10 482 70 38, emelie.morndal@corem.seCorem Property Group AB (publ)Address: P.O. Box 56085, SE-102 17 StockholmVisitors: Riddargatan 13 CReg.no: 556463-9440www.corem.se This press release is in all respects a translation of the Swedish original press release. In the event of any discrepancies between this translation and the Swedish original, the latter shall prevail.

Wärtsilä secures extensive U.S. power plant order and service agreement, showcasing end-to-end project expertise

Technology group Wärtsilä has secured a contract for 452 MW of power generation equipment and a long-term Operation and Maintenance (O&M) agreement with the Pecos Power Plant, owned by Mercuria Americas and Continental Resources. This milestone project, located in Pecos, Texas, USA, is designed to deliver flexible generation to maintain grid reliability in a power system with rapidly growing renewable penetration. Wärtsilä booked an initial order for 226MW in Q1 2025, increased the order by 226MW in Q3 2025, and the O&M agreement was signed in Q4 2025. The Pecos Power Plant, developed by Peak Reliability (a Mercuria Company) in partnership with Wärtsilä, combines proven development expertise with advanced power generation technology to deliver reliable and efficient energy to West Texas. The facility consists of 24 Wärtsilä 1850SG reciprocating engines that help meet the region’s growing electricity demand. Overall, the project highlights Wärtsilä’s capability in delivering comprehensive power plant solutions and underscores the company’s growing role as a lifecycle partner for large-scale independent power producers. “The flexibility of Wärtsilä’s technology will allow us to maximize our operational efficiency in an increasingly volatile power market. This further allows us to reliably serve our customers when they need power most. The region is experiencing record-breaking demand for electricity, and this project will play an important role in meeting this demand,” says Martin Parizek, Managing Director of Peak Reliability. The development effort led by the Peak Reliability team in strong collaboration with the Project Development team of Wärtsilä played a pivotal role in enabling the project to deliver power to the grid quickly. This natural gas plant will bring critical dispatchable energy generation to an area of ERCOT (Electric Reliability Council of Texas) that is situated in one of the world's largest pools of renewable energy. In addition to enhancing the reliability of the ERCOT grid, the power plant will also support west Texas industries and businesses through low cost, efficient, reliable power.   "Wärtsilä understands the pressing need to meet growing power demand with solutions that support energy supply, reliability and sustainability. By supporting delivery of end-to-end power supply projects from concept to execution, Wärtsilä is driving customer efficiency by reducing risks and time to market. Furthermore, our world-class expertise in operating and maintaining plants allows customers to focus on their core business, while we ensure optimal performance,” comments Risto Paldanius, Vice President, Americas at Wärtsilä Energy. The Operation and Maintenance agreement covers the full buildout of the project, forming a significant O&M power plant project for Wärtsilä Energy.  With this agreement, Wärtsilä will be responsible for ensuring the long-term performance, availability and reliability of the plant, supporting secure power supply in the ERCOT system.  The plant is expected to commence commercial operations in 2027. Media contact for more information on this release: Katri PehkonenCommunications ManagerWärtsilä EnergyMob: +358 50 591 6180katri.pehkonen@wartsila.com Image caption: Wärtsilä has secured a contract for 452 MW of power generation equipment and a long-term Operation and Maintenance agreement with the Pecos Power Plant, owned by Mercuria Americas and Continental Resources. © Wärtsilä Corporation All Wärtsilä releases are available at www.wartsila.com/media/news-releases and at news.cision.com/wartsila-corporation where also the images can be downloaded. Use of the image(s) is allowed only in connection with the contents of this press release. Wärtsilä images are available at www.wartsila.com/media/image-bank. Wärtsilä Energy in briefWärtsilä Energy is at the forefront of the transition towards a 100% renewable energy future. We help our customers and the power sector to accelerate their decarbonisation journeys through our market-leading technologies and power system expertise. Our solutions include flexible engine power plants, energy storage and optimisation technology, and services for the whole lifecycle of our installations. Our engines are future-proof and can run on sustainable fuels. Our track record comprises 81 GW of power plant capacity and over 130 energy storage installations in 180 countries around the world. About 35% of our operating installed base is under service agreements.www.wartsila.com/energy Wärtsilä in briefWärtsilä is a global leader in innovative technologies and lifecycle solutions for the marine and energy industries. We emphasise innovation in sustainable technology and services to help our customers continuously improve environmental and economic performance. Our dedicated and passionate team of 17,900 professionals in 199 locations in 78 countries shape the decarbonisation transformation of our industries across the globe. In 2025, Wärtsilä’s net sales totalled EUR 6.9 billion. Wärtsilä is listed on Nasdaq Helsinki.www.wartsila.com

Lundbeck Partners with Cradle to Discover and Optimize Brain Disorder Treatments

VALBY, Denmark & AMSTERDAM, 03 June 2026 – H. Lundbeck A/S (Lundbeck), a global biopharmaceutical company focused exclusively on brain health, and Cradle, a leading AI platform for protein engineering, today announced a partnership to help Lundbeck discover and optimize biotherapeutics that ultimately can improve patient outcomes. It is estimated that more than half of the world’s population is impacted by brain disorders, and the effects are felt throughout society. Speeding up innovation time to develop high-quality biologics is a critical part of bringing effective new treatments to patients. As part of its aim to ease this burden and bring new treatments to patients in need, Lundbeck is deploying Cradle’s AI-powered protein design platform to develop multiple higher-performing candidates that can accelerate breakthroughs for neurological conditions. "Lundbeck is committed to becoming a bionic company, embedding AI into how we work to complement human expertise and bring faster results," said Tarek Samad, SVP, Global Head of Research and Corporate Patents at Lundbeck. "Our partnership with Cradle fits perfectly with this commitment as their platform provides our scientists with powerful AI that fits seamlessly into our processes, strengthening our ability to discover and optimize therapeutics.” The partnership is powering Lundbeck's first end-to-end AI-guided protein engineering workflow, where experimental results are continuously fed back into the model, enabling each iteration to improve prediction accuracy and accelerate convergence toward viable candidates. The platform will initially be used to advance two antibody programs targeting CNS diseases. Lundbeck's protein engineers and computational biologists will use Cradle's generative AI platform to engineer higher-quality antibody candidates while reducing the number of wet-lab iterations required to reach lead candidates. "Lundbeck has a strong biotherapeutic pipeline in CNS and is now strengthening that position with the power of AI across their research and development organization," said Stef van Grieken, CEO and Co-Founder of Cradle. "The Cradle platform has been shown in internal and partner programs to accelerate design cycles significantly. By closing the loop between computation and the lab, we can help Lundbeck reach high-quality antibody candidates faster and with fewer iterations.” The Cradle partnership builds on Lundbeck’s systematic embrace of AI to accelerate its Focused Innovator strategy. It complements a recently announced partnership with the Danish Centre for AI Innovation, which provides Lundbeck access to Denmark's Gefion AI supercomputer with advanced AI computing power for large-scale scientific modelling and discovery. Together, the two partnerships will strengthen Lundbeck’s end-to-end AI discovery capabilities, from expanding the scientific search space to improving and accelerating specific biologic candidates. Across the organization, Lundbeck estimates AI-driven initiatives are already contributing more than 12,000 hours saved per week through efficiency gains. In drug discovery specifically, AI-enabled structural insights and predictions that once took months can now be generated in under 24 hours, while expanding the searchable scientific space by approximately 50,000x.  About H. Lundbeck A/S Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments. As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole. Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com  and connect with us via LinkedIn . Contacts     Anders Crillesen Jens HøyerSenior Director, Corp. Communication Vice President, Head of Investor RelationsAECE@lundbeck.com JSHR@lundbeck.com+45 27 79 12 86 +45 30 83 45 01   About Cradle Cradle’s mission is to make engineering biology easier, quicker and more cost-effective. Its enterprise-grade AI software platform currently serves eight out of the top 25 global pharma companies, and is used across over 50 R&D programs. With Cradle, scientists can engineer better proteins, faster and more successfully, speeding up the development cycle of new therapeutics and bio-based products such as, antibodies, enzymes, and bio-based materials by 2-12x. Cradle is based in Amsterdam, The Netherlands; Zurich, Switzerland and the United States with a team of machine learning and biotech research specialists with experience at many of the world’s leading technology and biotech companies, including Google, Novartis, Meta, Zymergen, Uber, Deepmind and Generate Biomedicines. Cradle is backed by IVP as well as Index Ventures and Kindred Capital. For more information, visit cradle.bio . Contacts     press@cradle.bio 

Zinzino AB (publ.): 250 International chefs and sommeliers recognize Zinzino’s BalanceOil+ with 2026 Superior Taste Award

Award-winning omega-3 supplement earns international recognition for taste in one of the world's most respected blind sensory evaluations More than 250 internationally renowned chefs and sommeliers have evaluated thousands of products from over 100 countries in one of the world's most respected blind tasting competitions. Among the recipients of the 2026 Superior Taste Award is BalanceOil+ Orange Lemon Mint, Zinzino's flagship omega-3 supplement. Presented by the International Taste Institute in Brussels, the Superior Taste Award is widely regarded as one of the food and beverage industry’s most respected certifications for taste and sensory quality. Products are evaluated anonymously through a rigorous, blind-tasting process by an independent jury that includes Michelin-starred chefs, award-winning sommeliers, and leading culinary experts from around the world. For Zinzino, the recognition is particularly significant because taste remains one of the biggest challenges within the omega-3 category. “Consumers increasingly understand the importance of omega-3 nutrition, but taste continues to be a critical factor in long-term product use,” said Emmalee Gisslevik, Senior Research & Development Specialist at Zinzino. “Receiving this recognition from an independent international jury of chefs and sommeliers validates our commitment to combining scientific excellence with an enjoyable consumer experience.” “Consumers today expect more from nutrition than ever before. They are looking for solutions that are personalized, scientifically grounded, and enjoyable to use every day,” said Chief Marketing Officer Gabriele Helmer. “Operating in more than 100 markets worldwide, Zinzino has helped pioneer the field of test-based personalized nutrition. This international recognition reinforces our belief that scientific innovation, premium quality, and an exceptional consumer experience will define the next generation of personalized nutrition.” Where science meets consumer experience As the global nutritional supplement market continues to evolve, consumer expectations are changing. Today’s consumers are looking not only for scientifically developed products and premium ingredients, but also for products they enjoy incorporating into their daily routines. Industry experts increasingly recognize consumer experience as an important factor in long-term product usage. Products that successfully combine nutritional value with consumer enjoyment are becoming increasingly important across the wellness and nutrition sectors. BalanceOil+ Orange Lemon Mint was developed to meet these expectations through a unique combination of sustainably sourced fish oil, extra virgin olive oil, and vitamin D. The formulation delivers high levels of EPA and DHA while providing a fresh citrus flavor profile, designed for everyday use. Continued recognition for product excellence The 2026 Superior Taste Award marks the second consecutive year that products from Zinzino’s BalanceOil family have been recognized by the International Taste Institute. In 2025, both BalanceOil+ Premium and BalanceOil Tutti Frutti received Superior Taste Awards, further reinforcing the consistent sensory quality across the product range. The latest recognition reflects Zinzino’s continued focus on combining scientific innovation, product quality, and consumer experience within the growing personalized nutrition market. About the Superior Taste Award Presented by the International Taste Institute in Brussels, Belgium, the Superior Taste Award is one of the world’s leading certifications dedicated exclusively to taste evaluation. Since 2005, the Institute has assessed thousands of products from more than 100 countries through independent blind sensory evaluations. In 2024 alone, more than 2,600 products received Superior Taste Awards after rigorous judging. Products are evaluated on criteria including first impression, aroma, taste, texture, and overall sensory experience. Only products achieving high overall sensory scores receive certification. About Zinzino Zinzino is a global direct sales company based in Scandinavia and a pioneer in test-based, personalized nutrition. Operating in more than 100 markets worldwide, the company develops, markets, and sells scientifically based nutritional supplements, skincare, and lifestyle products designed to help individuals better understand and optimize their nutritional habits through personalized nutrition solutions. For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, dag@zinzino.com  Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com Pictures for publication free of charge: marketing@zinzino.com Certified Adviser: Tapper Partners AB

Hemsö acquires district court in Hamburg

The district court building was completed in 1878 and has been used continuously as a courthouse ever since. The property has been listed as a protected historic building since 1981 and has undergone ongoing renovations through to 2026. The court handles a broad range of cases within its jurisdiction, including civil and criminal matters, family and youth cases, as well as general legal and administrative proceedings. “Over the past 15 years, Hemsö has built a high-quality portfolio of social infrastructure properties in Germany. At the same time, we have expanded our portfolio within both the education and justice sectors. In the Hamburg acquisition, we were able to leverage our strong balance sheet and high level of transaction certainty. We look forward to the partnership with our tenant,” says Jens Nagel, Head of Region Germany at Hemsö. Hamburg has a population of approximately two million people, while around five million people live in the wider metropolitan region. The acquisition of the district court, Hemsö’s first property in Hamburg, further strengthens the company’s German portfolio within the justice sector. Hemsö already owns five police properties in Germany. For more information, please contact: Jens Nagel, Head of Region Germany                                       +46 8-501 170 70Åsa Thoft, Head of Communications                                         +46 8-501 170 57

Crunchfish CEO to Speak at Digital Euro Association Webinar

More than 30 years ago, the internet achieved communication resilience through decentralization and packetized communications. Payments and most digital applications still depend on continuous access to authorization, infrastructure and centralized systems. Offline payments provide a unique lens through which to explore a broader architectural transition toward survivable digital systems. The session will explore a fundamental question facing digital systems: How can digital applications remain functional and trustworthy even when the underlying system itself is unavailable? The webinar will be structured around three complementary discussions: 1. Resilient Digital Money and Institutional Alignment The first part will examine the three fundamentally different approaches to offline payments: •         Immediate offline payments (portable money) •         Deferred offline payments (portable risk) •         Governed offline payments (portable authorization) •         Where do money and risk reside? •         Institutional Alignment: Bankable, Implementable, Governed The discussion will focus on why different offline architectures produce very different institutional outcomes for central banks, system operators, banks, and wallets. 2. Trust, Authorization and Governed Execution The second part will explore how survivability can be achieved while maintaining governance and settlement integrity. Topics include: •         Reservation-backed governed execution •         Portable authorization •         Trusted sessions and trusted intent •         The role of authorization in resilient digital systems •         Why governance, not survivability, is the key design challenge 3. Industry Trends: Agentic AI, Interoperability and Programmable Money The final section broadens the discussion beyond offline payments. Emerging developments such as: •         Agentic AI payments •         Programmable money •         Interoperability •         CBDC initiatives •         India’s payments architecture all point toward a future where authorization may become increasingly portable while execution remains centrally governed. Joachim Samuelsson, CEO of Crunchfish, commented: “Offline payments are often viewed as a niche payments problem. I believe they are much more than that. They provide a glimpse into how digital systems can remain trustworthy and operational even when parts of the underlying infrastructure become unavailable. The same principles are beginning to emerge in areas such as agentic AI, programmable money and interoperable digital ecosystems.” The webinar is hosted by the Digital Euro Association and moderated by DEA Executive Director Tamara Ferreira Schmidt. It will be possible to ask questions during the webinar. Registration is free and open to all: Date: 9 June 2026 Time: 17:00–18:00 CEST Online Event Free Registration: https://luma.com/c7rseywq For more information, please contact: Joachim Samuelsson, CEO of Crunchfish AB +46708 46 47 88 joachim.samuelsson@crunchfish.com This information was provided by the above for publication on June 3rd, 2026, at 14:30 CEST. Västra Hamnen Corporate Finance AB is the Certified Adviser. Email: ca@vhcorp.se. Telephone +46 40 200250. About Crunchfish –crunchfish.com  Crunchfish is a deep fintech company developing governed offline payments technology for payment systems, banks, and payment applications. The company enables offline payments as a Layer-2 solution on top of existing payment systems, allowing transactions to be executed without connectivity while ledger authority and settlement remain unchanged. Through a reservation-based model, resilience is achieved without creating parallel forms of money or unmanaged credit risk. Crunchfish’s architecture is patented and enables interoperability across multiple payment systems and markets. The solution strengthens system stability while also supporting economic incentives by ensuring that liquidity backing offline payments remains within the regulated financial system.

Smoltek sees opportunities in Japan’s big investments in semiconductors for AI and High-Performance Computing

Japan has launched an ambitious strategy to re-industrialize its semiconductor industry, supported by major government funding, strategic industrial policy, and global technology partnerships. The Japanese government has committed over JPY 3.9 trillion (≈ EUR 24–26 billion) in direct subsidies and support measures for semiconductor manufacturing, R&D, and ecosystem development through the late 2020s. Japan has several companies, such as Kyocera-AVX, Murata, Taiyo Yuden, TDK, that have global ambitions and investment plans.   For Smoltek Semi, this is a strong commercial opportunity. Japanese companies are now investing in new capacity and technologies to secure materials and supply chain capacity needed for next-generation logic, AI, and advanced packaging, and Smoltek’s CNF-MIM capacitor technology fits directly into that need. “Smoltek Semi has had dialogues with several Japanese semiconductor companies and capacitor manufacturers in recent years. We have also had technology evaluation agreements with a large Japanese capacitor manufacturer. With the renewed contract with Business Sweden, we can reconnect with leading Japanese technology companies,” explains Magnus Andersson, President of Smoltek Semi. Smoltek Semi sees the Japanese market as an opportunity to close technology agreements with companies seeking differentiated capacitor technology for future semiconductor platforms. Japan has long held global strength in semiconductor materials, equipment, and precision manufacturing, and the current industrial policy push creates new momentum for companies that can add value to this ecosystem. Smoltek’s technology may therefore become a useful enabler for Japanese players aiming to strengthen competitiveness in AI, advanced packaging, and high-performance computing applications. “Smoltek Semi’s engagement in Japan reflects the company’s ambition to bring disruptive capacitor technology to one of the world’s most strategically important semiconductor markets,” Magnus Andersson elaborates.

Veidekke: Acquires Danish technical installation company

The acquisition supports Hoffmann’s strategy of strengthening its expertise in technical building installations – an area of increasing customer demand and important for the execution of Hoffmann’s projects – through targeted acquisitions of smaller companies. – We are very pleased to bring the business of Installatøren A/S into Hoffmann. Installatøren is a highly professional company that will further strengthen an already well-functioning organisation, says Torben Bjørk Nielsen, Managing Director of Hoffmann. As a long-standing partner, Installatøren A/S is already well acquainted with Hoffmann’s solution-oriented approach and model for early contractor involvement with customers, making the companies a strong strategic and operational fit. Both companies are also based in Glostrup outside Copenhagen. For more information, contact: Jørgen Wiese Porsmyr, EVP/CFO Veidekke ASA, +47 907 59 058 Veidekk press photos Subscribe to notices from Veidekke  Veidekke is one of Scandinavia's largest contractors. In addition to undertaking all types of building and civil engineering assignments, the group also maintains roads and produces asphalt and aggregates. Veidekke emphasises stakeholder involvement and local experience. Its annual turnover is approximately NOK 43 billion, and half of its 8,000 employees own shares in the company. Veidekke is listed on the Oslo Stock Exchange, and has posted a profit every year since its inception in 1936.

OssDsign Catalyst® outperforms earlier-generation bone graft as a standalone treatment in trauma study

In the study, published in JBMR, researchers compared the bone healing response of two synthetic bone graft materials – one with a nano-scale structure (OssDsign Catalyst) and one with a micron-sized structure typical of earlier-generation grafts. The materials were implanted into critical-sized bone defects in the knee joints of rabbits and evaluated at 4, 8, 12 and 26 weeks. OssDsign Catalyst achieved full healing of the defect at the earliest timepoint of 4 weeks, as opposed to the earlier-generation graft which took twice as long. OssDsign Catalyst also showed continuous, progressive biological resorption and replacement with host bone throughout the study, with graft material decreasing by 60% over 26 weeks. In contrast, the earlier-generation graft showed minimal remodeling, remaining largely unchanged from week four onwards. Importantly, the coupled remodeling of OssDsign Catalyst was not only visible in histology but supported by statistically significant quantitative data — providing strong scientific evidence for one of the key advantages of fourth-generation synthetic bone grafts. "While many earlier-generation synthetic grafts have failed to match traditional bone graft options in clinical outcomes, OssDsign Catalyst is now closing that gap. Preclinical research remains essential to deepen understanding and strengthen the scientific foundation for clinical adoption, and we are pleased to see these standalone results published in one of the leading journals in our field," comments Mark Waugh, CEO of OssDsign. The study is published in the latest issue of The Journal of Bone and Mineral Research and is accessible here: https://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.b.70103

Paradox Interactive’s shares have been approved for admission to trading on Nasdaq Stockholm

Nasdaq Stockholm’s Listing Committee has today approved the application by Paradox Interactive AB (publ) (“Paradox” or the “Company”) for admission of the Company’s shares to trading on Nasdaq Stockholm Main Market. The approval is conditional upon the fulfilment of customary conditions, including that a prospectus is approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The first day of trading on Nasdaq Stockholm is planned for Tuesday, 9 June 2026. In connection with the listing on Nasdaq Stockholm Main Market, the Company’s shares will be delisted from Nasdaq First North Growth Market and the expected last day of trading on Nasdaq First North Growth Market is Monday, 8 June 2026. “Being admitted to Nasdaq Stockholm's Main Market is a natural next step. It is a validation of the fantastic company that so many people have helped build. The move strengthens our position and gives additional momentum to our long-term efforts to build one of the world's leading developers and publishers of strategy and management games. We hope that our players, employees, and everyone interested in our future will continue to be part of this journey,” says Fredrik Wester, CEO of Paradox. There will be no offering or issuance of new shares in connection with the admission of the Company’s shares to trading on Nasdaq Stockholm Main Market. The shares will retain their ticker symbol (PDX) as well as ISIN code (SE0008294953). Shareholders of Paradox do not need to take any action in connection with the admission to trading on Nasdaq Stockholm. For complete information regarding the admission to trading on Nasdaq Stockholm, reference is made to the prospectus that will be published (in Swedish only) in connection with the listing, which is expected to be approved by the Swedish Financial Supervisory Authority and published on the Company’s website (www.paradoxinteractive.com) around 5 June 2026. Legal adviserGernandt & Danielsson is the Company’s legal adviser in relation to the listing on Nasdaq Stockholm.

ATP and EQT Announce Global Partnership

The ATP has signed a multi-year partnership with leading global investment organisation EQT, which will be the first official private markets partner of the ATP Tour through 2030. As a governing body of men's professional tennis, ATP stages premier tournaments across six continents and showcases the world’s greatest players. This represents EQT’s first-ever global sports sponsorship at a pivotal time in the firm’s growth. As EQT adds new strategies and products, enters new markets, and broadens access to private markets, building global brand recognition is becoming increasingly critical. This partnership provides access to a global platform across major markets with a broad, high-value audience. The partnership with the ATP coincides with EQT’s global brand relaunch, “Better Never Ends”, linking its belief in continuous improvement with the pursuit of progress at the heart of professional tennis. The agreement supports the ATP’s strategy to build deeper, multi-market partnerships that drive growth and deliver value across the Tour. A dedicated activation programme will create opportunities for players to participate in partner-led moments, while integrating some of the sport’s leading athletes into EQT’s brand campaigns. As a Platinum Partner, EQT will activate across ATP Masters 1000, ATP 500 and ATP 250 tournaments throughout the season, connecting with a global audience of more than one billion fans. The partnership includes prominent brand visibility, alongside access to premium hospitality and stakeholder engagement opportunities across key international markets. Per Franzen, EQT’s Managing Partner & CEO, said: "An ever-larger share of value creation in the global economy is happening in private markets, and individual investors want access to that opportunity. As the largest private markets firm outside the U.S., EQT has both the scale and responsibility to help make that a reality. That is why we decided to partner with the ATP, which has the right platform to build EQT's brand recognition among our target audiences around the world. We are proud to partner with an organization that, like EQT, is defined by long-term thinking, high performance, and a truly global ambition." Andrea Gaudenzi, ATP Chairman, said: “The scale of this partnership and its global footprint reflect EQT’s commitment to the ATP Tour. It’s an exciting moment for both organisations and another step in our focus on working with brands that share our values and are invested in the long-term future of tennis. EQT is a natural fit, with a shared emphasis on long-term performance, active growth and sustainable value creation for players, fans and commercial partners.” The announcement builds on a period of record sponsorship growth for the ATP, underlining the strength of the Tour as a premium platform for brand visibility, business engagement and international expansion. ContactEQT Press Office, press@eqtpartners.com

Acting CEO and CFO Sophie Reinius is leaving Formpipe (Lasernet) for a new assignment

Sophie Reinius has been with Formpipe since 2024, and during her time at the company has played a central role in developing its financial governance, as well as contributing to strengthening the organization’s operational and strategic capacity through the divestment of the Public business area and the streamlining of operations into the Lasernet Group. She was appointed Acting Chief Executive Officer on January 1, 2026, a role she has held in parallel with her position as CFO. “The Board would like to extend its sincere thanks to Sophie for her significant contributions and commitment to Formpipe. She has helped create profitable stability and a strong foundation for the company’s continued development as a focused SaaS company,” says Chairman of the Board Annikki Schaeferdiek. “It has been a privilege to work with Formpipe’s employees and contribute to the company’s development. I am proud of what we have achieved and look forward to taking the next step in my career,” says Sophie Reinius. Sophie Reinius will remain in her role until a successor takes office, but no later than November 2026. The process of appointing a permanent CEO is ongoing, and a process to recruit a new CFO will be initiated. Formpipe thanks Sophie for her valuable contributions and wishes her every success in her future career. As previously communicated, the legal entity will remain Formpipe Software AB for the time being, until completion of the redemption programme. Thereafter, the legal name will formally be changed to Lasernet Group AB. Formpipe Software AB is a public company listed on Nasdaq Stockholm.

Notice of Telia Company’s Extraordinary General Meeting 2026

The shareholders of Telia Company AB (publ), reg. no. 556103-4249, are hereby given notice of the Extraordinary General Meeting to be held on Thursday, July 2, 2026, at 10.00 a.m. CEST at Telia Company's head office, Stjärntorget 1 in Solna, Sweden. Registration for the Extraordinary General Meeting will commence at 9.00 a.m. CEST on the same day. The shareholders may also exercise their voting rights at the Extraordinary General Meeting by postal voting in accordance with the provisions of Telia Company's Articles of Association. Participation Shareholders who wish to participate in the Extraordinary General Meeting must: · be recorded as a shareholder in the presentation of the share register prepared by the Swedish Central Securities Depository Euroclear Sweden AB concerning the circumstances on Wednesday, June 24, 2026, and · give notice of participation no later than Friday, June 26, 2026. Participation at the meeting venue Shareholders who wish to attend the meeting venue in person or by proxy must give notice of participation no later than Friday, June 26, 2026, on Euroclear Sweden AB's website https://www.euroclear.com/sweden/generalmeetings/, by telephone +46 (0) 8 402 90 50, or by post to Telia Company AB, "Telia Company EGM 2026", c/o Euroclear Sweden AB, P.O. Box 191, SE-101 23 Stockholm, Sweden. Shareholders shall, in their notice of participation, state their name, personal identification number or company registration number, address, telephone number and advisors, if applicable. Shareholders represented by a proxy or a representative should send documents of authorization to the address above well in advance of the Extraordinary General Meeting. A template proxy form is available on Telia Company's website www.teliacompany.com. Participation by postal voting Shareholders who wish to participate in the Extraordinary General Meeting by postal voting in advance must give notice of participation by casting their postal vote so that the postal vote is received by Euroclear Sweden AB (administering the forms on behalf of Telia Company) no later than Friday, June 26, 2026. A special form shall be used for postal voting. The postal voting form is available on Telia Company's website www.teliacompany.com. The postal voting form can be submitted either by e-mail to GeneralMeetingService@euroclear.com or by post to Telia Company AB, "Telia Company EGM 2026", c/o Euroclear Sweden AB, P.O. Box 191, SE-101 23 Stockholm, Sweden. Shareholders may also cast their postal votes electronically through BankID verification via Euroclear Sweden AB's website https://www.euroclear.com/sweden/generalmeetings/. If a shareholder postal votes by proxy, a power of attorney shall be enclosed with the postal voting form. A template proxy form is available on Telia Company's website www.teliacompany.com. If a shareholder is a legal entity, a certificate of incorporation or a corresponding document shall be enclosed with the postal voting form. Further instructions are included in the postal voting form and on Euroclear Sweden AB's website https://www.euroclear.com/sweden/generalmeetings/. Please note that shareholders who wish to attend the meeting venue in person or by proxy must give notice of participation in accordance with the instructions under the heading "Participation at the meeting venue" above. This means that a notice of participation only through postal voting is not sufficient for shareholders who wish to participate in the Extraordinary General Meeting by attending the meeting venue. Shareholding in the name of a nominee To be entitled to participate in the Extraordinary General Meeting, shareholders whose shares are registered in the name of a nominee (including Finnish shareholders that are registered within the Finnish book-entry system at Euroclear Finland Oy) must re-register such shares in their own name so that the shareholder is recorded in the presentation of the share register as of Wednesday, June 24, 2026. Such re-registration may be temporary (voting rights registration) and can be requested from the nominee in accordance with the nominee's procedures in such time in advance as the nominee determines. Voting rights registrations effected by the nominee no later than Friday, June 26, 2026, will be considered in the presentation of the share register. Proposed agenda 1. Opening of the Extraordinary General Meeting 2. Election of the Chair of the Extraordinary General Meeting 3. Preparation and approval of the voting list 4. Approval of the agenda 5. Election of two persons to check the minutes 6. Determination of whether the Extraordinary General Meeting has been duly convened 7. Determination of the number of Board members 8. Resolution to determine the remuneration for new Board member 9. Election of new Board member10. Closing of the Extraordinary General Meeting Resolutions proposed by the Nomination Committee The composition of the Nomination Committee is based on the ownership structure in Telia Company as of July 31, 2025, in accordance with the instruction for the Nomination Committee. The Nomination Committee comprises Magnus Johansson, Chair (the Swedish state), Katarina Hammar (Nordea Funds), Sussi Kvart (Handelsbanken Fonder) and Emilie Westholm (Folksam). In addition, the Chair of the Board of Directors, Lars-Johan Jarnheimer, has been appointed as co-opted member of the Nomination Committee. The Nomination Committee presents the following proposals: · Item 2 – The Nomination Committee proposes that the Chair of the Board of Directors, Lars-Johan Jarnheimer, is elected to be the Chair of the Extraordinary General Meeting. · Item 7 – The Nomination Committee proposes that the Board of Directors, for the period until the end of the next Annual General Meeting, shall consist of seven members elected by the General Meeting. · Item 8 – The Annual General Meeting on April 9, 2026 approved the yearly remuneration to the Board of Directors as follows: SEK 2,170,000 to the Chair of the Board of Directors, SEK 730,000 to each other member of the Board elected by the General Meeting, SEK 375,000 to the Chair of the Audit Committee, SEK 215,000 to each other member of the Audit Committee, SEK 75,000 to the Chair of the Remuneration Committee and SEK 75,000 to each other member of the Remuneration Committee. The Nomination Committee proposes that the proposed new Board member be remunerated pro rata for the period from the Extraordinary General Meeting until the end of the Annual General Meeting 2027, at the same annualized levels as resolved by the Annual General Meeting 2026 (including any applicable committee fees). · Item 9 – The Nomination Committee proposes the election of Susanne Blanke as a new Board member. Information about the proposed new Board member, as well as the Nomination Committee's motivated statement, is available on Telia Company’s website www.teliacompany.com. Susanne Blanke is VP AI Strategy & Transformation at Husqvarna Group, where she leads the company's AI-driven transformation of its operating model and business. She has previously held the roles of VP Customer Experience and VP Strategy at Husqvarna. Prior to joining Husqvarna in 2021, Susanne held senior positions at H&M and eBay/Tradera. At H&M, she led global digital growth as Global Head of Growth, and before that, global store development as Global Head of Store Development. She has previously worked as a management consultant at Boston Consulting Group and in strategy at Ericsson. Susanne holds an MSc in Media Technology from KTH Royal Institute of Technology and an MSc in Business & Economics from Stockholm University. Susanne is a Board member of engineering consultancy company Rejlers, where she serves on the audit committee. Resolutions proposed by the Board of Directors · Item 3 – Preparation and approval of the voting list The voting list proposed to be approved is the voting list prepared by Euroclear Sweden AB on behalf of Telia Company, based on the Extraordinary General Meeting’s register of shareholders, postal votes received and shareholders having given notice of participation and being present at the meeting venue. Other information Number of shares and votes The total number of shares and votes in Telia Company amounts to 3,932,109,286 at the date this notice is issued. Shareholders' right to request information At the request of any shareholder, the Board of Directors and the Chief Executive Officer shall provide information on any circumstances that may affect the assessment of a matter on the agenda, provided that the Board of Directors believes it would not be of significant detriment to Telia Company. Documentation The Board of Directors' and the Nomination Committee's proposals to the Extraordinary General Meeting are set out in this notice. Information about the proposed new Board member, as well as the Nomination Committee's motivated statement, is available on Telia Company's website www.teliacompany.com. Authorization The Board of Directors, or such person that the Board of Directors may appoint, shall be authorized to make the minor adjustments in the resolutions adopted by the Extraordinary General Meeting as may be required in connection with registration at the Swedish Companies Registration Office and Euroclear Sweden AB and to take such other measures required to execute the resolutions. Processing of personal data For information on how your personal data is processed, please refer to: www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. If you have questions regarding Telia Company’s processing of your personal data, you can contact us by emailing dpo-tc@teliacompany.com. Telia Company AB has the company registration number 556103-4249 and the Board’s registered office is in Stockholm. Stockholm, June 2026 Telia Company AB (publ) The Board of Directors NOTES TO EDITORS For more information, contact Tobias Gyhlénius, Head of Group Communications, on +46 (0)771 77 58 30, visit our newsroom  and follow us on LinkedIn . To download our logo, high-resolution images of Telia leaders, offices and solutions, or B-roll footage for editorial use, visit our media bank . ABOUT TELIA Telia Company (STO: TELIA) is a leading telecommunications operator in the Nordic and Baltic regions. Every day, we deliver world-class connectivity and communications services to millions of customers through our sustainable and secure networks – enabling people, businesses and societies to thrive and grow. Our unique position at the center of digitalization shapes our ambition to be a trusted and progressive partner and gives us our purpose: to reinvent better connected living. Find out more at www.teliacompany.com/en.

DexTech Medical's myeloma study fully recruited, preliminary results very positive

The study was conducted at Karolinska University Hospital Huddinge and at Uddevalla Hospital. The treatment has lasted for a total of 14 weeks with 2 doses per month. Three dose levels of OsteoDex (ODX) have been studied, 3mg/kg body weight, 6mg/kg, and 9mg/kg. The Principal Investigator (PI) is Dr Katarina Uttervall, MD, PhD, Department of Hematology/HERM, Karolinska University Hospital Huddinge. Dr Dorota Knut is the principal investigator at the Department of Hematology at Uddevalla Hospital. Analysis of biomarkers takes place at the Central Laboratory, Karolinska University Hospital Solna, NKS.  Adult myeloma patients with, according to IMWG (International Myeloma Working Group) criteria, progressive treatment-resistant disease, who had previously received 1–5 lines of treatment were included in the study. The primary objective is to confirm ODX safety and tolerability and with a secondary objective to demonstrate indications of treatment response. The last patient in dose group 2 (6mg/kg) was fully treated week 50, 2025 (7 doses). The patient continued to have stable, i.e. non-progressive, disease just over 5 months after the end of treatment and before new progress resumed. All patients in dose group 3 (9mg/kg) had achieved stable (non-progressive) disease after discontinuation of treatment at the end of February. The patients have continued to maintain non-progressive disease at the end of May. No significant ODX-related adverse events have been noted. Thus, no induced toxicity on organ systems, such as kidneys, liver, or bone marrow. Primary endpoint has been met, with the absence of significant ODX-related toxicity. The results also show that all patients responded positively to ODX treatment, with a transition from progressive (according to IMWG criteria) to non-progressive disease during ODX treatment. More than 70% of the patients maintained their achieved stable, non-progressive, disease even after the ODX treatment was discontinued. This is consistent with the mechanism of action, i.e. significant enrichment of ODX in the myeloma areas of the skeleton. The patients in dose group 3 are now being followed continuously (>June) until new disease progression, which is why the completion of the CSR (clinical study report) is postponed until all results from the extended follow-up are available. The company has analyzed all clinical data, including the prostate cancer studies (mCRPC), and finds the effects of the same mode of action (MOA) in both mCRPC and multiple myeloma. Simply described, ODX rapidly changes/modifies the tumor cells' microenvironment and thereby impairs their breeding ground and the conditions for continued growth (progression). The mechanism is unique to ODX as an anticancer drug and has very interesting implications for the treatment of other cancers with bone involvement, e.g. breast cancer. The absence of ODX-related toxicity opens up great opportunities for combination therapies (very common in modern cancer treatment) without adding toxicity. "- We are now compiling strong data to present to our stakeholders as soon as the remaining long-term follow-up data is available. We feel very optimistic in light of study data and a unique MOA," says CEO Anders R Holmberg. For more information about DexTech, please contact: Gösta Lundgren – CFO DexTech Medical AB Phone: +46 (0) 707104788 E-post: gosta.lundgren@dextechmedical.com This information is information that DexTech Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on June 4, 2026, at 08.00 a.m. CET. DexTech Medical AB is a Swedish research company that, based on its technology platform, has developed four drug candidates that are protected by patents. The lead candidate is OsteoDex for the treatment of castration-resistant prostate cancer (CRPC) with bone metastases. A successful clinical phase II study has been conducted with OsteoDex where the results show high tolerability with mild side effects and treatment effect on patients who fail existing drugs. DexTech's goal is to out-license each drug candidate no later than after completion of the phase II study. DexTech Medical AB is listed on the Spotlight Stock Market.

WirelessCar expands its global footprint with Bangalore office

Gothenburg and Bangalore, June 4, 2026 — WirelessCar, one of the world’s leading innovators of digital vehicle services, has opened an office in Bangalore, India. The site will operate as part of WirelessCar’s global organization.   The Bangalore office gives WirelessCar a stronger base in India and supports the company’s continued international expansion. The site will contribute to customer deliveries across markets, serving both existing customers and new opportunities.  India is also an important market for WirelessCar’s long-term growth. As the world’s third-largest automotive market by volume, it is seeing growing interest in electrification, connected vehicle technologies, infotainment and safety-related features.  "This is a pivotal step for WirelessCar,” said Niklas Florén, CEO of WirelessCar. “Establishing ourselves in India opens doors across Asia and positions us where the future of mobility is being shaped. This investment demonstrates our commitment to being a truly global partner to the automotive industry.”  “Bangalore will play a critical role in our global delivery organization as we support customers across markets,” said Jessica Nymark, VP Connected Services at WirelessCar. “By building scalable and cost-competitive capabilities in India, we strengthen our ability to serve existing customers, support new opportunities and grow with the needs of the connected vehicle industry.”  WirelessCar began establishing its presence in India in 2025, when Ajay Sundar was appointed Country Manager for India. Since then, the company has focused on building its local team, onboarding employees and creating a foundation for collaboration between WirelessCar India and the company’s global organization.  “The Bangalore office gives our local team a strong base for collaboration and delivery,” said Ajay Sundar, Country Manager India at WirelessCar. “It also brings us closer to India’s technology ecosystem of talent, partners and vendors.” 

Baseload Capital and Furusato Netsuden demonstrate a scalable model for geothermal growth in Japan

Japan holds one of the world’s largest geothermal resources. Yet despite decades of discussion around energy security and decarbonization, geothermal today accounts for less than 1% of the country’s electricity mix. For Baseload Capital and Furusato Netsuden, the completion of Waita No. 2 marks more than an operational milestone. It signals what the companies believe could become a turning point for geothermal development in Japan. The 4.995 MW plant began commercial operations in March 2026 and was developed together with stakeholders in the Waita district of Oguni Town, Kumamoto Prefecture. From the beginning, the project was built around close collaboration with the local community and long-term coexistence with local industries and traditions. That approach matters in Japan, where geothermal development has historically faced barriers related to land use, regulation, and local acceptance. Baseload Capital and Furusato Netsuden believe future growth will depend not only on access to geothermal resources, but on development models capable of building long-term local trust and participation. “Waita No. 2 is important not only because we commissioned a geothermal power plant,” said Alexander Helling, CEO of Baseload Capital. “It is important because it demonstrates that geothermal development in Japan can be done in a way that creates trust locally, aligns incentives, and becomes repeatable. That changes the conversation from one isolated project to long-term market potential.” Japan imports the vast majority of its energy, most of which is fossil fuels, leaving the country exposed to global fuel price volatility and energy security risks. At the same time, the country possesses geothermal resources capable of supporting stable domestic renewable energy generation for decades. The Waita No. 2 project was developed in collaboration with Waita-kai LLC, an organization representing residents in the area and participating in the project structure. The model is designed to ensure that value creation from geothermal development is more closely connected to the local community. “Japan does not lack geothermal resources,” said Kazuyuki Akaishi, Representative Director of Furusato Netsuden. “What has often been missing is a development model that communities feel part of. Waita No. 2 shows that geothermal can be developed together with local communities, not around them.” The project also reflects Baseload Capital’s broader strategy in Japan following its partnership with Furusato Netsuden in 2025. Rather than focusing only on individual projects, the ambition is to help establish a long-term platform for geothermal growth in Japan. As countries search for reliable clean power and greater energy independence, Baseload sees Japan as an increasingly important geothermal market – particularly for locally anchored projects that can be replicated efficiently across the country.

Statement from the board of directors of Formpipe Software AB (publ) in relation to Tabellae BidCo's public offer

This statement is made by the board of directors[1] of Formpipe Software AB (publ)[2] (“Formpipe” or the “Company”) pursuant to Rule II.19 of the Stock Market Self-Regulation Committee’s Takeover rules for Nasdaq Stockholm and Nordic Growth Market NGM (the “Takeover Rules”). Summary of the Offer On 4 June 2026, Tabellae HoldCo ApS[3], Mission Trail Partners, LP (“Mission Trail”) and Aktiebolag Grenspecialisten (“Grenspecialisten”) (together the “Consortium“), acting through Tabellae BidCo ApS (“Tabellae BidCo” or the “Offeror”), announced a public offer to the shareholders of Formpipe to tender all outstanding shares in the Company to Tabellae BidCo at a price per share of SEK 30 in cash (the “Offer”). Mission Trail and Grenspecialisten, both being members of the Consortium, currently hold 5,456,446 and 3,136,432 shares and votes in Formpipe, respectively. Consequently, the Consortium currently controls 8,592,878 shares and votes in Formpipe, which corresponds to approximately 29.3 percent of the outstanding shares and votes in Formpipe. All shares held by Mission Trail and Grenspecialisten will be contributed to Tabellae BidCo upon completion of the Offer. The total value of the Offer, based on the 20,720,037[4] outstanding shares in Formpipe not directly or indirectly held by Tabellae BidCo or its closely related parties, amounts to approximately SEK 622 million. The Offer values Formpipe, based on all 29,312,915 shares in Formpipe, at approximately SEK 879 million. The offered consideration in the Offer represents a premium of: · approximately 53.8 percent compared to the closing share price of SEK 19.50 on Nasdaq Stockholm on 3 June 2026, being the last trading day prior to the announcement of the Offer; · approximately 34.5 percent compared to the closing share price of SEK 22.30 on Nasdaq Stockholm on 26 March 2026, being the last trading day prior to Formpipe’s publication of the notice convening its 2026 annual general meeting (the “AGM Notice”), which included a proposal to implement a voluntary share redemption program pursuant to which shareholders would be offered the right to redeem shares for a cash consideration of SEK 30 per share (the “Redemption Program”); · approximately 29.4 percent compared to the volume weighted average trading price of SEK 23.18 for the shares on Nasdaq Stockholm during the last 30 trading days ended 26 March 2026, being the last trading day prior to Formpipe’s announcement of its AGM Notice; · approximately 25.6 percent compared to the volume weighted average trading price of SEK 23.88 for the shares on Nasdaq Stockholm during the last 90 trading days ended 26 March 2026, being the last trading day prior to Formpipe’s announcement of its AGM Notice; and · approximately 18.0 percent compared to the volume weighted average trading price of SEK 25.43 for the shares on Nasdaq Stockholm during the last 180 trading days ended 26 March 2026, being the last trading day prior to Formpipe’s announcement of its AGM Notice. If, prior to settlement of the Offer, Formpipe distributes dividends or in any other way distributes or transfers value to its shareholders, the consideration in the Offer will be reduced accordingly. An offer document regarding the Offer is expected to be made public on or around 18 June 2026. The acceptance period of the Offer is expected to commence on or around 22 June 2026 and expire on or around 22 July 2026. Completion of the Offer is conditional upon, among other things, the Offer being accepted to such extent that Tabellae BidCo becomes the owner of shares representing more than 90 percent of the total number of outstanding shares in Formpipe (on a fully diluted basis) and the receipt of all necessary clearances, approvals, decisions and other actions from authorities or similar, required for the Offer and the completion of the acquisition of the Company, in each case which, in Tabellae BidCo’s opinion, are acceptable. Tabellae BidCo has reserved the right to waive, in whole or in part, these and the other conditions for completion of the Offer. The board of directors has, upon written request from the Offeror, allowed Tabellae BidCo to conduct a due diligence review of the Company in connection with the preparations for the Offer. Tabellae BidCo has not received any inside information in connection with such due diligence review, that has not subsequently been made public by Formpipe. For further information about the Offer, please see Tabellae BidCo's website, https://designingthefuturetogether.se. The board of directors' evaluation of the Offer For the purpose of this statement and the handling of the Offer, the board of directors has consisted of the board members Annikki Schaeferdiek, Jim Bretschneider and Johan Stakeberg. Board member Erik Ivarsson is an analyst and portfolio manager at Grenspecialisten and board member Martin Bjäringer has, through his company Julnie S.A., undertaken to accept the Offer on certain conditions (see below). Erik Ivarsson and Martin Bjäringer are therefore deemed to have a conflict of interest pursuant to Rule II.18 of the Takeover Rules and have for that reason not participated, and will not participate, in the board of directors' handling of, or decisions on, matters related to the Offer. In evaluating the Offer, the board of directors has considered a number of factors which the board of directors considers relevant. These factors include, but are not limited to, the Company's current strategic and financial position, prevailing market conditions, the Company’s expected future development and the opportunities and risks related thereto. The board of directors has also evaluated the Offer using valuation methods normally used to evaluate public offers for listed companies, including how the Offer values Formpipe in relation to comparable listed companies and comparable transactions, bid premiums in previous public offers, the stock market’s expectations regarding the Company and the board of directors' view of the Company’s value based on its expected future cash flows. The board of directors notes that the Offer represents a premium of approximately 53.8 percent compared to the closing share price of  SEK 19.50 for Formpipe's share on Nasdaq Stockholm on 3 June 2026 (which was the last trading day prior to the announcement of the Offer), a premium of approximately 34.5 percent compared to the closing share price of SEK 22.30 on the last trading day prior to the announcement of the AGM Notice, and a premium of approximately 29.4 percent, approximately 25.6 percent and approximately 18.0 percent, respectively, compared to the volume weighted average trading price for Formpipe's share during the last 30 trading days, 90 trading days and 180 trading days, respectively, prior to the announcement of the AGM Notice. In evaluating the Offer, the board of directors has considered that Mission Trail and Grenspecialisten, which own and control in total approximately 29.3 percent of all outstanding shares in the Company, are part of the Consortium and will contribute such shares in the Company to Tabellae BidCo in connection with the completion of the Offer. In addition, the board of directors has considered that the Company’s shareholders ALCUR Fonder AB, Julnie S.A. and Jofam AB, representing in total 7,331,625 shares, representing approximately 25.0 percent of all outstanding shares in the Company, have undertaken to accept the Offer, subject to certain conditions. Please refer to the Offeror’s announcement of the Offer for further information about the undertakings. As part of its evaluation of the Offer, the board of directors has also investigated other opportunities in light of the discussions with Tabellae BidCo and taken into account interest from other potential offerors. In accordance with Rule III.3 of the Takeover Rules, the board of directors has obtained a valuation opinion (a so-called fairness opinion) regarding the Offer from Astelia Advisory AB (“Astelia”). The fairness opinion, which is attached as an appendix to this statement, concludes that Astelia considers the Offer to be fair from a financial point of view for the shareholders of the Company, subject to the assumptions and considerations set out in the fairness opinion. For the fairness opinion, Astelia receives a fixed fee which is not dependent on the size of the consideration in the Offer, the extent to which acceptances of the Offer are received or whether the Offer is completed. The board of directors has engaged ABG Sundal Collier AB as financial advisor and Cirio Advokatbyrå as legal advisor in connection with the Offer. The board of directors' recommendation Based on the above, the board of directors unanimously recommends the shareholders of Formpipe to accept the Offer. Effects on the Company and its employees Under the Takeover Rules, the board of directors is required to, based on what Tabellae BidCo has stated in its announcement of the Offer, present its opinion regarding the impact that implementation of the Offer will have on the Company, particularly in terms of employment, and its opinion regarding Tabellae BidCo's strategic plans for the Company and the effects it is anticipated that such plans will have on employment and on the locations where the Company conducts its operations. In its announcement of the Offer, Tabellae BidCo states: “The Offeror values the skills and talents of Formpipe’s employees and intends to continue to safeguard the excellent relationship that Formpipe has with its employees. Given the Offeror’s current knowledge of Formpipe’s business and in light of current market conditions, the Offeror does not intend to materially alter the operations of Formpipe following the implementation of the Offer, save that the Offeror intends to pursue the operational and commercial integration of Formpipe and Tabellae. The Offeror intends to determine what measures, if any, will be taken to integrate the two organizations and realize synergies following a thorough assessment, to be undertaken together with Formpipe, of the combined business following completion of the Offer. The Offeror will only be in a position to specify its intentions with respect to the employees and management of Formpipe and the Offeror upon completion of such assessment. There are currently no decisions on any material changes to Formpipe’s or the Offeror’s employees and management or to the existing organization and operations, including the terms of employment and locations of the business.” The board of directors assumes that this statement is correct and has in relevant respects no reason to take a different view. ____________________ This statement shall in all respects be governed by and construed in accordance with substantive Swedish law. Disputes arising from this statement shall be settled exclusively by Swedish courts. Stockholm, 4 June 2026 Formpipe Software AB (publ) The Board of Directors [1] Board member Erik Ivarsson is an analyst and portfolio manager at Aktiebolag Grenspecialisten and board member Martin Bjäringer has, through his company Julnie S.A., undertaken to accept the Offer on certain conditions. Erik Ivarsson and Martin Bjäringer are therefore deemed to have a conflict of interest pursuant to Rule II.18 of the Takeover Rules and have for that reason not participated, and will not participate, in the board of directors' handling of, or decisions on, matters related to the Offer. [2] The annual general meeting held on 29 April 2026 resolved on a change of name to Lasernet Group AB. The name change has not yet been registered with the Swedish Companies Registration Office. [3] Tabellae HoldCo ApS is controlled by Valedo Partners IV AB, which, together with its co-investors, hold approximately 62.4 percent of the shares and votes in Tabellae HoldCo ApS. The remaining shares in Tabellae HoldCo ApS are held by Tabellae A/S’s (an operational subsidiary wholly-owned by Tabellae BidCo ApS) founders, board members and management. [4] Excluding, as per the date of the announcement of the Offer, (i) 5,456,446 shares held by Mission Trail, and (ii) 3,136,432 shares held by Grenspecialisten.

Volvo Autonomous Solutions and Boliden complete dam construction milestone with autonomous transport

Volvo Autonomous Solutions (V.A.S.) and Boliden have completed the autonomous transport project at Boliden's Garpenberg site in Sweden. The project was the first step under the memorandum of understanding (MOU) signed between Volvo and Boliden in 2023, and it marks an important milestone in a collaboration that also includes future projects. As a part of the project, material was moved from an on-site quarry on Boliden premises and used to reinforce a local dam and heighten the dam wall. In total, close to 700,000 tonnes of rock fill material were transported autonomously— roughly equivalent to 280 Olympic swimming pools, or the combined weight of around 100 Eiffel Towers. Volvo's autonomous haulage system ran more than 11.000 transport cycles covering 56.000 kilometers. “We are very pleased to reach the 700 000 milestone of autonomous transports at our tailings facility in Garpenberg. Of course, we will continue to seek safe and productive solutions in partnership with the aim of developing world leading mining operations,” says Rikard Mäki, Head of Electrification and Automation, Boliden. "Autonomy has clear benefits for the mining industry, especially when it comes to removing people from hazardous environments and improving the safety and efficiency of operations. With more than 700,000 tonnes transported at Garpenberg, we have demonstrated that autonomous haulage works at scale, in real conditions and in real customer operations,” said Ingo Sturmer, CTO at V.A.S. The solution deployed at Garpenberg is Autona / earth, Volvo Autonomous Solutions' offering for mines and quarries. Autona / earth combines the autonomous Volvo FH for mining with Volvo's in-house developed virtual driver, infrastructure, operational support and maintenance needed to run autonomous transport. Delivered as Transport-as-a-Service, Autona / earth integrates autonomous technology into customer’s existing operations, with V.A.S. managing the technical complexity and regulatory compliance required for deployment. The completion of the Garpenberg project demonstrates that autonomous transports offer a competitive solution in certain mining operations. It provides a strong foundation for the continued collaboration between Volvo Autonomous Solutions and Boliden and signals to the wider industry that successful autonomous operations are built on strong partnerships. For further information, please contact: Klas Nilsson Director Group Communications +46 70453 65 88 Klas.Nilsson@boliden.com About Volvo Autonomous Solutions  Volvo Autonomous Solutions (V.A.S.) is the business area within the Volvo Group focused on developing and commercializing autonomous transport solutions in selected industry verticals. V.A.S. delivers end-to-end autonomous transport solutions that combine a purpose-built vehicle, a virtual driver, required infrastructure, operations and uptime support, and a fleet management system that orchestrates transport operations and manages logistics flows. Solutions are tailored to each customer’s needs and designed to support safer, more productive and more sustainable operations.

Epiroc wins order for LinkOA, extending its autonomous haulage system to aggregates sector

The proof-of-concept project will demonstrate how automation can be applied in mid-scale quarry operations, where design variability and more complex conditions compared to more standardized surface mining operations have traditionally limited adoption of automation. “We are proud to partner with Heidelberg Materials to support them on their autonomous journey,” says Helena Hedblom, Epiroc’s President and CEO. “Our LinkOA system is already a proven mining automation technology, and with this project we look forward to bringing the same productivity and safety benefits to the aggregates sector.” The order follows Epiroc’s crucial role in creating the world’s largest OEM-agnostic and fully autonomous mine, Roy Hill in Australia, using LinkOA. The parties have agreed not to disclose the order value. Heidelberg Materials announced recently  that it is “working closely with established technology partners” to ramp up the use of autonomous heavy mobile equipment globally, aiming to reach around 30 autonomous vehicles this year and more than 100 by the end of 2028. As one of Heidelberg Materials’ technology partners, Epiroc will deploy LinkOA for some of the company’s Komatsu HD605 haul trucks, which will also interact with loaders and auxiliary vehicles, at a quarry in Western Australia.    The project focuses on validating safe mixed-fleet operation, improved haulage efficiency, reduced operator dependency, and system performance across varying conditions. Autonomous haulage brings proven productivity and safety benefits such as 24/7 operation, removal of operators from hazardous environments, and reduction of accidents linked to human error and fatigue.   LinkOA is Epiroc’s open, OEM-agnostic autonomy platform that unifies haulage, drilling and blasting under a single intelligent control layer. Using advanced sensors, cameras and AI, LinkOA improves situational awareness, removes personnel from hazardous environments, and enables real-time, data-driven decision-making across mixed fleets. In 2025, Hancock Iron Ore’s Roy Hill mine, with support of the LinkOA system used on 78 mining trucks, became the world’s largest OEM-agnostic, fully autonomous mine. More than 350 million tonnes of material have been moved autonomously at this mine. Also last year, Epiroc, using LinkOA, partnered with Luck Stone, one of the United States’ leading producers of crushed stone, to deploy a fully autonomous SmartROC D65 drill rig. This was also the first fully autonomous surface drill rig delivered to the quarry market worldwide. LinkOA was named Engineering Product of the Year at the 2026 Digital Engineering Awards. A truck at a quarry – not one of Heidelberg Materials’ sites. For more information please contact:Ola Kinnander, Media Relations Manager+46 70 347 2455media@epiroc.com Epiroc is a global productivity partner for mining and infrastructure customers and accelerates the transformation toward a sustainable society. With ground-breaking technology, Epiroc develops and provides innovative and safe equipment, such as drill rigs, rock excavation and construction equipment and tools for surface and underground applications. The company also offers world-class service and other aftermarket support as well as solutions for automation, digitalization and electrification. Epiroc is based in Stockholm, Sweden, had revenues of around SEK 62 billion in 2025 and has around 19 000 passionate employees supporting and collaborating with customers in around 150 countries. Learn more at www.epirocgroup.com.

IONCOR Selects Epec PDUs to Support Next-Generation Battery System Deliveries

The partnership supports IONCOR’s continued growth and development of high-performance battery systems for demanding applications. By integrating Epec Flow PDUs into its deliveries, IONCOR further enhances the reliability, safety, and scalability of its solutions. “Together with Epec we are representing more than system integration, it’s a joint effort to push electrification forward to scale operations and deliveries,” says Roberts Abele, CEO of IONCOR. “Epec’s role in our system deliveries reflects their strong capabilities and supports our work in delivering reliable electrification solutions.” The cooperation combines IONCOR’s battery system expertise with Epec Flow power distribution technology to support reliable and efficient electrification solutions for demanding applications. “We are proud to support IONCOR’s growth journey and to be selected as part of their system deliveries,” says Jyri Kylä-Kaila, CEO of Epec. “This cooperation reflects the increasing demand for smart and reliable electrification technologies in the industry.” The companies share a commitment to advancing sustainable and intelligent electrification solutions and see strong potential for future collaboration in the rapidly evolving battery and electric vehicle market. The collaboration will also be highlighted during The Battery Show Europe in Stuttgart, Germany, on June 9-11, 2026. 

Forus selects Elisa Industriq’s Gridle to operate 15 MW of battery storage in Finland

Forus Oy has selected Elisa Industriq’s Gridle to optimize and operate 15 MW of battery energy storage across two sites in Finland. The projects support grid balancing and flexibility needs in a power system with increasing renewable energy generation. The assets, 5 MW / 10 MWh in Imatra and 10 MW / 20 MWh in Sodankylä, are grid-scale batteries designed to balance the Finnish electricity grid and capture maximum value from electricity markets. The projects are implemented through the project companies Imatran Akku Oy and Sodankylä Akku Oy. Suomen Sähköverkot Oy, backed by Finnish private investors, has acquired a majority ownership stake in the projects. Forus has led the project development, including site identification, permitting, and EPC contracting. Gridle will provide Forus with a route-to-market service, acting as the optimizer and market operator for both projects. Gridle connects the assets to electricity markets, operates them, and manages their participation across balancing and wholesale markets to maximize value and performance. “We chose Gridle because it combines proven operational reliability, strong market expertise and experience in operating critical infrastructure. As battery markets become more competitive, we need a partner that can continuously optimize performance and adapt to evolving market conditions,” says Julius Maylett, Head of Project Management at Forus. Gridle has developed its in-house optimization and market access capabilities by operating distributed battery portfolios across industrial, residential and telecom environments, the most complex form of battery optimization. This is a strong foundation for expansion into grid-scale optimization. Gridle has recently announced several grid-scale projects, such as with Finnish energy companies Vantaan Energia and Nivos. “Grid-scale batteries are a strategic focus for Gridle. Maximizing value requires continuous optimization, accurate forecasting, and reliable operation in changing market conditions. We are pleased to see pioneering companies such as Forus turn to Gridle to maximize the returns of their energy storage investments,” says Markus Logren, Business Lead at Gridle, Elisa Industriq. Forus continues to expand its pipeline of energy storage and renewable energy projects. The Imatra and Sodankylä projects represent the next step in scaling storage assets across Finland. More information & interview requests: Elisa Industriq Mediadesk, mediadesk@elisaindustriq.com, tel. +358 50 305 1605Forus, Julius Maylett, julius.maylett@forus.fi, tel. +358 40 187 6408 About Gridle Gridle is an AI-powered energy flexibility service that maximizes the value of flexible energy assets such as batteries. Gridle turns energy flexibility, the ability to shift when electricity is produced or consumed, into financial value. Gridle controls energy assets intelligently and decides when energy assets should use, store or produce energy. It then offers this flexibility capacity to electricity markets that balance supply and demand, enabling customers to cut energy costs and gain new revenue streams. The service is vendor-neutral and ensures the security of mission-critical assets and infrastructure. Drawing on Elisa’s 140+ years of innovation and automation and its expertise in operating nationally critical infrastructure, Gridle delivers dependable energy services that translates directly into operational efficiency and measurable financial outcomes. elisaindustriq.com/gridle  About Elisa Industriq Elisa Industriq creates software solutions for operational intelligence by multiplying industrial knowledge with AI innovation. Our businesses – camLine, sedApta, Polystar, CalcuQuote, TenForce, and Gridle – serve over 2,500 clients internationally in the manufacturing, telecommunications, and energy sectors.  Elisa Industriq delivers business value for customers by reducing costs, improving quality, and generating growth. Our software solutions integrate with customers’ existing systems to optimize their operations in areas including manufacturing execution, supply chain optimization, network analytics, and energy management.  Elisa Industriq is part of Elisa, a pioneer in telecommunications and digital services headquartered in Finland. Our shared mission is a sustainable future through digitalization. Elisa Industriq employs over 1,500 experts in Europe, Asia, and North America. elisaindustriq.com About Forus Forus Oy is a Finnish project developer focused on scaling commercially viable climate solutions. The company develops projects across renewable energy and storage, and other emerging technologies that support the energy transition. Forus combines technical project development with a strong commercial focus, covering the full lifecycle from site identification and permitting to EPC contracting and construction readiness. Forus exists to accelerate the energy transition by turning complex infrastructure projects into viable, scalable and bankable solutions. The company is backed by experienced private investors and is actively developing its portfolio in Finland. forus.fi/en  

Nordea Economic Outlook: Summer 2026 update

The Nordic countries have so far not been hit hard by the conflict in the Middle East. None of the countries has significant trade with the region, and the economies are among the most energy-efficient in the world, with a significant share of consumption in all countries coming from renewable energy sources. This gives the Nordic countries a competitive advantage in times of rising oil prices, says Helge Pedersen, Nordea Group Chief Economist. The Danish economy stands on a solid foundation with strong public finances and high employment. Geopolitical turmoil will likely lead to lower economic growth and higher inflation than previously expected, although both remain at relatively favourable levels. Consumption is expected to drive activity forward. The Finnish economy has returned to broad-based growth, with both private consumption and industrial output picking up. This growth is beginning to support the labour market and public finances. However, higher energy prices and rising interest rates in the wake of the Middle East crisis will likely dampen economic activity later in the year. Norway’s economy shows resilience to the Middle East conflict, although higher interest rates weigh on the outlook. Persistent above-target inflation, fuelled by higher oil and commodity prices, will likely prompt further tightening from Norges Bank. Unemployment remains low, and the krone continues to strengthen. Sweden is well-positioned to withstand challenges from the Middle East war, with conditions in place for healthy growth. Rising international demand will support exports while the labour market continues to improve. Low inflationary pressure at the outset gives the Riksbank room to wait and see this year. Read Economic Outlook here . Real GDP, % y/y, May 2026 2024 2025E 2026E 2027EWorld 3.4 3.5 3.1 3.3Denmark 3.5 2.9 2.1 1.9Finland 0.4 0.2 1.0 1.5Norway (mainland) 0.6 1.8 1.5 1.3Sweden 2.0 1.8 2.3 2.1Source: Nordea Markets For further information Helge J. Pedersen, Group Chief Economist, Mob: +45 22697912E-mail: helge.pedersen@nordea.com    Nordea is a leading Nordic financial services group and the preferred choice for millions of customers across the region. For more than 200 years, we have proudly served as a trusted financial partner for individuals, families and businesses – enabling dreams and aspirations for a greater good. Our vision is to be the best-performing financial services group in the Nordics, accelerating through our scale, people and technology. The Nordea share is listed on the Nasdaq Helsinki, Nasdaq Copenhagen and Nasdaq Stockholm exchanges.

Eye Health New E-Book Initiative from AstaReal

[AstaReal Vision Ebook.png] The e-book, Astaxanthin and the Evolution of Vision Care in a Screen-Centric World , describes how high screen time, reduced outdoor activity, and an ageing population are affecting vision health worldwide. It also highlights research on ocular nutrition and how different nutrients, including astaxanthin, may help support eye function. The book also explores research related to digital eye strain, or Computer Vision Syndrome, a growing issue associated with prolonged screen use. Among the studies highlighted is the 2025 study  in which children aged 10 to 14 showed reduced eye fatigue and improved stereoscopic vision after daily intake of AstaReal’s natural astaxanthin. “Research on eye health in general, and digital eye strain in particular, has developed rapidly in recent years. At the same time, we see a growing need for more knowledge about how today’s screen use affects younger generations and the role preventive approaches may play going forward.” The e-book also covers topics such as myopia, presbyopia, oxidative stress, and age-related vision changes, while describing how the global eye health market is evolving and how astaxanthin is gaining an increasingly prominent position. “Interest in vision nutrition is growing rapidly, both in research and product development. By bringing together science, market trends, and clinical data, we want to contribute to a more science-based approach to the future of eye health,” says Behnaz Shakersain, Scientific Affairs Manager at AstaReal AB. The new e-book was developed as a joint initiative by AstaReal’s global science team, bringing together researchers and experts from multiple regions, and is available for download here 

For the first time, British savers have an independent watchdog safeguarding their financial future

Anders Ramsten managed £140 billion of retail fund assets at Swedbank. Institutions have access to professional fund evaluation tools. Everyday investors never did. PowerFunds is the result. Millions of British savers have their largest single investment, in many cases bigger than their house, in a fund a consultant or they themselves chose years ago. Nobody has reviewed it since. The information needed to evaluate those funds exists. What ordinary investors receive instead is simplified marketing and curated lists. PowerFunds is putting that information where it belongs: in the hands of the people whose money is actually at stake. British savers can now check for free whether the funds they already own are among the best, and see where stronger-rated alternatives exist. PowerFunds rates every fund on two levels: how strong the category is, and how well the fund performs compared with the best index fund in the same investment category, based on long-term returns and fees. Each fund receives one of four clear ratings: Leading, Performing, Middling or Lagging. For £10 a month, PowerFunds monitors every fund a subscriber holds, alerting them the moment one starts to slip. "The biggest risk for many investors is not choosing the wrong fund. It is staying in the wrong fund for years without realising it. We have created the first monitoring layer for retail investors that is structurally independent of the funds it assesses." — Anders Ramsten, founder of PowerFunds Only 8.6% of UK adults received regulated financial advice in the past year, according to the FCA's Financial Lives 2024 survey. S&P SPIVA's Europe Year-End 2024 report found that 93% of actively managed equity funds underperformed their benchmark over ten years. Based on analysis of UK fund performance data, on a £100,000 investment, that gap can exceed £140,000 over twenty years of investing. Same type of fund, different choice. For most savers, that gap is the difference between retiring when they choose to and working until they have to. PowerFunds has secured seed funding from Symvan Capital, a London-based venture capital firm. With more than 7,000 users already on the platform, PowerFunds is now scaling up across the UK and Swedish markets. "At Symvan, we back teams with strong vision, clear market opportunity and the ability to execute. PowerFunds' focus on improving outcomes for everyday investors stood out immediately." — Kealan Doyle, CEO, Symvan Capital PowerFunds does not manage money or provide investment advice. Revenue comes from subscribers and affiliate agreements with the platforms carrying the highest-rated funds, and its ratings are structurally independent: a single, consistent methodology applies to every fund on the market. Most fund ratings tell you who won their type of race. PowerFunds tells you whether the race was worth running. About PowerFunds PowerFunds is built by a team with backgrounds spanning Swedbank, Spotify, Ogilvy, Young & Rubicam, Investor AB and Kindred. The platform covers every fund on the UK and Swedish markets and is built on an open, academically grounded methodology. PowerFunds is an alumnus of AI Forge, one of the UK’s leading AI incubators. Contact Martin Fahnehielm, CMO Martin.fahnehielm@powerfunds.se +46 765 26 66 80 Links PowerFunds  Symvan Capital  AI Forge  Anders Ramsten - CEO  Jan Seevers - CTO  Martin Sandberg - CGO  Martin Fahnehielm - CMO 

Neste, Goldwin, Idemitsu and Toray partner to supply renewable nylon fiber for THE NORTH FACE brand

Neste Corporation, Press release, 4 June 2026 at 12 p.m. (EET) Neste RE is produced from ISCC certified and traceable renewable raw materials, such as waste and residues like used cooking oil. Source: Neste Goldwin Inc., Neste, Idemitsu Kosan Co., Ltd., and Toray Industries, Inc. have established a supply chain for nylon fiber made from renewable raw materials. Neste supplies Neste RE™, a renewable raw material that enables the production of high-performance renewable nylon fiber and reduces the reliance on fossil feedstocks. The nylon fiber produced through this project is scheduled to be used by Goldwin for a part of THE NORTH FACE products in August 2026. Renewable naphtha, or Neste RE, is made from bio-based raw materials such as used cooking oil and other renewable raw materials . It is a lower-GHG-emission alternative to conventional fossil feedstocks. With the use of neat (i.e., unblended) renewable Neste RE, over 85%* of the greenhouse gas (GHG) emissions of the raw material are reduced compared to the use of virgin fossil raw materials. Bio-based plastics derived from Neste RE are of identical quality to those made from virgin fossil feedstocks and can be turned into exactly the same products and used for the same applications.“Renewable materials made from Neste RE meet the performance standards of global brands like THE NORTH FACE operated by Goldwin Inc. This project with Goldwin, Idemitsu, and Toray shows how the fashion industry's dependence on fossil resources can also be reduced for high-performance products. It demonstrates how our drop-in solutions can rapidly transform complex value chains to help brands work towards their climate targets,” says Maiju Helin, Director of Polymers and Chemicals at Neste.Fossil-based feedstocks, like naphtha, can be replaced with Neste RE without changes to the polymers and chemicals manufacturing infrastructure or processes; it is a seamless drop-in solution. In building this supply chain, the participating companies utilized existing facilities and applied the mass balance** approach.Mitsubishi Corporation coordinated the participating companies in establishing the supply chain for renewable nylon fiber in Goldwin's products.This collaboration marks Neste’s second supply chain collaboration for THE NORTH FACE products, following a similar partnership in July 2024 .Link to the joint press release published by Goldwin, Idemitsu, Toray and Neste (in Japanese) *) Life Cycle Assessment on Environmental Impacts of Neste Renewable Polymers and Chemicals (30 June 2021).**) A mass balance approach is applied to attribute the renewable Neste RE raw materials used in the process to the product.Neste CorporationCommunications

Prevas Wins Contract with Kährs for AI-Based Quality Sorting

The solution is based on Prevas’ proprietary Intelligent Vision Platform, where AI and image analysis work together to interpret and classify each individual wood surface. By combining deep learning with proven image processing algorithms, the system can make fast and reliable decisions directly on the production line. This enables more accurate and consistent sorting, regardless of operator or production conditions. "This is a clear example of how we, together with our customers, can transform complex challenges into tangible results. By replacing subjective assessments with data-driven analysis, we create a stable and scalable process that delivers long-term value," says Milad Abdhagh, Machine Vision Sales Specialist & Account Manager at Prevas. The purpose of the collaboration is to maximize the value generated from every produced plank while minimizing variations between operators, shifts, and production volumes. Through AI-based image analysis and models trained on deep domain expertise, consistent product quality can be ensured – every time. Prevas contributes broad expertise across the entire value chain, from algorithm development to mechanical engineering, electrical design, control cabinet manufacturing, and installation. This enables a full-service delivery and creates a solution where software, hardware, and the production environment work seamlessly together. "Combining deep learning with traditional image processing in real time places high demands on both the application and the process, especially since wood surfaces can vary significantly in appearance and characteristics. Together with Kährs, we are developing a solution that will deliver more consistent decisions, more accurate sorting, and a more predictable production process," says Niklas Brusén, Machine Vision & System Engineer at Prevas.  Kährs has worked with wood for nearly 170 years and has spent decades driving the development of wood flooring with a strong focus on quality, design, and sustainability. The collaboration with Prevas represents another step toward a more digitalized production environment, where advanced technology helps reduce waste, increase competitiveness, and promote a more sustainable use of natural resources. 

Metacon publishes information document regarding rights issue

In connection with the Rights Issue, the Company has prepared an information document (the “Information Document”) in accordance with Article 1.4(db) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"). The Information Document has been prepared in accordance with the requirements of Annex IX of the Prospectus Regulation. Metacon today, on 4 June 2026, announces that the Information Document has been registered with the Swedish Financial Supervisory Authority and is available on the Company's website, www.metacon.com, and will also be available on Nordic Issuing's website, www.nordic-issuing.se. Timetable for the Rights Issue +--------------------------------------+---------------------------+|Last day of trading in the share, |8 June 2026 ||including subscription rights | |+--------------------------------------+---------------------------+|First day of trading in the share |9 June 2026 ||excluding subscription rights | |+--------------------------------------+---------------------------+|Record date for the rights issue |10 June 2026 |+--------------------------------------+---------------------------+|Trading in subscription rights |12 June 2026 - 23 June 2026|+--------------------------------------+---------------------------+|Subscription period |12 June 2026 - 26 June 2026|+--------------------------------------+---------------------------+|Trading in BTAs |12 June 2026 - 8 July 2026 |+--------------------------------------+---------------------------+|Estimated date for the announcement of|26 June 2026 ||the preliminary outcome of the Rights | ||Issue | |+--------------------------------------+---------------------------+ Advisors Pareto Securities AB is Sole Manager and Bookrunner, BAHR Advokatbyrå AB is legal adviser to the Company, and Baker & McKenzie Advokatbyrå KB is legal adviser to Pareto Securities AB in connection with the Rights Issue. For further information, please contact: Christer Wikner, CEO & Group CEO, +46 707 647 389, christer.wikner@metacon.com Mattias Jansson, CFO, +46 722 316 862, mattias.jansson@metacon.com About Metacon AB (publ) Metacon AB (publ) is a Swedish company that develops, manufactures and supplies systems for hydrogen production. The offering covers the entire chain from design and installation to service and maintenance. The company is listed on the Nasdaq First North Growth Market in Stockholm. In the field of electrolysis, Metacon develops and supplies complete electrolysis plants for large-scale hydrogen production. Operations are conducted in close collaboration with PERIC Hydrogen Technologies in Handan, China, one of the world’s leading players in pressurised alkaline electrolysis technology. In the field of reforming, the company develops solutions for hydrogen production based on patented catalytic reactor technology, HIWAR®. These are advanced, highly efficient systems that produce hydrogen through catalytic steam reforming. The systems can be fuelled by biogas, biomethane or other renewable feedstocks such as bioethanol and green ammonia, and can be installed without connection to the electricity grid. For more information, see: www.metacon.com | X: @Metaconab | On LinkedIn:www.linkedin.com/company/metaconab  Important information The information contained in this press release is not intended for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore or South Africa, or in any other country or jurisdiction where this would be unlawful or would require a prospectus or additional information documents, registration or other measures in addition to those required under Swedish law. This press release is for information purposes only and does not constitute an offer to sell or issue, purchase or subscribe for, any of the securities described herein (collectively, the “Securities”) or any other financial instrument in Metacon AB (publ) (“Metacon”). Any offer relating to securities in connection with the Rights Issue is made solely through the Information Document that Metacon has published today on 4 June 2026 on www.metacon.com. Before making an investment decision regarding securities in the Rights Issue, persons reading this press release should ensure that they fully understand and accept the risks that will be set out in the Information Document, if published. No reliance should be placed on the information in this press release or its accuracy or completeness. The offers are not being made to, and subscription forms are not being accepted from, subscribers (including shareholders), or persons acting on behalf of subscribers, in all jurisdictions where such subscription applications would contravene applicable laws or regulations or would require the preparation or registration of a prospectus or additional information documents or the taking of other measures beyond those required under Swedish law. Actions in contravention of the restrictions may constitute a breach of applicable securities legislation. None of the Securities have been or will be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state or other jurisdiction in the United States, and may not be offered, pledged, sold, delivered or otherwise transferred, directly or indirectly, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with other applicable securities legislation. There will be no public offering of any Securities in the United States. In the UK, this press release is directed at and is being communicated only to persons who are “qualified investors” (as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024) and who: (i) have professional experience in investment matters and fall within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), (ii) are high-net-worth entities falling within Article 49(2)(a)–(d) of the Order, or (iii) are persons to whom an invitation or inducement to participate in investment business (within the meaning of section 21 of the Financial Services and Markets Act 2000) may otherwise lawfully be communicated or caused to be communicated (all such persons being collectively referred to as “Relevant Persons”). Persons in the UK who are not Relevant Persons must not act on or rely on the information in this press release or use it as a basis for taking any action. In the UK, any investment or investment activity to which this press release relates is available only to, and will be undertaken only with, Relevant Persons. This press release contains certain information that reflects Metacon’s current views on future events and financial and operational developments. Words such as “intends”, "believes", “expects”, “may”, “plans”, “estimates” and other expressions that imply indications or predictions regarding future developments or trends, and which are not based on historical facts, constitute forward-looking information and reflect Metacon’s views and expectations and involve a number of risks, uncertainties and assumptions that may cause actual events and results to differ materially from any expected future events or performance expressed or implied by the forward-looking statement. The information in this press release is subject to change without prior notice and, except as required by applicable law, Metacon assumes no responsibility or obligation to publicly update or revise any of the forward-looking statements contained herein, nor does it intend to do so. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release. As a result of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements as a prediction of actual future events or otherwise.

Bioretec Ltd – Manager’s transactions – van Hellenberg Hubar-Fisher

Bioretec LtdCompany release4 June 2026 at 14:25 p.m. EEST Bioretec Ltd - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Sarah van Hellenberg Hubar-Fisher Position: Chief Executive Officer Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 159307/6/8 ____________________________________________ Transaction date: 2026-06-02 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE ISIN: FI4000480454 Nature of transaction: ACQUISITION Transaction details (1): Volume: 1660000 Unit price: 0.02258 EUR Aggregated transactions (1): Volume: 1660000 Volume weighted average price: 0.02258 EUR Further enquiries Tuukka Paavola, CFO, +358 50 386 0013 Certified adviser Nordic Certified Adviser AB, +46 70 551 67 29 Information about Bioretec Bioretec is a globally operating Finnish medical device pioneer at the forefront of transforming orthopedic care with fully biodegradable implant technologies. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries. The company's latest innovation, the RemeOs™ product line, is based on a high-performance magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The first RemeOs product market authorization was received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025. Bioretec's Activa product line features fully bioabsorbable orthopedic implants made from a proprietary, self-reinforced PLGA both CE marked and FDA cleared for a wide range of indications in adult and pediatric patients. Bioretec is shaping the future of orthopedic treatment with a focus on healing through absorption, paving the way for more effective and patient-friendly solutions. To learn more about Bioretec, visit www.bioretec.com

The Supply Gap No One Is Filling: How CHARBONE Is Building the UHP Industrial Gas Platform Big Players Won’t

Sweden —June 4th 2026 ESGFIRE Management Interview | CHARBONE Corporation (TSXV: CH | OTCQB: CHHYF | FSE: K47) Clean hydrogen has spent years as a promise. CHARBONE Corporation is making it a commercial reality — one regional hub at a time. The company isn’t chasing the hydrogen mega-projects that dominate headlines. Instead, CHARBONE is building a decentralized, vertically integrated platform for ultra-high-purity industrial gases: the molecules powering semiconductor fabs, AI data centers, pharmaceutical manufacturing, and aerospace. It’s a market that exists today, is growing fast, and is structurally underserved at the regional level. With Phase 1A commercial production live at Sorel-Tracy since December 2025, confirmed sales across UHP hydrogen, helium, and oxygen into both Canada and the United States, and multi-year supply agreements already in place with a subsidiary of one of the world’s largest industrial conglomerates — CHARBONE is no longer a pre-revenue story. We sat down with CFO Benoit Veilleux to understand the platform strategy, the commercial milestones ahead and why CHARBONE believes it has no known advanced-stage competition in the market it is building. 1.CHARBONE’s latest corporate presentation positions the company as a vertically integrated ultra-high-purity industrial gases platform. How should investors understand CHARBONE’s business model today, and what role does clean UHP hydrogen play within the broader platform? CHARBONE:“Our mission is straightforward: to become the leading decentralized, vertically integrated UHP industrial gases company in North America and Asia-Pacific — producing, storing, and distributing critical high-purity gases to the high growth industries. What that means in practice is that we’re building a full-stack platform. We’re not just a hydrogen producer or just a distributor, we sit across the entire value chain: production, purification, compression, storage, and last-mile delivery to customers. Clean UHP hydrogen is our core production molecule, and Sorel-Tracy is where we’ve proven that model works commercially, but the platform is explicitly designed to handle all industrial gases like helium, oxygen, nitrogen, argon, and others. That breadth matters because it means our regional supply hubs and distribution infrastructure generate revenue from a wider basket of molecules, not just hydrogen. Helium is a strong example: it’s classified as a strategic critical material by the EU, Canada, and the United States, it has no viable substitutes in semiconductor manufacturing or MRI applications, and supply is highly geographically concentrated. We’re already distributing helium commercially today. The modular build-out model is what keeps capital requirements manageable. Each hydrogen project is designed with a multi-phases approach, each phase deployable in six to twelve months, a fraction of the three-to-seven-plus years it takes to deploy a traditional centralized mega-plant. We scale with demonstrated demand rather than building speculatively. We’re confident that combination of platform breadth and capital discipline is what makes Charbone a differentiated opportunity at this stage of growth.” 2.CHARBONE highlights demand from sectors such as semiconductors, AI and data centers, advanced pharmaceuticals, and aerospace and defense. What makes these end markets attractive for CHARBONE, and why is supply reliability and gas purity so important to these customers? CHARBONE:“These sectors share one critical characteristic: zero tolerance for supply disruption or quality deviation. If gas purity falls below the 99.999% UHP threshold in a semiconductor fab running chip etching or deposition processes, you can ruin an entire wafer batch. The same logic applies to pharmaceutical manufacturing, precision aerospace components, and the cooling infrastructure inside AI data centers. The customers aren’t buying a commodity, they’re paying for certainty of supply and certified purity. What makes these markets particularly attractive for our model is that they are structurally underserved at the regional level. Global supply of UHP gases is dominated by a handful of mega-plant operators whose business model is optimized for very large customers and very large volumes. Mid-tier industrial customers, our target segment, often struggle to access reliable proximate supply. We believe Charbone has no known advanced-stage competition in the modular, decentralized clean UHP hydrogen production market. That’s not a claim we make lightly; it reflects a genuine structural gap. The market context reinforces the growth trajectory. The global UHP gas market is projected to grow from approximately US$37.5 billion in 2025 to US$52.8 billion by 2030, driven by those same sectors. Capital investment in low-emissions hydrogen nearly doubled in 2024 to $4.3 billion and is projected to nearly double again in 2025 to approximately $8 billion, according to the IEA. We’re targeting a position at the intersection of that demand growth and the structural supply gap that the majors aren’t built to fill. 3.Sorel-Tracy is now described as commercially producing, with Phase 1A launched and initial sales reported in Canada and the United States. What has this first commercial phase demonstrated, and what still needs to be proven as CHARBONE scales the project? CHARBONE: “Sorel-Tracy has been a critical proof point on several fronts simultaneously. We launched Phase 1A commercial production in December 2025 and confirmed multiple sales into both the U.S. and Canadian markets in Q1 2026. What’s meaningful is that the validation wasn’t a single-molecule, we confirmed separate initial orders for UHP hydrogen, UHP oxygen, and UHP helium in Q1, with multiple deliveries across both countries. That demonstrates the distribution network is functioning, our gas meets UHP specification across molecules, and customers on both sides of the border can be served from a single platform. As for what still needs to be demonstrated, execution at the next phase of scale is the central test. We’re progressing toward Phase 1B, targeting increased production capacity in H2 2026. Growing the customer base, building recurring revenue through longer-term supply agreements, and proving the per-phase economics are the milestones we’re focused on. We’re confident in the foundation, and we’re in execution mode. 4.Investors are focused on revenue visibility and customer validation. Without disclosing confidential customer information, can you describe the types of customers buying or evaluating CHARBONE’s UHP hydrogen, helium, oxygen, and other industrial gases? CHARBONE:“Our target is mid-tier industrial gas customers, or companies large enough to have consistent, recurring demand for UHP gases, but that are not always well-served by the global players who prioritize very large accounts and centralized delivery models. These customers sit in advanced manufacturing, specialty laboratories, industrial processing, and adjacent sectors where gas purity and supply reliability are operationally critical. What I can say publicly is that we have multi-year supply agreements in place with a subsidiary of one of the world’s largest chemical and industrial conglomerates. That is a meaningful validation signal. Organizations of that scale have rigorous supplier qualification processes, and the fact that we’ve secured multi-year commitments at this stage of our development reflects both product quality and distribution reliability. On the hydrogen side, our initial Sorel-Tracy sales covered customers in both Canada and the United States, demonstrating geographic reach even at Phase 1A production levels. As we scale toward Phase 1B and beyond, we’re targeting a customer mix that tilts progressively toward higher-volumes and longer-term agreements, the kind that provide the recurring revenue visibility investors are focused on, and that our regional supply hub model is specifically designed to support.” 5.CHARBONE is developing regional supply hubs alongside its hydrogen production assets. How do these hubs support recurring revenue, improve customer reliability, and help diversify the business beyond a single production facility or molecule? CHARBONE:“The regional supply hub network is what elevates Charbone from a hydrogen producer into a full-service industrial gas platform. The hubs allow us to store, handle, and distribute multiple gases from strategically located facilities close to customers. We currently have hubs operating or under development in Ontario, Quebec, Nova Scotia, and New York State, with hydrogen and helium tube trailers already deployed supporting commercial deliveries across those geographies. Our target is six to eight hubs across North America. The revenue architecture the hubs enable is important to understand. The multi-year supply agreements we’ve established are anchored to hub-based distribution. When customers have a reliable, proximate source of supply with established logistics, they commit to longer-term arrangements. That creates the recurring revenue base that provides more predictable cash flow than spot sales. The diversification benefit is equally significant. A single-molecule, single-site business carries concentrated execution risk. By combining owned production assets with a distribution network capable of serving the full basket of industrial gases, we’re building a business whose revenue is spread across molecules, customer types, and geographies. We’re confident that model improves earnings quality and reduces the risk profile relative to a pure-play hydrogen producer. The hubs also provide a low-capital-intensity way to add revenue — the asset-light, partnership-driven distribution model means we can expand commercial reach faster than our production build-out alone would allow. 6.CHARBONE’s agreement with Vema Hydrogen appears to support a Québec-based “well-to-market” hydrogen supply chain by combining Vema’s Engineered Mineral Hydrogen production with CHARBONE’s purification, compression, and distribution capabilities. How should investors understand the strategic importance of this agreement? CHARBONE:“The Vema agreement is a strong example of our platform strategy in action. Vema has developed Engineered Mineral Hydrogen technology, a process that harnesses natural subsurface chemical reactions to produce low-carbon hydrogen. They’ve completed drilling and initiated pilot operations in Québec. What they need is a partner who can receive that feedstock and deliver it reliably to market. That is precisely what our purification, compression, and distribution infrastructure is built to do. Strategically, this is compelling for a few reasons. First, it adds a new low-carbon hydrogen feedstock source to our Québec supply chain without us having to build a new production facility, that’s capital-efficient growth. The agreement is structured to serve up to 15 tons per day of merchant hydrogen demand, which is meaningful scale. Second, it reinforces Québec’s positioning as a regional hydrogen hub and our role as the infrastructure and distribution layer within that hub. Third, it broadens the downstream application set. The framework contemplates not only industrial gas customers but also e-fuels, clean mobility, and low-carbon maritime and aviation markets. Charbone’s purification and distribution capabilities can integrate into multiple parts of that value chain. Québec is an ideal geography for this model: concentrated industrial demand, proximity to key transportation networks, and access to renewable energy. We’re aiming to use this as a template that can be replicated as the hydrogen supply chain matures in other regions.” 7. Many small-cap investors are focused on financing discipline and dilution risk. How does CHARBONE plan to fund growth across Sorel-Tracy, regional hubs, and future projects while maintaining capital discipline? CHARBONE:“This is a question I take seriously in my role as CFO. I’d point to a few things. First, our track record: in 2025, we reduced our net loss by 6% year-over-year to approximately $2.7 million, while simultaneously completing the Sorel-Tracy equipment acquisition, launching Phase 1A commercial production, and initiating revenues across three gas molecules. That’s a demonstration that we manage costs actively even while executing on growth. On the capital structure, we’ve been deliberate about building runway without unnecessary dilution pressure. We closed a $3.1 million private placement in January 2026 and drew the first $3 million tranche of a new $10 million secured convertible loan facility in April 2026. That facility has optional drawdowns during its term, giving us the flexibility to deploy capital in line with project milestones rather than all at once. Charbone founders, management and close partners retain approximately 39% ownership, which we view as a meaningful alignment signal. More broadly, the modular build-out model is itself a capital discipline tool. Each phase is sized to be deployed in six to twelve months, matched to demonstrated local demand and access to renewable power. We’re not building speculative capacity. There is also the potential contribution from Canada’s Clean Hydrogen Investment Tax Credit, which could provide a tax credit of up to 40% of eligible equipment cost. That’s a meaningful offset to capital outlay at Sorel-Tracy and potentially at future Canadian sites. As revenues grow, we anticipate funding an increasing share of growth from operating cash flow. While the convertible loan provides important runway to execute our plans, we understand that we’re in an early growth phase and remain open minded about strategic capital and industry partners that may help expedite our footprint operationally and in the capital markets. 8.Looking ahead over the next 12 to 18 months, what are the most important measurable milestones investors should watch to assess CHARBONE’s execution and growth? CHARBONE: “There are several concrete milestones I’d point investors toward, in rough order of near-term visibility. First, Phase 1B at Sorel-Tracy. We’re targeting increased hydrogen production capacity in H2 2026. That’s the most immediate operational test of our modular expansion model and the most direct read on whether the per-phase economics we’ve disclosed are achievable. Second, Detroit and Wisconsin. Detroit is targeting Phase 1 launch in H2 2026 following site selection and permitting work in the next couple of months — 1 ton per day of clean UHP hydrogen, following a similar commissioning approach to Sorel-Tracy and targeting the Great Lakes semiconductor and advanced manufacturing corridor. Wisconsin is advancing through H2 2026 permitting, with 200 kg per day of capacity supported by Charbone’s own Wolf River hydro dam assets on land we already own. Progress on permitting, offtake conversations, and construction timelines at both sites will be meaningful signals. Third, Malaysia. We’ve confirmed equity participation intent in April 2026 and completed an executive mission in Q1. We’re targeting progression from intent to executed agreements and project development activity. Fourth, on the commercial side: revenue growth, expansion of the customer base, and conversion of pipeline conversations into multi-year supply agreements. We’re generating initial revenues today across hydrogen, helium, and oxygen. The 12-to-18-month question is whether we can demonstrate a revenue trajectory consistent with the Sorel-Tracy projected financials we’ve disclosed, C$5.1 million annually at Phase 1 and C$11 million at Phase 2, and whether hub expansion into the additional North American locations we’re targeting contributes to that trajectory. And fifth, the Vema partnership progressing from conditional agreement toward an operational supply framework in Québec. Each of these milestones, collectively, should give investors a clear and measurable picture of how the platform is developing.” 9. If CHARBONE executes successfully, what should the company look like by the end of 2027 in terms of production capacity, regional hubs, revenue mix, and customer relationships? CHARBONE: “While there are external factors that may be out of Charbone’s control, I can share how we think about the trajectory. Regarding our production plants, if we execute the way we’re targeting, Sorel-Tracy would be well into its multi-phase build-out, with Phase 1B complete and subsequent phases advancing. The indicative annual revenue potential we’ve disclosed publicly for that single site is C$11 million at Phase 2 and C$17 million at Phase 3, at approximately 50% margins. Those numbers are illustrative, not guidance, but they reflect the economics we’re aiming to demonstrate. Detroit and Wisconsin would be in or approaching commercial production while Malaysia would be generating returns from our equity participation structure in one of the world’s top-10 semiconductor manufacturing hubs. Regarding our regional supply hubs, we’re targeting six to eight hubs across North America, anchoring recurring distribution revenue across multiple molecules and geographies. On revenue mix, we’re aimin for a profile where hydrogen production, helium and specialty gas distribution, multi-year supply agreements, and international partnership revenues each contribute meaningfully with no single site or molecule dominating. That diversification is central to the platform thesis. Opportunities to invest in a vertically integrated UHP industrial gases platform at this stage of growth are rare, and the build-out we’re executing is designed to reflect that.” 10.What is the biggest misconception investors have about clean hydrogen or ultra-high-purity industrial gases? CHARBONE: “I’d highlight two. The first is that clean hydrogen is a speculative, long-horizon bet. That characterization may apply to large-scale green hydrogen projects targeting export markets or heavy industry decarbonization which have long timelines and infrastructure challenges. However, for UHP hydrogen needed for industrial applications like semiconductor fabs, AI data centers, precision laboratories, and advanced pharmaceutical manufacturing, that market exists today, is growing, and is structurally undersupplied at the regional level. Charbone’s customers aren’t waiting for the hydrogen economy to arrive. They’re buying gas now, and they have a problem sourcing it reliably and locally. The second misconception is about competitive barriers. Some investors assume the major industrial gas companies cover this market broadly. In practice, they’re optimized for very large customers and very large, centralized plants with deployments that take years and hundreds of millions to billions in capital. The mid-tier, regional segment Charbone is serving requires a fundamentally different model: local production, no gas to liquid conversion losses, minimal transportation cost, and deployment in months, not years. Again, we believe we have no known advanced-stage competition in that specific space. That’s not a function of the market being small, it’s a function of the majors not being built for it. We’re not asking investors to bet on a future state of the world. We’re building a business in a market that exists, backed by a capital-disciplined model designed to scale with demand. The structural tailwinds from semiconductor growth, AI infrastructure build-out, and decarbonization mandates are real and additive, but we don’t need them to accelerate to make our near-term business case work.”  Legal Disclaimer This interview is based upon reliable sources, namely regulated press releases from the company and investor presentations. Nevertheless, this interview may contain interpretations, estimates, or opinions of the authors, or other non-factual information. If that is the case, this is continuously stated above. Furthermore, any projections, forecasts, or similar are explicitly stated as such. The author holds shares and/or other securities of this company and the relevant company may or may not have paid the author for this content. . Because of the above, ESGFIRE urges the visitors to always analyze all materials critically in an objective manner, e.g., concerning the reliability of the relevant source and of what constitutes the authors’ personal interpretations. The visitor is hereby reminded that the post does, as set forth in the Post, contain interpretations, estimates, or opinions of the authors. This post was written by Filip Erhardt, at ESGFIRE, published 4/6 2026  by Filip Erhardt. Investing in stocks is combined with certain risks and it is possible to lose your entire investment. Our posts are made for educational purposes only and are not to be interpreted as tips, financial advice or recommendations of any kind to either buy or sell any stocks. Furthermore, this Interview is produced and distributed as general investment research intended for broad public dissemination. It does not take into account the specific investment objectives, financial situation or particular needs of any individual investor. Any price targets, valuations, or similar forward-looking assessments are based on publicly available information and the author’s own methodology, and should be understood strictly as opinions, not as personal recommendations. This material shall not be construed as personal investment advice under MiFID II or Swedish law. Readers are strongly encouraged to make their own investment decisions independently or seek advice from a licensed financial adviser.

Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics

Transaction Highlights ·  USD 30.5M in total cash + stock transaction · Of which USD 3.0M equity investment made during Q1 2026. · Net consideration of approx. USD 28.5M accounting for USD 2M of cash in Vesica Health · USD 13.75M due at close, comprised of USD 11.0M cash and USD 2.75M in Photocure equity. · USD 13.75M due based on two future milestones related to Medicare reimbursement, comprised of USD 5.5M cash and USD 8.25M in Photocure equity. · Advanced Diagnostic Laboratory Test (ADLT) milestone - USD 2.75M of Photocure Equity if company achieves ADLT status designation on or prior to 1 October 2026 (if this is not achieved by that date, the USD 2.75M roll into the second milestone). · Centers for Medicare and Medicaid Services (CMS) milestone - USD 5.5M of cash and USD 5.5M of Photocure equity if Vesica Health is awarded CMS reimbursement prior to end of December 2029 (assuming the ADLT milestone rolls, then the full milestone is USD 5.5M in cash and USD 8.25M in Photocure Equity). · All equity considerations will be based on Volume Weighted Average Price (VWAP) of Photocure on the Oslo Stock Exchange over the 30 trading days prior to Close, which is concurrent with this announcement. · Consideration due at Close will be funded through cash and treasury shares on hand. Consideration due for milestones will be funded with available cash and facilities. · The equity consideration due for milestones may, pursuant to the agreement with the sellers, be settled with the issuance of new shares or delivery of treasury shares to the sellers. · There are no financing conditions for the acquisition. Strategic Rationale The acquisition of Vesica Health adds a complementary noninvasive molecular diagnostic capability to Photocure’s precision diagnostics bladder cancer portfolio, extending further reach upstream in the patient evaluation pathway. Vesica Health offers AssureMDx, a multi-omic urine-based biomarker test designed to support risk stratification and identify hematuria patients at increased risk for bladder cancer to improve early detection. AssureMDx integrates six epigenetic and somatic biomarkers to help inform urologic evaluation through a urine-based testing approach. Approximately seven million patients in the U.S. present with hematuria annually, highlighting a substantial opportunity to improve patient identification and risk stratification. AssureMDx has been validated in prospective multicenter studies, including a large study of 838 hematuria patients demonstrating 96% sensitivity, 99.7% Negative Predictive Value (NPV), and 0.96 Area Under the Curve (AUC) for bladder cancer detection. The assay was recognized in American Urological Association (AUA) guidelines in September 2025 for the evaluation of microhematuria, received an American Medical Association (AMA) Proprietary Laboratory Analyses (PLA) code effective January 2026, and was granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation (BDD) in February 2026. As of May 14, 2026, a proposed Medicare ruling may expedite future reimbursement pathway. AssureMDx’s commercialization can be significantly accelerated through Photocure’s established bladder cancer leadership, commercial infrastructure, urology footprint, and payer relationships. For Photocure, the addition of AssureMDx expands its portfolio with complementary noninvasive and procedural diagnostic technologies across the bladder cancer care pathway. The acquisition also expands Photocure’s reach into the large and rapidly growing hematuria evaluation market, supporting earlier patient risk stratification across existing urology call points. In addition, AssureMDx is expected to create meaningful operational and commercial synergies through expanded laboratory capabilities, attractive gross margins, and leverage of Photocure’s existing customer relationships and commercial organization. “This transaction represents a significant step forward in our strategy to build a comprehensive bladder cancer platform,” said Dan Schneider, Chief Executive Officer of Photocure. “We believe that Photocure can expand on progress with Blue Light Cystoscopy by building a portfolio of complementary precision diagnostics to inform physician decision-making and provide value for patients at different stages of the diagnostic pathway. By combining Vesica Health’s best-in-class hematuria early detection capabilities with our established diagnostic solution and commercial infrastructure, we are well positioned to accelerate growth and deliver improved outcomes for patients with urological cancers.” “AssureMDx represents a highly differentiated molecular assay designed to support risk stratification and earlier evaluation of hematuria patients,” said Christopher Thibodeau, Chief Executive Officer of Vesica Health. “Noninvasive genomic testing and blue light cystoscopy are highly complementary technologies within the bladder cancer care continuum, and bringing these approaches together through Photocure’s established platform has the potential to accelerate clinical adoption, support more informed clinical decision-making, and expand access to advanced noninvasive bladder cancer diagnostics.” “As the evaluation of hematuria continues to evolve, there remains a significant need for tools that can help identify patients at increased risk for bladder cancer earlier in the diagnostic pathway,” said Dr. Sam S. Chang, Professor of Urology and Chief Surgical Officer at Vanderbilt-Ingram Cancer Center. “The combination of noninvasive molecular testing such as AssureMDx with advanced visualization technologies such as Blue Light Cystoscopy has the potential to support more informed clinical decision-making and improve patient management across the bladder cancer care continuum.” Business Outlook · For full year 2026, Photocure continues to expect product revenue growth in the range of 7% to 11% on a constant currency basis, alongside continued expansion of adjusted EBITDA margins. · Assuming Medicare reimbursement by mid-2028 and positive clinical readouts supporting commercialization, Photocure expects initial AssureMDx revenues in 2027 and positive adjusted EBITDA contribution from AssureMDx operations by 2030, with market access and commercialization costs funded through free cash flow. · Modest Vesica Health operating losses expected in the near-term, quickly ramping to segment EBITDA margins north of 30%.  · The consolidated business is expected to accelerate revenue growth from a standalone mid-to-high teens CAGR to above 25% CAGR from 2026-2030, while maintaining strong profitability with consolidated adjusted EBITDA margins above 25% by 2030 and additional upside potential. · Importantly, completion of FDA down-classification, entry of additional scope manufacturers into the U.S. market including reintroduction of flexible scopes, will provide further upside to the standalone growth outlook. Conference Call and Webcast Photocure will host a conference call  on June 5, 2026 at 11.00 CEST to discuss the transaction. A company presentation is made available on the Photocure's website, www.photocure.com. Advisers DNB Carnegie, a part of DNB Bank ASA, acted as financial adviser. Morgan, Lewis & Bockius LLP is acting as US legal adviser and Advokatfirmaet Selmer is acting as Norwegian legal adviser to Photocure for this acquisition. Note to editors All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.  This press release may contain product details and information which are not valid, or a product is not accessible, in your country. Please be aware that Photocure does not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. About Photocure ASA Photocure is a commercial diagnostic company with global reach, committed to driving progress in uro-oncology precision diagnostics, delivering meaningful advances for patients with urological cancers. Our unique core technology has led to better health outcomes for patients worldwide. The company aims to provide an array of transformative solutions that help physicians with timely diagnostic information, to inform more personalized decisions on how best to manage each individual patient. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit www.photocure.com. About Vesica Health, Inc. Vesica Health is a privately held precision diagnostics company pioneering noninvasive solutions for the early detection and management of bladder cancer. Headquartered in Irvine, California, Vesica operates a CAP-accredited, CLIA-certified laboratory and holds worldwide commercialization rights for AssureMDx. The company is led by an experienced team with a proven track record in diagnostic development, clinical evidence generation, and commercial execution. Learn more at: www.vesicahealth.com. About Bladder Cancer Bladder cancer ranks as the 8th most common cancer worldwide – the 5th most common in men – with 1 949 000 prevalent cases (5-year prevalence rate)[1a], 614 000 new cases and more than 220 000 deaths in 2022.[1b] Approx. 75% of all bladder cancer cases occur in men.1 It has a high recurrence rate with up to 61% in year one and up to 78% over five years.[2] Bladder cancer has the highest lifetime treatment costs per patient of all cancers.[3] Bladder cancer is a costly, potentially progressive disease for which patients have to undergo multiple cystoscopies due to the high risk of recurrence. There is an urgent need to improve both the diagnosis and the management of bladder cancer for the benefit of patients and healthcare systems alike. Bladder cancer is classified into two types, non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), depending on the depth of invasion in the bladder wall. NMIBC remains in the inner layer of cells lining the bladder. These cancers are the most common (75%) of all BC cases and include the subtypes Ta, carcinoma in situ (CIS) and T1 lesions. In MIBC the cancer has grown into deeper layers of the bladder wall. These cancers, including subtypes T2, T3 and T4, are more likely to spread and are harder to treat.[4] [1 ]Globocan. a) 5-year prevalence / b) incidence/mortality by population.  Available at: https://gco.iarc.fr/today, accessed [February 2024].[2 ]Babjuk M, et al. Eur Urol. 2019; 76(5): 639-657[3 ]Sievert KD et al. World J Urol 2009;27:295–300[4 ]Bladder Cancer. American Cancer Society. https://www.cancer.org/cancer/bladder-cancer.html For more information, please contact: Dan SchneiderPresident and CEOPhotocure ASAEmail: ds@photocure.com Priyam ShahVice President Investor RelationsTel: +17176815072Email: priyam.shah@photocure.com Media and IR enquiries: Geir BjørloCorporate Communications (Norway)Tel: +47 91540000Email: geir.bjorlo@corpcom.no Important Information This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Dick Peters, Corporate Controller of Photocure ASA at the time and date stated above. This announcement is not and does not form a part of any offer to sell, or a solicitation of an offer to purchase, any securities. The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Copies of this announcement are not being made and may not be distributed or sent into any jurisdiction in which such distribution would be unlawful or would require registration or other measures. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "strategy", "intends", "estimate", "will", "may", "continue", "should" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although Photocure believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. The information, opinions and forward-looking statements contained in this announcement speak only as at its date and are subject to change without notice. Photocure ASA undertakes no obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this announcement, other than as required by law. This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of Photocure. Neither Photocure nor its advisors accept any liability arising from the use of this announcement. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Safello enters into strategic partnership agreement with Wictor Family Office, entailing a share subscription right in Safello

The partnership agreement is entered into in order to establish a strategic collaboration relating to custody of crypto assets and financial products backed by crypto assets. As a part of the strategic partnership, the parties intend to negotiate and enter into one or more agreements regarding crypto asset services provided by Safello AB. In particular, the parties shall negotiate an agreement regarding custody of crypto-assets, in the course of which WFO will store crypto-assets with Safello AB. The aim is to go live with the services under the custody agreement before the end of the year. Launch of the custody services will be conditional upon any necessary regulatory approvals.  Provided that WFO under such custody agreement reaches an AUM-target of SEK 250 million in custody over a continuous rolling two calendar months’ period, Wictor Holding is granted a right, but are not obliged to, invest SEK 10 million in Safello Group through a directed share issue at a pre-money equity valuation of SEK 100 million. The number of shares to be subscribed for, and the subscription price per share, will be determined on the basis of the said valuation and the fully diluted share capital of Safello Group at the time of exercise. The right to subscribe for shares is subject to the limitations of any outstanding issue authorization granted to the board of Safello Group from time to time, and conditional upon that the share issue can be made at market terms as well as generally accepted practices on the Swedish securities market at the time of exercise. Safello is entering into the strategic partnership agreement and granting the above described investment right to incentivise WFO’s utilisation of the custody services, and for Safello to position itself as the go-to custodian of choice for family offices and wealth managers in relation to crypto assets. “Crypto has matured into a robust asset class with a market capitalization of approximately $2.5 trillion, operating within a well-regulated framework under the EU’s MiCA regulation. It deserves a place in diversified portfolios. I’m excited to see Wictor Family Office pioneering direct crypto exposure in Sweden, addressing client demand in an asset class long dominated by ETPs,” says Frank Schuil, CEO at Safello Group. “As Sweden continues to produce a new generation of successful entrepreneurs, the expectations placed on wealth managers are evolving. To remain competitive with international institutions, we must continuously adapt and expand our offering to meet our clients’ changing needs. Secure and efficient custody of digital assets has become an increasingly important requirement for many of our clients. We are therefore proud to enter into this agreement with Safello.  This partnership strengthens our ability to deliver a modern, comprehensive wealth management offering. We look forward to competing more effectively with the larger international banks and continuing our ambition to be a truly contemporary family office, one that reflects the needs and opportunities of today’s entrepreneurs and wealth creators,” says Sara Viktorsson, CEO at Wictor Family Office. ### This information is such that Safello Group AB is required to disclose in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below, for publication at 20.05 CEST on 4 June 2026. For more information, please contactMikael Schlaug, CFO, ir@safello.com Certified AdviserAmudova AB is Safello’s certified adviser. Safello is the leading cryptocurrency exchange in the Nordics, with over 425,400 users. The company’s mission is to make crypto accessible to everyone. Safello offers a secure and seamless solution for buying, selling, storing, depositing and withdrawing cryptocurrencies directly from the blockchain – all through smooth transactions with instant delivery. Safello AB operates in Sweden and is authorized as a crypto-asset service provider under MiCA. The parent company, Safello Group AB, has been listed on Nasdaq First North Growth Market since 2021. For more information, visit www.safello.com.

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

· The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly migraine days versus placebo over Weeks 1–12 in patients with one to four prior preventive treatment failures · Bocunebart was generally well tolerated, with no new safety signals identified · The totality of the presented clinical data from the bocunebart Phase I-IIb program strengthens the evidence for PACAP pathway inhibition as a novel therapeutic approach for people severely impacted by migraine Valby, Denmark, Thursday 4 June 2026 – Lundbeck today announced the first presentation of primary data from the Phase IIb PROCEED trial evaluating bocunebart (Lu AG09222), an investigational monoclonal antibody targeting pituitary adenylate cyclase-activating polypeptide (PACAP). The data presented at the American Headache Society (AHS) Congress in Orlando, Florida, USA (4-7 June) support the potential of bocunebart as a preventive treatment in patients with one to four prior preventive migraine treatment failures, with particularly notable treatment effect in those with chronic migraine. Bocunebart is designed to bind to and inhibit PACAP, a neuropeptide implicated in migraine pathophysiology through pathways distinct from calcitonin gene-related peptide (CGRP). This differentiated mechanism positions bocunebart as a potential alternative treatment option for patients who do not achieve adequate benefit from currently available preventive therapies. “I am encouraged by the positive results from the PROCEED trial. Despite advances in migraine management, a substantial proportion of patients still do not achieve adequate disease control with currently available therapies. The clinical evidence to date highlights the potential of bocunebart as a new therapeutic approach for migraine prevention and offers hope to patients living with this debilitating condition”, said the coordinating investigator of the trial and presenting author, Dr. Jessica Ailani, certified headache specialist, Washington DC. In the intravenous (IV) dosing part of the PROCEED trial, bocunebart met the primary endpoint, demonstrating a statistically significant reduction from baseline in monthly migraine days (MMDs) over Weeks 1–12 compared with placebo. Patients treated with bocunebart experienced a mean reduction of -4.24 monthly migraine days versus -2.86 days with placebo, corresponding to a treatment difference of -1.38 days (p=0.0178). In pooled data across the Phase II program of severe, chronic migraine patients, bocunebart showed a more pronounced effect with a mean reduction of -5.94 MMDs versus -3.63 MMDs with placebo, corresponding to a treatment difference of -2.31 days (p<0.001) in patients that had experienced prior preventive treatment failures. Bocunebart was generally well tolerated, with no new safety signals identified during the treatment period. Across the Phase II program, the most commonly reported treatment-emergent adverse event (≥5%) for bocunebart was nasopharyngitis. “Today’s data mark an important milestone in our efforts to bring forward innovative treatments for people living with migraine, particularly those who continue to experience substantial disease burden despite currently available therapies” said Johan Luthman, EVP and Head of Research and Development at Lundbeck. “The PROCEED results strengthen our confidence in targeting the PACAP pathway and support continued clinical development of bocunebart.” In addition, Lundbeck presents Phase I clinical data evaluating the safety and tolerability of bocunebart when co-administered with ubrogepant in participants with migraine. Together with previously presented data on co-administration with triptans, these findings further support the safety profile of bocunebart when used alongside commonly prescribed acute migraine therapies. Based on the positive PROCEED trial, Lundbeck is advancing preparations for further clinical development of bocunebart in migraine prevention. Lundbeck will host a conference call and live webcast for investors and analysts on Friday, June 5, 2026, at 15:00 CET (09:00 a.m. ET) to discuss the announcement. The webcast can be accessed through the Investor Relations section of  Lundbecks’s website at www.lundbeck.com. A replay will be available shortly after the conclusion of the event. About Lundbeck’s bocunebart scientific presentations at the AHS congress Targeting PACAP in migraine prevention: Early outcomes from the PROCEED phase IIb trial of bocunebart (Lu AG09222) Poster presentation: Jessica Ailani Date: Thursday, June 4, 2026 Time: 6:00 pm – 7:30 pm EDT Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with Ubrogepant in Participants with Migraine. Poster presentation: Amaal Starling Date: Thursday, June 4, 2026 Time: 6:00 pm – 7:30 pm EDT About the PROCEED migraine trial The PROCEED trial assessed the efficacy, safety, and tolerability of bocunebart versus placebo when administered once monthly for three months. The Phase IIb trial was designed to establish the optimal dose and route of administration (subcutaneous and intravenous) of bocunebart. A predefined interim analysis of the subcutaneous part of the PROCEED trial demonstrated futility and triggered enrolment into the intravenous (IV) part of the trial. In the IV part of PROCEED a total of 429 patients from 14 countries (Bulgaria, Czechia, Denmark, France, Georgia, Germany, Hungary, Lithuania, Japan, Poland, Romania, Slovakia, Spain, and the United States) were treated. The primary efficacy endpoint was defined as the difference between bocunebart and placebo in mean change from baseline in the number of monthly migraine days over Weeks 1 to 12. The target population for this trial included patients diagnosed with migraine according to the International Classification of Headache Disorders, Third Edition (ICHD-3),[1] who had experienced treatment failure with one to four different preventive migraine medications within the past 10 years. About the HOPE migraine trial The HOPE trial was an interventional, multi-national, multi-site, randomized, double-blind, parallel-group, placebo-controlled Phase IIa trial designed to assess the safety, tolerability and efficacy of a single IV infusion of bocunebart for the prevention of migraine in patients that had failed prior treatments. The trial consisted of a 4-week double-blind treatment period with a follow-up period for 8 weeks. The primary endpoint was the change from baseline in the number of monthly migraine days over weeks 1 to 4, compared to placebo. Secondary endpoints were ≥50% reduction from baseline in MMDs (Weeks 1 to 4) and change from baseline in the number of monthly headache days (Weeks 1 to 4), compared to placebo. The target population for this trial was defined as patients diagnosed with migraine as outlined in the International Classification of Headache Disorders Third Edition (ICHD-3) with unsuccessful prior preventive treatments A total of 237 patients, recruited from specialist settings, were randomly allocated via a randomization system to one of three treatment groups: two doses of bocunebart or placebo. About bocunebart Bocunebart is an investigational monoclonal antibody (mAb) with a novel mechanism of action. It is designed to bind to and inhibit the signalling of pituitary adenylate cyclase-activating polypeptide (PACAP), a neuropeptide implicated in migraine pathophysiology.  This mechanism operates through a pathway distinct from that targeted by anti-calcitonin gene-related peptide (anti-CGRP) therapies. Bocunebart represents a potential new treatment class in migraine prevention and may provide an alternative option for people living with migraine who continue to be severely affected by the condition. Bocunebart is an investigational drug that is not approved for marketing by any regulatory authority worldwide, and the efficacy and safety of bocunebart have not been established. About migraine Migraine is a complex and disabling neurological disease characterized by recurrent attacks of severe headache typically accompanied by an array of symptoms, including nausea, vomiting, and sensitivity to light or sound.[1] Migraine is among the most prevalent neurological diseases worldwide and remains the leading cause of disability for people under the age of 50 and the 2nd leading cause of disability.[2] The disease has a profound impact on daily functioning, including relationships, social participation, household responsibilities, and work productivity. As migraine frequency and severity increase, attacks become more difficult to control, contributing to greater disease burden and can progress to chronic migraine in the absence of appropriate preventive management.[3] Contacts Anders Crillesen Jens HøyerSenior Director, Vice President, Head of Investor RelationsExternal & InternalRelationsAECE@lundbeck.com JSHR@lundbeck.com+45 27 79 12 86 +45 30 83 45 01   About H. Lundbeck A/S Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments. As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole. Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com  and connect with us via LinkedIn .   References: 1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd Edition. Cephalalgia, 2018. 38(1): p. 1-211 2. Burch, R.C., D.C. Buse, and R.B. Lipton, Migraine: epidemiology, burden, and comorbidity. Neurol Clin, 2019. 37(4): p. 631-649 3. Lipton RB, Buse DC, Nahas SJ, Tietjen GE, Martin VT, Löf E, Brevig T, Cady R, Diener HC. Risk factors for migraine disease progression: a narrative review for a patient-centered approach. J Neurol. 2023 Dec;270(12):5692-5710. doi: 10.1007/s00415-023-11880-2. Epub 2023 Aug 24. PMID: 37615752; PMCID: PMC10632231 

Sectra’s year-end report 2025/2026: Long-term investments drive growth and profit

Fourth quarter: February–April 2026 · Contracted order bookings decreased 46.5% to SEK 1,551.6 million (2,900.3), of which SEK 1,322.9 million (2,382.1) pertained to guaranteed order bookings. Of the guaranteed order bookings, 13% were recognized during the quarter and a further 16–26% will pertain to revenue within 12 months after the end of the quarter. · Net sales increased 13.0% to SEK 1,033.2 million (914.1). Based on unadjusted exchange rates compared with the year-earlier quarter, the increase would have been 17.8%. Recurring revenue accounted for SEK 682.2 million (574.6) of net sales, up 18.7%. Based on unadjusted exchange rates, the increase would have been 24.1%. Cloud recurring revenue (CRR) increased 49.2% to SEK 274.7 million (184.1). · Operating profit increased 5.1% to SEK 209.1 million (198.9), corresponding to an operating margin of 20.2% (21.8). Based on unadjusted exchange rates compared with the year-earlier quarter, the increase would have been 18.0%. The outcome includes SEK 26.6 million (26.1) in costs for share-based incentive programs. · Profit for the period amounted to SEK 157.5 million (131.2). · Cash flow from operations amounted to SEK 519.7 million (222.3). This change was primarily linked to advances from customers. 2025/2026 fiscal year[1] · Contracted order bookings decreased 12.7% to SEK 7,599.5 million (8,706.1), of which SEK 5,854.5 million (7,653.0) pertained to guaranteed order bookings. The comparative figures include a very large Canadian order with a contracted order value of SEK 3.1 billion. · Net sales increased 9.3% to SEK 3,541.7 million (3,239.8). Based on unadjusted exchange rates compared with the year-earlier quarter, the increase would have been 16.5%. Recurring revenue accounted for SEK 2,451.3 million (2,067.4) of net sales, up 18.6%. Based on unadjusted exchange rates, the increase would have been 26.7%. Cloud recurring revenue (CRR) increased 54.9% to SEK 915.8 million (591.1). · Operating profit rose 15.9% to SEK 710.6 million (613.0), corresponding to an operating margin of 20.1% (18.9). Based on unadjusted exchange rates compared with the year-earlier period, operating profit would have increased 34.3%. The outcome includes SEK 80.7 million (63.5) for share-based incentive programs. The increase for incentive programs was due to a new program that started during the second half of the previous fiscal year. · Profit for the period amounted to SEK 563.8 million (475.6). · Cash flow from operations amounted to SEK 1,097.3 million (824.9). · The Board and CEO propose that the 2026 AGM resolve on an ordinary dividend of SEK 1.30 (1.10) per share and an extraordinary dividend of SEK 1.00 (1.00) per share, considering the year’s cash flow and Sectra’s financial position. In addition, it is proposed that the Board be authorized to decide on the acquisition of own shares (see the year-end report) in order to enable the repurchase of Class B shares to secure the company’s commitments under a new share-based incentive program that the Board intends to propose to the AGM.[1] Figures in parentheses pertain to the corresponding period/quarter in the preceding fiscal year. Figures for the comparative year are presented excluding the effects of a patent settlement that had a positive impact of SEK 110 million on operating profit. The business transaction was a non-recurring item and was recognized during the third quarter of 2024/2025 The patent settlement had no effect on order bookings and net sales. For further information, see the attached year-end report. Comments from Torbjörn Kronander, President and CEO of Sectra AB “Digitization, AI and increasing security requirements are drivers that are fundamentally changing how both we and our customers work. For us, this is about embracing change and converting new technologies into customer value. With a corporate culture that encourages innovation and ideas, and puts them into practice, we are continuing to strengthen Sectra’s position in medical IT and cybersecurity—areas where our solutions make a difference in people’s lives, health and safety all over the world. “The Group’s net sales exceeded SEK 1 billion for the first time in a single quarter. This positive performance was made possible as a result of satisfied and loyal customers. All of our operating areas are growing and reporting increased operating profit, despite the negative impact of currency effects and delays in product deliveries in Secure Communications. “Our ongoing transformation of the business model from software sales to service deliveries helped to increase the total share of recurring revenue by 5 percentage points to close to 70% during the fiscal year. This also led to a more even performance between quarters compared with our past seasonal trends, which is clear from our earnings outcomes for the last three quarters. “AI is an enormous wave rolling in and no one knows exactly how it will affect the future. We are choosing to ride this wave and course-correct as we go, rather than paddling behind and struggling to catch up. “At a time when politics, technology and business risks are becoming increasingly interconnected, our ability to combine innovation with high security and long-term trust is growing in importance. We will continue capitalizing on this and other strengths to make the world a healthier and safer place. Our stable financial position gives us the ability to continue investing in innovation and capacity for the future. Together with our customers, we are shaping and driving developments forward, which means that our speed is a crucial strength. The trust we receive from our customers is not something we take for granted. We must continue to earn it and build on it every day.” Read the attached financial report for further CEO comments and information. Presentation of the financial reportTorbjörn Kronander, President and CEO of Sectra AB, and Jessica Holmquist, CFO of Sectra AB, will present the financial report and answer questions. The presentation will be held in English. Time: June 5, 2026, at 10:00 a.m. (CEST) Follow live or listen to the recording afterward: https://investor.sectra.com/q4report2526 This information constitutes information that Sectra AB (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. CEST on June 5, 2026.

Elisa, the Finnish Border Guard and the Finnish Navy successfully tested the securing of submarine cables

The detection equipment installed by Elisa enables the acoustic monitoring of submarine cables in the Gulf of Finland, supporting a broader monitoring of seabed safety. The project is based on Distributed Acoustic Sensing, i.e. DAS technology, in which Elisa's submarine cable acts as a sensor that measures exceptional vibrations on the seabed. The DAS device analyses the changes caused by vibrations in the reflections of light passing through the optical fibre, which can be used to detect, for example, the approach of a ship dragging its anchor. After successfully completed field testing, the system is being built into an automated service that automatically alerts both authorities and critical infrastructure owners of exceptional situations. "The protection of undersea infrastructure is a nationally important task. The recent cable breaks in mind, we have built a solution that provides an early warning of an approaching threat. We are very pleased with the tests that have now been carried out and the good cooperation with the Finnish Border Guard and the Finnish Navy. Our quick response to the incident at the turn of the year prevented damage to other cables. Our goal is to use the early warning system to alert the authorities even before the first damage occurs," says Jouni Petrow, Elisa's Director, New Business. "The Finnish Border Guard is leading the work in Finland based the EU action plan on submarine cables to protect critical maritime infrastructure in the Baltic Sea. By enabling these tests, we are promoting new ways of protecting the critical maritime infrastructure of the EU's Baltic Sea coastal states. It is important that in addition to the authorities, companies that own critical infrastructure are involved," says Ilja Iljin, Specialist at the Border Guard Headquarters, who is preparing the implementation of the cable action plan. The Finnish Navy is responsible for forming the national maritime common operational picture. Recent events highlight the need for capacity of the infrastructure owners to control their own critical infrastructure on the sea floor. The new technologies will enable more comprehensive observation from below the surface, which is a very challenging operating environment in general and in the Baltic Sea in particular. Cooperation between the authorities and the owners of critical infrastructure is very important, enhancing our common situational awareness. The Finnish Naval Academy, Fingrid, Gasgrid, the Geological Survey of Finland and the Institute of Seismology at the University of Helsinki are also involved in the project. The tests carried out at the beginning of June included vessels of the Finnish Border Guard and the Navy, divers, a remote-controlled underwater robot and test equipment from other participants. The tests simulated the detection and location of faults in the undersea infrastructure, and how well the DAS system detects them.

Paradox Interactive publishes prospectus

Paradox Interactive AB (publ) (“Paradox” or the “Company”) announced on 3 June 2026 that Nasdaq Stockholm’s Listing Committee has approved the Company’s application for admission to trading of the Company’s shares on Nasdaq Stockholm Main Market. In connection therewith, Paradox has prepared a prospectus (the “Prospectus”) which has today been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and published on the Company’s website. For complete information regarding the admission to trading on Nasdaq Stockholm, reference is made to the Prospectus prepared by Paradox, which has today been approved by the Swedish Financial Supervisory Authority. The Prospectus is available on the Company’s website (www.paradoxinteractive.com/investors/prospectuses) and will also be published on the Swedish Financial Supervisory Authority’s website. The first day of trading on Nasdaq Stockholm is planned for Tuesday, 9 June 2026. In connection with the listing on Nasdaq Stockholm Main Market, the Company’s shares will be delisted from Nasdaq First North Growth Market and the expected last day of trading on Nasdaq First North Growth Market is Monday, 8 June 2026. No offering or issuance of new shares will take place in connection with the admission to trading of the Company’s shares on Nasdaq Stockholm Main Market. The shares will retain their existing ticker symbol (PDX) and ISIN code (SE0008294953). Shareholders of Paradox do not need to take any action in connection with the admission to trading on Nasdaq Stockholm. Legal adviserGernandt & Danielsson is the Company’s legal adviser in relation to the listing on Nasdaq Stockholm.

Steel from Raahe in the World’s Largest Cruise Ships

Legend of the Seas. Photos: SSAB Meyer Turku is currently building massive Icon-class cruise ships for Royal Caribbean Group. The third vessel in the series, Legend of the Seas, has now been completed and will begin sailing in the Mediterranean in July. The fourth and fifth vessels in the series are currently under construction at the shipyard. In addition, Royal Caribbean Group has confirmed orders for the sixth and seventh ships, which are scheduled for delivery in summer 2029 and 2030. Meyer Turku specializes in the design and construction of the world’s most modern and energy-efficient cruise ships. Legend of the Seas is 365 meters long, 70 meters high and 50 meters wide, with a standard capacity of around 5,600 passengers (up to 7,600 at maximum). The vessel employs well over 2,000 crew members and features 28 restaurants, 7 swimming pools, as well as extensive entertainment, retail and service offerings. Steel at the Core of Cruise Ship Structures Both standard steels and high-strength shipbuilding steels are delivered from SSAB to the shipyard. The steel plates used in the hull structures of the cruise ships are supplied by SSAB’s Raahe mill. Deliveries include several strength grades of shipbuilding steel, used in applications such as hull blocks and deck structures. Building a large cruise ship requires a significant amount of steel. Steel forms the structural backbone of the vessel. “Material properties such as strength and uniformity are critical for safety and performance,” says Ossi Kangas, Product Manager for Plate and Strip Products at SSAB Europe. At the shipyard, the steel plates are transferred from the storage yard to further processing, including shot blasting and priming, before entering production. Plates are cut into block components that are assembled into small blocks. These are then combined into larger blocks, which are welded into mega-blocks. The mega-blocks are transferred to the dry dock, where they are joined together, gradually forming the shape of the ship. Product Development Plays a Key Role In Raahe, steel is produced in an integrated process in which carbon is removed from molten iron and the properties of the steel are precisely tailored for different applications. At the plate mill, steel slabs are rolled to plates and further processed in accordance with customer requirements. Product development and quality assurance are an integral part of production: properties are continuously tested both during the process and in research laboratories. Products are also developed in close collaboration with customers to meet the demanding requirements of applications such as large cruise ships. At the Raahe steel plant’s main laboratory, both raw materials used in steel production and final products are analyzed. The scale of the fully automated spectral laboratory is illustrated by the fact that around 240,000 samples are analyzed annually, resulting in approximately 4.4 million determinations. Long-term Partnership Supports Demanding Shipbuilding SSAB has a long history of cooperation with the Meyer Turku shipyard. Over the years, this collaboration has developed into a close partnership, where understanding the demanding needs of the shipbuilding industry — whether in terms of schedules, quality or technical requirements — is essential. One of SSAB’s competitive advantages in the shipbuilding sector is its efficient supply chain. Steel plates are transported from Raahe to the Turku shipyard by rail, where they are unloaded into an automated plate storage facility. This streamlined logistics model supports delivery reliability and enables a steady flow of materials into production, which is critical in large-scale projects with tight schedules. “In shipbuilding, everything starts with reliability. In projects of this scale, the precision of material deliveries and consistent quality are critical,” says Janne Pirttijoki, Head of Production at SSAB Europe. “We value consistency in quality and predictability of deliveries in a partner. With SSAB, we have been able to build an efficient supply chain,” comments CEO Casimir Lindholm from Meyer Turku. Towards Lower-Emission Shipbuilding Shipbuilding steels represent a significant share of SSAB’s plate business: when all vessel types are included, they account for approximately one fifth. The transformation of the steel industry towards low-carbon production is opening new opportunities in shipbuilding as well. SSAB is developing solutions that support customers’ climate targets and enable the construction of vessels with lower emissions. “The role of low-emission steel products is also growing in shipbuilding. Together with our customers, we are seeking solutions to reduce the climate impact across the entire value chain,” Pirttijoki concludes. FACT BOX Meyer TurkuMeyer Turku Oy builds the world’s most modern and energy-efficient cruise ships, car ferries and special vessels. In 2025, the company’s revenue was EUR 2.1 billion. It employs more than 2,300 top professionals at the Turku shipyard, where ships have been built since 1737. Legend of the Seashttps://www.meyerturku.fi/en/products-and-technology/world-class-cruise-ships/

Hexagon Composites ASA: Approval of prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. 5 June 2026: Reference is made to the stock exchange announcement made by Hexagon Composites ASA (the "Company") on 7 May 2026 regarding the successful private placement of 68,750,000 new shares in the Company (the "Private Placement Shares") at a price of NOK 8.00 per share, raising gross proceeds of NOK 550 million (the "Private Placement"), and a potential subsequent offering (the "Subsequent Offering") of up to 15,625,000 new shares in the Company (the "Offer Shares") at the same subscription price as in the Private Placement. Reference is further made to the resolutions made by the annual general meeting of the Company held on 4 June 2026 to, inter alia, (i) issue the Private Placement Shares, and (ii) authorize the Board of Directors of the Company to issue up to 15,625,000 Offer Shares in the Subsequent Offering. Approval and publication of prospectusThe Norwegian Financial Supervisory Authority has today, 5 June 2026, approved a prospectus prepared by the Company for the Subsequent Offering and the listing of the Offer Shares and the Private Placement Shares on Euronext Oslo Børs (the "Prospectus"). The Prospectus, including the subscription form for the Subsequent Offering, will, subject to regulatory restrictions in certain jurisdictions, be made available at www.dnb.no/emisjoner. The Subsequent OfferingThe Subsequent Offering consists of an offer of up to 15,625,000 Offer Shares at a subscription price of NOK 8.00 per Offer Share (being the same subscription price as in the Private Placement), thereby raising gross proceeds of up to NOK 125 million. The Subsequent Offering will be directed towards shareholders in the Company as of 7 May 2026 (as registered in the VPS on 11 May 2026), who (i) were not included in the pre-sounding phase of the Private Placement; (ii) were not allocated shares in the Private Placement and (iii) are not resident in a jurisdiction where such offering would be unlawful, or for jurisdictions other than Norway, would require any prospectus filing, registration or similar action ("Eligible Shareholders"). Each Eligible Shareholder will receive 0.12 non-tradeable subscription right (the "Subscription Rights") for each share held by such Eligible Shareholder in the Company as of the Record Date, rounded down to the nearest whole right. Each Subscription Right will, subject to applicable securities laws, give the preferential right to subscribe for, and be allocated, one Offer Share in the Subsequent Offering. Over-subscription will be permitted, but there can be no assurance that Offer Shares will be allocated for such subscriptions. Subscription without Subscription Rights will not be permitted. The subscription period for the Subsequent Offering commences on 8 June 2026 at 09:00 (CEST) and, subject to any extension, expires on 19 June 2026 at 16:30 (CEST) (the "Subscription Period"). The Subscription Rights must be used to subscribe for Offer Shares before the end of the Subscription Period. Subscription Rights which are not exercised before the end of the Subscription Period will have no value and will lapse without compensation to the holder. Subscriptions for Offer Shares must be made by submitting a correctly completed copy of the subscription form attached to the Prospectus to the Manager during the Subscription Period. Subscribers who are residents of Norway with a Norwegian personal identification number may also subscribe for Offer Shares through the VPS online subscription system (or by following the link on www.dnb.no/emisjoner, which will redirect the subscriber to the VPS online subscription system). Complete information on the terms and conditions of the Subsequent Offering, including subscription procedures, is set out in the Prospectus. Subscriptions may only be made on the basis of the Prospectus.  AdvisorsDNB Carnegie, a part of DNB Bank ASA, is acting as manager for the Subsequent Offering (the "Manager"). Advokatfirmaet Schjødt AS is acting as legal counsel to the Company. For more informationBerit-Cathrin Høyvik, Senior Director, Communications, Hexagon CompositesTelephone: +47 988 92 161 | berit-cathrin.hoyvik@hexagongroup.com  Eirik Løhre, CFO, Hexagon CompositesTelephone: +1 704 777 5171 (US Eastern time zone) | eirik.lohre@hexagongroup.com About Hexagon Composites ASAHexagon delivers safe and innovative solutions for a cleaner energy future. Our solutions enable storage, transportation, and conversion to clean energy in a wide range of mobility and industrial applications. Learn more at www.hexagongroup.com and follow @HexagonASA on LinkedIn. IMPORTANT INFORMATIONThis announcement does not constitute or form a part of any offer of securities for sale or a solicitation of an offer to purchase securities of the Company in the United States or any other jurisdiction. The securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"). The securities of the Company have not been, and will not be, registered under the U.S. Securities Act, and may not be offered or sold in the United States absent registration under the US Securities Act or an available exemption from, or transaction not subject to, the registration requirements of the US Securities Act. There will be no public offering of securities in the United States. Any sale in the United States of the securities mentioned in this communication will be made solely to "qualified institutional buyers" as defined in Rule 144A under the U.S. Securities Act. No public offering of the securities will be made in the United States. The Company has not authorized any offer to the public of securities in any Member State of the European Economic Area nor elsewhere. With respect to any Member State of the European Economic Area (each an "EEA Member State"), no action has been undertaken or will be undertaken to make an offer to the public of securities requiring publication of a prospectus in any EEA Member State. In any EEA Member State, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the EU Prospectus Regulation, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. The expression "EU Prospectus Regulation" means Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (together with any applicable implementing measures in any Member State). In the United Kingdom, these materials are only being communicated to (a) persons who have professional experience, knowledge and expertise in matters relating to investments and qualifying as "investment professionals" for the purposes of article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (all such persons being referred to as "relevant persons") and (b) only in circumstances falling within the circumstances set out in Part 1 of Schedule 1 to The Public Offers and Admissions to Trading Regulations 2024. These materials are directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "anticipate", "believe", "continue", "estimate", "expect", "intend", "may", "should", "will" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date and are subject to change without notice. This announcement is made by and is the responsibility of, the Company. The Manager is acting exclusively for the Company and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, or for advice in relation to the contents of this announcement or any of the matters referred to herein. Neither the Manager nor any of its affiliates make any representation as to the accuracy or completeness of this announcement and none of them accepts any responsibility for the contents of this announcement or any matters referred to herein. This announcement is not a prospectus. This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company. Neither the Manager nor any of its affiliates accepts any liability arising from the use of this announcement. Each of the Company, the Manager and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any statement contained in this announcement whether as a result of new information, future developments or otherwise. The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions.

BTC AB resolves to carry out a rights issue of preference A shares in connection with listing on Spotlight Stock Market

The Board of Directors of B Treasury Capital AB, (“BTC AB” or the “Company”), has today resolved, pursuant to the authorisation granted by the Annual General Meeting held on 31 March 2026, to carry out a rights issue of 195,078 preference A shares (“BTC PREF”), with preferential rights for the Company's existing holders of Class B shares, (the “Rights Issue”). In connection with the Rights Issue, BTC PREF is intended to be admitted to trading on Spotlight Stock Market with first day of trading expected on 20 July 2026 (the “Listing”). The subscription price has been set at SEK 120.00 per BTC PREF. Provided that the Rights Issue is fully subscribed, the Company will receive proceeds of approximately SEK 23.4 million before issue costs. The purpose of the Rights Issue is to strengthen the Company’s capital base and support the continued execution of the Company’s Bitcoin treasury strategy. If the Rights Issue is oversubscribed, the Board of Directors may, in whole or in part, pursuant to the authorisation granted by the 2026 Annual General Meeting, resolve on an over-allotment issue of a maximum of 83,333 shares, corresponding to issue proceeds of a maximum of approximately SEK 10.0 million before issue costs (the “Over-allotment Issue”). The terms of any Over-allotment Issue will be the same as those of the Rights Issue.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.SummaryThe purpose of the Rights Issue is to strengthen the Company’s capital base and support the continued execution of the Company’s Bitcoin treasury strategy.The Rights Issue is intended to bring capital directly onto the Company’s balance sheet without creating debt or large repayment obligations, enabling BTC AB to acquire bitcoin in a flexible and risk-efficient way.Shareholders who are registered as holders of Class B shares in the share register maintained by Euroclear Sweden AB on the record date, 12 June 2026, have preferential rights to subscribe for BTC PREF in the Rights Issue.For each existing Class B share held on the record date, one (1) subscription right will be received. Four (4) subscription rights will entitle the holder to subscribe for one (1) BTC PREF.The subscription price has been set at SEK 120.00 per BTC PREF.The subscription period in the Rights Issue runs from and including 16 June 2026 up to and including 30 June 2026. Trading in subscription rights will take place from and including 16 June 2026 up to and including 25 June 2026.BTC PREF is the Company’s preference share. According to its terms, BTC PREF carries a preferential dividend of SEK 12.00 per year per share, payable monthly in arrears.If the Rights Issue is fully subscribed, BTC AB will receive issue proceeds of approximately SEK 23.4 million before issue costs.Through the Rights Issue, a maximum of 195,078 new BTC PREF may be issued, corresponding to a dilution of approximately 0.019 percent of the share capital and approximately 0.004 percent of the votes.Subscription undertakings corresponding to approximately SEK 6.3 million, equivalent to approximately 27.1 percent of the Rights Issue, have been received. In addition, the Company has received non-binding intentions to subscribe for BTC PREF from all members of the Board of Directors and certain members of management of BTC AB, corresponding to approximately SEK 2.4 million, equivalent to approximately 10.2 percent of the Rights Issue. The intentions to subscribe are not legally binding and do not constitute formal commitments to subscribe.The estimated date for announcement of the outcome of the Rights Issue is 2 July 2026.If the Rights Issue is oversubscribed, the Board of Directors may, in whole or in part, pursuant to the authorisation granted by the 2026 Annual General Meeting, resolve on an Over-allotment Issue of a maximum of 83,333 shares, corresponding to issue proceeds of a maximum of approximately SEK 10.0 million before issue costs. The terms of any Overallotment Issue will be the same as those of the Rights Issue.Background and reasons for the Rights IssueBTC AB is a Sweden-based company with Bitcoin as its core reserve asset. The Company is a pure-play Bitcoin treasury company operating under a Swedish corporate equity structure. As a dedicated operator in Bitcoin treasury management, BTC AB focuses on acquiring, securing and maintaining Bitcoin as part of a long-term capital strategy.The Rights Issue is carried out to strengthen the Company’s capital base and support the continued execution of the Company’s Bitcoin treasury strategy. The net proceeds are intended to be used primarily for additional acquisitions of bitcoin and for liquidity reserve purposes related to the Company’s preference share structure.The preference share structure is intended to allow BTC AB to raise equity capital without creating debt or large repayment obligations. The structure is also intended to enable BTC AB to prudently increase its amplification through preferred equity, with the objective of accelerating growth in Bitcoin per Share while limiting dilution for ordinary equity shareholders.BTC PREF carries a preferential dividend and has a liquidation preference corresponding to the redemption amount. BTC AB may redeem all or some of the BTC PREF in accordance with the terms set out in the Company’s articles of association and the information document.Background and reasons for the ListingIn connection with the Rights Issue, BTC AB has applied for admission to trading of BTC PREF on Spotlight Stock Market. The first day of trading is expected to be on or around 20 July 2026.Following the directed issue of preference shares in December 2025, the Company now seeks to broaden its shareholder base through the Rights Issue, and the Listing provides an organised secondary market and transparent pricing for existing and new holders. The preference share is a key part of the Company's financing strategy, as the Board considers it an effective instrument for raising capital for its Bitcoin treasury strategy without increasing financial leverage or diluting ordinary shareholders.The Rights IssueThe Board of Directors has resolved to carry out the Rights Issue. For each existing Class B share held on the record date, one (1) subscription right will be received. Four (4) subscription rights will entitle the holder to subscribe for one (1) BTC PREF. The subscription price has been set at SEK 120.00 per BTC PREF.Provided that the Rights Issue is fully subscribed, the Company will receive approximately SEK 23.4 million before transaction related costs.Upon full subscription, 195,078 BTC PREF will be issued, and the Company’s share capital will increase by SEK 97.5390, corresponding to a dilution of approximately 0.019 percent of the share capital and approximately 0.004 percent of the votes.Shareholders who do not participate in the Rights Issue have the possibility to receive certain financial compensation by selling their subscription rights. In order not to lose the value of the subscription rights, the holder must either exercise the subscription rights to subscribe for BTC PREF or sell them during the period for trading in subscription rights.If not all BTC PREF are subscribed for with subscription rights, the Board of Directors shall, within the maximum amount of the Rights Issue, resolve on allotment of BTC PREF subscribed for without subscription rights in accordance with the following.First, allotment shall be made to those who have subscribed for BTC PREF with subscription rights, regardless of whether the subscriber was a shareholder on the record date or not, and, in the event that allotment to these subscribers cannot be made in full, allotment shall be made pro rata in relation to the number of subscription rights exercised for subscription of BTC PREF and, to the extent this cannot be done, by drawing of lots. Second, allotment shall be made to others who have subscribed for BTC PREF without subscription rights, and, in the event that allotment to these subscribers cannot be made in full, allotment shall be made pro rata in relation to the number of BTC PREF subscribed for by each person and, to the extent this cannot be done, by drawing of lots.Subscription undertakingsA number of external investors have entered into subscription undertakings to subscribe for BTC PREF in the Rights Issue, corresponding in aggregate to approximately SEK 6.3 million, equivalent to approximately 27.1 percent of the Rights Issue. The individual subscription undertakings are set out in the table below. The subscription undertakings are not secured through bank guarantees, blocked funds, pledges or similar arrangements. No remuneration is paid for the subscription undertakings. The Rights Issue is not covered by guarantee commitments.Subscriber                           I Number of BTC PREF        I Amount (SEK)Tobias Persson Rosenqvist I 50,000                                I 6,000,000Niklas Estensson                 I 2,500                                  I 300,000Mikael Koponen                   I 300                                     I 36,000Total                                     52,800                                   6,336,000In addition, all members of the Board of Directors and certain members of management of BTC AB have expressed non-binding intentions to subscribe for BTC PREF in the Rights Issue, corresponding in aggregate to approximately SEK 2.4 million, equivalent to approximately 10.2 percent of the Rights Issue. These intentions reflect the relevant persons’ current intention to participate in the Rights Issue but are not legally binding and do not constitute formal subscription commitments.Preliminary timetable for the Rights Issue, all dates refer to 2026 unless otherwise stated10 June: Last day of trading in Class B shares including the right to receive subscription rights11 June: First day of trading in Class B shares excluding the right to receive subscription rights12 June: Record date for participation in the Rights Issue15 June: Publication of the information document16 June to 25 June: Trading in subscription rights on Spotlight Stock Market16 June to 30 June: Subscription period in the Rights Issue 16 June to until the Rights Issue is registered with the Swedish Companies Registration Office (Sw. Bolagsverket): Estimated trading in paid subscribed shares on Spotlight Stock Market2 July: Estimated date for announcement of the outcome of the Rights Issue14 July: Estimated registration of the Rights Issue with the Swedish Companies Registration Office20 July: Estimated first day of trading in BTC PREF on Spotlight Stock MarketChange in share capital and number of sharesIf the Rights Issue is fully subscribed, the Company’s share capital will increase by a maximum of SEK 97.5390, from SEK 500,416.7505 to SEK 500,514.2895. The number of shares will increase by a maximum of 195,078 BTC PREF, from 1,000,833,501 shares to 1,001,028,579 shares (consisting of 499,999,900 Class A shares, 780,313 Class B shares, 499,992,888 Class C shares and 255,478 BTC PREF). This corresponds to a dilution of approximately 0.019 percent of the share capital and approximately 0.004 percent of the votes.Information documentFull terms and instructions for the Rights Issue as well as additional information about the Company will be set out in the information document, which is expected to be published on 15 June 2026. The information document and application form will be available at btc.se and at the dedicated page btc.se/pref.Over-allotment IssueIf the Rights Issue is oversubscribed, the Board of Directors may, pursuant to the authorisation granted by the 2026 Annual General Meeting, resolve in whole or in part on an Over-allotment Issue. The Over-allotment Issue may comprise up to 83,333 shares, corresponding to maximum issue proceeds of approximately SEK 10.0 million before issue costs. The terms of any Over-allotment Issue will be the same as those of the Rights Issue. When resolving on the Over-allotment Issue, the Board of Directors shall determine allotment in accordance with the principles for allotment applied in the Rights Issue. The reason for the deviation from the shareholders' preferential rights is to accommodate a higher demand than initially anticipated in the event of oversubscription in the Rights Issue, and to enable the Company to receive additional issue proceeds in such case. The right to subscribe for shares in the Over-allotment Issue shall accrue to those who have subscribed for shares in the Rights Issue without receiving full allotment.The Over-allotment Issue means that the share capital may increase by a maximum of an additional SEK 41.6665 and that the number of shares may increase by a maximum of an additional 83,333 shares, which, together with the Rights Issue, corresponds to a dilution of approximately 0.028 percent of the share capital and approximately 0.005 percent of the votes in the Company following registration of the new shares with the Swedish Companies Registration Office.AdvisorsEminova Partners acts as financial advisor in connection with the Rights Issue. Aqurat Fondkommission AB acts as issuing agent in connection with the Rights Issue.Important informationThe information in this press release does not constitute an offer to acquire, subscribe for or otherwise trade in shares, preference shares, subscription rights or other securities in BTC AB. No action has been taken, and no action will be taken, to permit a public offering in any jurisdiction other than Sweden. Invitation to eligible persons to subscribe for BTC PREF in BTC AB will only be made through the information document published by the Company.The information in this press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa or South Korea or any other jurisdiction where such action would be unlawful, subject to legal restrictions or require measures other than those required under Swedish law. Any action in violation of this instruction may constitute a breach of applicable securities legislation. This press release does not constitute an offer or invitation to acquire or subscribe for securities in the United States. No shares, preference shares, subscription rights or other securities issued by the Company, the “Securities”, have been or will be registered under the United States Securities Act of 1933, the “Securities Act”, or the securities legislation of any state or other jurisdiction in the United States, and no Securities may be offered, subscribed for, exercised, pledged, sold, resold, delivered or transferred, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with the securities legislation of the relevant state or other jurisdiction in the United States. The Securities have neither been approved nor registered, and will not be approved or registered, by the United States Securities and Exchange Commission, any state securities authority or any other authority in the United States. Nor has any such authority assessed or expressed an opinion on the offering or the accuracy and reliability of the information document. To assert otherwise is a criminal offence in the United States.This press release is not a prospectus within the meaning of Regulation EU 2017/1129, the “Prospectus Regulation”, and has not been approved by any regulatory authority in any jurisdiction. In an EEA Member State other than Sweden, this communication is only intended for and directed only at “qualified investors” in the relevant Member State within the meaning of the Prospectus Regulation.In the United Kingdom, this document and other materials relating to the securities referred to herein are distributed and directed only to, and any investment or investment activity to which this document relates is available only to and will be engaged in only with, “qualified investors” within the meaning of the UK version of Regulation EU 2017/1129, which forms part of UK law by virtue of the European Union Withdrawal Act 2018, who are i persons having professional experience in matters relating to investments and who fall within the definition of “investment professionals” in article 19 5 of the Financial Services and Markets Act 2000 Financial Promotion Order 2005, the “Order”, ii “high net worth entities” etc. as referred to in article 49 2 a to d of the Order, or iii such other persons to whom such investment or investment activity may lawfully be directed under the Order, all such persons together being referred to as “relevant persons”. Any investment or investment activity to which this communication relates is available in the United Kingdom only to relevant persons and will be engaged in only with relevant persons. Persons who are not relevant persons should not take any action based on this document and should not act or rely on it.Forward-looking statementsThis press release contains certain forward-looking information that reflects the Company’s current view of future events as well as financial and operational development. Words such as “intends”, “assesses”, “expects”, “may”, “plans”, “believes”, “estimates” and other expressions that indicate predictions or indications of future development or trends, and that are not based on historical facts, constitute forward-looking information. Forward-looking information is by its nature associated with both known and unknown risks and uncertainties, since it depends on future events and circumstances. Forward-looking information does not constitute a guarantee of future results or development, and actual outcomes may differ materially from what is expressed or implied in forward-looking information.For further information, please contact:Christoffer De Geer, CEOEmail: hello@btc.seWebsite: www.btc.seAbout BTC ABBTC AB is a Sweden-based company with Bitcoin as its core reserve asset. The Company is a pure-play Bitcoin treasury company operating under a Swedish corporate equity structure. As a dedicated operator in Bitcoin treasury management, BTC AB focuses on acquiring, securing and maintaining Bitcoin as part of a long-term capital strategy. BTC AB is listed on Spotlight Stock Market.This information is information that B Treasury Capital AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication through the agency of the contact person set out above on 5 June 2026 at 12.00 CEST. 

TradeDoubler AB: Report from TradeDoubler’s Annual General Meeting

The Annual General Meeting (“AGM”) of TradeDoubler AB (publ) was held today on 5 June 2026 in Stockholm. The AGM was conducted with both physical participation and postal voting. The AGM resolved on all proposed matters in accordance with previously published proposals. Below is a summary of the main decisions taken. Adoption of the income statement and balance sheet The Meeting resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet for the financial year 2025. Disposition of the result The AGM resolved, in accordance with the Board of Directors’ proposal, that no dividend shall be paid for the financial year 2025 and that the available funds shall be carried forward to a new account. Discharge from liability The AGM resolved to discharge each member of the Board of Directors and the CEO from liability for the financial year 2025. Board of Directors and auditor The AGM resolved, in accordance with the nomination committee’s proposal, that the number of ordinary members shall be five with no deputies. It was further resolved that the company shall have a registered audit firm as auditor. The AGM resolved, in accordance with the nomination committee’s proposal, to re-elect Pascal Chevalier, Gautier Normand, Jérémy Parola, Erik Siekmann and Xavier Penat as Board members for the period until the end of the next Annual General Meeting. Pascal Chevalier was re-elected as chairman of the Board of Directors. The AGM resolved, in accordance with the nomination committee’s proposal, to re-elect the registered auditing firm Ernst & Young Aktiebolag as auditor for the period until the end of the next Annual General Meeting with the auditor Jennifer Rock as the company’s principal auditor. Remuneration to the Board of Directors and auditors The AGM resolved, in accordance with the nomination committee’s proposal, that remuneration shall be paid in the amount of SEK 180,000 to each Board member and that remuneration to the auditor shall be paid in accordance with approved invoice. Remuneration report The AGM resolved, in accordance with the board of directors’ proposal, to approve the board of directors’ remuneration report regarding remuneration to senior executives in accordance with Chapter 8, Section 53 a of the Swedish Companies Act. Adoption of guidelines for compensation to the company management The AGM resolved, in accordance with the Board of Directors’ proposal, to adopt guidelines for compensation to the company management. Authorisation for the Board of Directors to resolve upon issuance of shares, warrants and/or convertibles The AGM resolved in accordance with the Board of Directors’ proposal to authorise the Board of Directors, until the next Annual General Meeting, on one or several occasions, with or without deviation from the shareholders’ preferential rights, with or without provision on non-cash consideration, set-off or otherwise with conditions pursuant to the Swedish Companies Act, to resolve on new issues of shares, warrants and/or convertibles. Authorisation for the Board of Directors to resolve upon acquisition of own shares The AGM resolved in accordance with the Board of Directors’ proposal to authorise the Board of Directors, until the next Annual General Meeting, on one or several occasions, to resolve on the acquisition of a maximum number of own shares so that, after the purchase, the company holds not more than ten (10) per cent of the total number of shares in the company. Authorisation for the Board of Directors to resolve upon the transfer of own shares The AGM resolved in accordance with the Board of Directors’ proposal to authorise the Board of Directors, until the next Annual General Meeting, on one or several occasions, to resolve on the transfer of shares in the company. The shares may only be transferred in conjunction with the financing of company acquisitions and other types of strategic investments and acquisitions, and the transfers may not exceed the maximum number of treasury shares held by the company at any given time. Transfer of own shares shall be made either on Nasdaq Stockholm or in another manner. Amendment of the articles of association The AGM resolved, in accordance with the Board of Directors’ proposal, to amend § 1 of the company’s articles of association whereby the company’s current company name is changed to Nyorda AB. In the event that the company name Nyorda AB cannot be registered with the Swedish Companies Registration Office, the current company name shall remain. For the full details of each proposal adopted by the AGM, please refer to www.tradedoubler.com. For further information, please contact: Matthias Stadelmeyer, CEO of TradeDoublerTel: +46 8 405 08 00Email: ir@tradedoubler.com The information was submitted for publication at 12:00 CEST on 5 June 2026. About Tradedoubler Tradedoubler is an international leader in digital marketing and technology.  Combining over 20 years of digital marketing expertise, a global presence and a market-leading technology platform, Tradedoubler offers customised performance-based solutions for advertisers and publishers. Founded in Sweden in 1999, Tradedoubler was a pioneer in affiliate marketing in Europe and has since developed its offering to include data-driven insights and purchase journey tracking through its proprietary BI tool. The share is listed on Nasdaq OMX Stockholm. More information is available at www.tradedoubler.com

Legato Merger Corp. III Shareholders Approve Business Combination with Einride

NEW YORK, NY & STOCKHOLM, SWEDEN — June 5, 2026 — Einride AB ("Einride" or the "Company"), a technology company driving the transition to cost-efficient electric and autonomous freight operations, and Legato Merger Corp. III (NYSE American: LEGT) ("Legato"), a publicly traded special purpose acquisition company, today announced that Legato's shareholders voted to approve the previously announced business combination  between Einride and Legato and the related matters (the "Transaction") at a special meeting of shareholders held on June 4, 2026 (the "Special Meeting"). A Current Report on Form 8-K disclosing the full voting results will be filed by Legato with the Securities and Exchange Commission. The Transaction values Einride at a pre-money equity value of $1.35 billion. As previously announced,  Einride raised $113 million through an oversubscribed PIPE financing in connection with the Transaction. The PIPE was supported by new and existing investors, including Stockholm-based EQT Ventures and a global asset management company based on the West Coast of the United States. "At Einride, we are redesigning the way freight moves. We are building the world’s most efficient freight network and going public gives us the platform to deploy our electric and autonomous technologies at the speed this market demands,” said Roozbeh Charli, Chief Executive Officer at Einride. Einride, which is driving the transition to cost-efficient electric and autonomous freight operations for large shippers across the U.S., Europe, and the Middle East, currently counts more than 30 enterprise customers across seven countries, with approximately $92 million in expected annual recurring revenue (ARR) from signed contracts and over $800 million in potential long-term ARR through joint business plans with blue-chip customers. Upon the completion of the Transaction, the combined company's ordinary shares, represented by American Depositary Shares, and warrants are expected to commence trading on the Nasdaq under the ticker symbol "ENRD" and “ENRDW,” respectively. About Einride Founded in 2016, Einride is a technology company that develops and operates digital, electric, and autonomous freight solutions, accelerating the transition to future-proofed transportation. Its technology platform includes AI-powered planning and optimization, autonomous technologies, one of the world's largest electric heavy-duty fleets, and charging infrastructure. Einride serves customers across North America, Europe, and the Middle East.  About Legato Merger Corp. III: Legato is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition or other similar business combination with one or more businesses or entities. Forward-Looking Statements This communication contains certain “forward-looking statements” within the meaning of U.S. federal securities laws including, but not limited to, statements regarding the additional investments and Transaction. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions available to the Company and Legato, and, as a result, are subject to risks and uncertainties. Any such expectations and assumptions, whether or not identified in this communication, should be regarded as preliminary and for illustrative purposes only and should not be relied upon as being necessarily indicative of future results. Many factors could cause actual future events to differ materially from the forward-looking statements in this communication, including but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of definitive agreements with respect to the Transaction; (2) the outcome of any legal proceedings that may be instituted against Legato, Einride, the combined company or others following the announcement of the Transaction and any definitive agreements with respect thereto; (3) The inability to complete the Transaction due to the failure to satisfy conditions to closing the Transaction; (4) risks related to the scaling of the Company’s business and the timing of expected business milestones; (5) the ability to meet stock exchange listing standards following the consummation of the Transaction; (6) the risk that the Transaction disrupts current plans and operations of the Company as a result of the announcement and consummation of the Transaction; (7) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Transaction; (9) risks associated with changes in laws or regulations applicable to operations; (10) the possibility that the Company or the combined company may be adversely affected by other economic, geopolitical, business, and/or competitive factors; (11) supply shortages in the materials necessary for the production of Einride’s solutions; (12) negative perceptions or publicity of the Company; (13) risks related to working with third-party manufacturers for key components of Einride’s solutions; (14) the termination or suspension of any of Einride’s contracts or the reduction in counterparty spending; and (15) the ability of Einride or the combined company to issue equity or equity- linked securities in connection with the business combination or in the future. Forward-looking statements are not guarantees of future performance. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s registration statement on Form F-4 (“Registration Statement”) filed with the U.S. Securities and Exchange Commission (the “SEC”), and other documents filed by the Company and/or Legato from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward- looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and all forward-looking statements in this communication are qualified by these cautionary statements. The Company and Legato assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except to the extent required by applicable law. Neither the Company nor Legato gives any assurance that either the Company or Legato will achieve its expectations. The inclusion of any statement in this communication does not constitute an admission by the Company or Legato or any other person that the events or circumstances described in such statement are material. Additional Information and Where to Find It In connection with the Transaction, the Company filed the Registration Statement, including a preliminary proxy statement/prospectus, which was declared effective by the SEC on May 14, 2026. This communication does not contain all the information that should be considered concerning the Transactions and is not intended to form the basis of any investment decision or any other decision in respect of the Transaction. Before making any investment decision, investors and shareholders of Legato are urged to read the Registration Statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the Transaction as they become available because they will contain important information about the Transaction. Investors and shareholders will be able to obtain free copies of the Registration Statement, proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by the Company or Legato through the website maintained by the SEC at www.sec.gov. In addition, the documents filed by Legato may be obtained by written request to Legato at Legato Merger Corp. III, 777 Third Avenue, 37th Floor, New York, NY 10017. No Offer or Solicitation This communication does not constitute an offer to sell or a solicitation of an offer to buy the securities of Legato, Einride or the combined company resulting from the Transaction, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act. This communication is restricted by law; it is not intended for distribution to, or use by any person in, any jurisdiction in where such distribution or use would be contrary to local law or regulation.

Inside information: Summa Defence Plc enters into a EUR 8 million bridge financing arrangement and updates its liquidity and working capital position

Summa Defence Plc           Company announcement, inside information          5 June 2026 at 4:30 p.m. EEST Summa Defence Plc (the “company”) has today entered into a loan agreement with Largus Holding AB concerning a bridge financing arrangement of EUR 8.0 million. Largus Holding AB is a Swedish privately owned investment company controlled by Erik Salén. Largus Holding AB forms part of the Salén investment sphere, a Swedish family-owned investment group with a long history of entrepreneurship, active ownership and long-term investments. The purpose of the financing is to strengthen the company’s short-term liquidity and working capital position and to support the stabilisation of the Group’s financing structure while the company prepares longer-term equity- and debt-based financing solutions. The loan will be made available to the company following the signing of the loan agreement. The loan carries an annual interest rate of 14 per cent, a set-up fee of 6 per cent of the principal amount and matures on 3 July 2026. The company may prepay the loan before maturity, subject to a prepayment penalty of 10 per cent of the principal amount repaid early. The loan agreement includes certain undertakings relating to the company’s use of the loan proceeds and future issuances of financial instruments. The bridge financing has been structured with the intention that it may be converted into a convertible bond. Subject to the approval of the required authorisation by the Annual General Meeting on 24 June 2026 for the Board of Directors of the company, the agreement between the parties and applicable corporate and regulatory requirements, the loan, accrued interest and set-up fee may be converted into convertible bonds or otherwise set off against shares at a subscription or conversion price of EUR 0.20 per share. If the loan is converted into a convertible bond, the maturity date would be on or about 31 March 2027. If the Annual General Meeting does not approve the required authorisation or if the Board of Directors of the company has not directed the convertible bond for subscription by Largus Holding AB by 3 July 2026, the loan principal, accrued interest and set-up fee shall be repaid in cash by 4 July 2026. As previously announced, without new financing or payment arrangements, the company’s current working capital is not sufficient for its needs for the next 12 months. Following the bridge financing, and provided that the loan is drawn down as planned, the company expects its short-term liquidity position and working capital to improve materially and estimates that the financing will cover the company’s liquidity and working capital needs for approximately three to five months, depending on delivery schedules and the implementation of payment, financing and operational measures. The bridge financing is expected to address the company’s immediate liquidity situation, but it does not remove the company’s need to complete a longer-term financing solution. As part of such longer-term financing solution, the company intends to prepare a rights issue, subject to the authorisations proposed to the Annual General Meeting, market conditions and separate resolutions by the Board of Directors of the company. The current intention of the Board of Directors is that the subscription price in the contemplated rights issue would correspond to the subscription or conversion price of EUR 0.20 per share contemplated under the possible convertible bond arrangement. If the required financing, payment arrangements and operational measures cannot be implemented as planned or to a sufficient extent, this may have a material adverse effect on the company’s business operations, financial position, liquidity and ability to continue as a going concern. The company will communicate further information as the preparations progress. SUMMA DEFENCE PLCBoard of Directors Further information:Robert Blumberg, CEOPhone: +358 40 839 7408Email: robert.blumberg@summadefence.com Summa Defence in brief Summa Defence Plc is a Finnish defence and security technology group whose mission is to create a strong industrial foundation of innovative defence and dual use SMEs for strengthening the comprehensive security of society. Summa Defence aims for both organic and inorganic growth across three focus areas: maritime technologies, land technologies and new technologies. The company’s vision is to be a forerunner in comprehensive security industry. The shares of Summa Defence Plc are listed on the Nasdaq First North Growth Market in Sweden (SUMMAS) and Finland (SUMMA). www.summadefence.fi/en/ The company’s Certified Adviser is Augment Partners AB, info@augment.se, tel. +46 8 604 2255.

Episurf Medical acquires a mixed property portfolio of 30 properties in Södermanland and Östergötland with an agreed property value of SEK 920 mn from Livi Fastigheter AB

The acquisition in brief Episurf has entered into an agreement to acquire all shares in Grännäs Fastigheter Holding AB, reg. no. 559572-2470, and Goldcup 39848 AB, reg. no. 559585-9330, from Livi Fastigheter AB. The property portfolio comprises 30 properties and constitutes a mixed portfolio of residential properties and LSS housing. The lettable area amounts to approximately 51,000 sqm. The total agreed property value amounts to SEK 920 mn, with a possible deferred consideration of SEK 25 mn based on the occupancy rate at closing. Payment of the purchase price The purchase price is financed through an issue of B-shares of SEK 200 mn at a price of SEK 0.10 per B-share, a convertible loan of SEK 66.5 mn with a 24-month maturity and interest of STIBOR + 1.75 percent, and financing from banks and credit institutions. The conversion price is determined by the time at which conversion is called: SEK 0.11 per B-share during the first six months, SEK 0.12 per B-share during the following twelve months and SEK 0.13 per B-share during the final six months. The buyer is entitled to call for conversion during the final six-month period. Dilution The issue of B-shares and conversion of the convertible loan may result in dilution for existing shareholders of up to approximately 59 percent based on the current number of registered shares. Calculated on all issued and contracted shares prior to the acquisition (fully diluted basis), the dilution amounts to approximately 7 percent. Background and rationale On 30 December 2025, Episurf's board of directors announced that the Company had decided to acquire property companies to broaden its operations and strengthen its financial position. Episurf has since entered into agreements to acquire Frusipe Intressenter Target 1 AB, KlaraBo Empire Holding AB, Mofast Invest II AB, a property portfolio from Botrygg AB, a property portfolio from Lilium, two smaller properties from HanssonGruppen and a property portfolio from Setune Assets AB in Uppsala. With the acquisition of the property portfolio from Livi Fastigheter, Episurf continues to build its Nordic property platform with a focus on cash flow and return. Based on already signed property acquisitions, the annual rental income of Episurf's property segment is expected, on a pro forma basis following the acquisition, to increase from approximately SEK 357 mn to approximately SEK 439 mn, and total property assets from approximately SEK 4,319 mn to approximately SEK 5,264 mn. Key figures for the property portfolio The property portfolio has an agreed property value of SEK 920 mn, a lettable area of approximately 51,000 sqm and net operating income (NOI) of SEK 57 mn, corresponding to an NOI yield of approximately 6.2 percent. Annual rental income amounts to approximately SEK 77.7 mn. The occupancy rate amounts to approximately 95%. For further information, please contact: Jens Andersson, CEO, Episurf Medical Email: jens.andersson@episurf.com About Episurf Medical Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The Company's objective is to create value growth through the acquisition and management of Nordic properties. The Company also has a medical technology operation based on the individualized implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. Episurf Medical's head office is in Stockholm, Sweden. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication, through the agency of the contact person set out above, at 16:30 CET on 5 June 2026. THIS PRESS RELEASE HAS BEEN PUBLISHED IN SWEDISH AND ENGLISH. IN THE EVENT OF ANY DISCREPANCY BETWEEN THE LANGUAGE VERSIONS, THE SWEDISH VERSION SHALL PREVAIL.

Klaria receives 25 MSEK in loan financing with the possibility of an additional 15 MSEK

The purpose of the bridge loan is to strengthen Klaria's financial flexibility during the ongoing process that the Company is conducting together with BDO London to access all available markets around the world.  Klaria would also like to highlight that the preparatory activities ahead of CNX Therapeutics' expected launch of Sumatriptan Alginate Film in Europe are progressing according to plan, including ongoing large-scale manufacturing of the product. In addition, the market for migraine treatment continues to grow, and Klaria believes that the Company's product has a good opportunity to take a very strong position in the treatment of acute migraine – completely replacing many of the existing sumatriptan products. "This financing significantly strengthens our flexibility, thus creating stability during the process we are now conducting together with BDO. At the same time, we continue to progress towards the market launch of Sumatriptan Alginate Film in Europe together with our licensing partner CNX Therapeutics. The product's unique advantages in the form of an overall lower dose and rapid and reliable delivery of the sumatriptan to the bloodstream with much lower variability mean that we see the perfect conditions to establish a very strong penetration in the large and growing worldwide market for acute migraine treatment," says Klaria's Chairman of the Board Fredrik Hübinette. The bridge loan will be disbursed immediately and runs up until May 27 2027. The loan has an arrangement fee of 1,5 MSEK, and a fixed interest rate for the loan period of 30-day Stibor +1.5 percentage points.

Nel ASA: Settlement agreement with Iwatani Corporation of America

(June 6, 2026 – Oslo, Norway) Reference is made to the press release dated February 7, 2024, in which Nel ASA (Nel, OSE: NEL) announced that Iwatani Corporation of America had filed a lawsuit against Nel and certain entities that were, at the time, part of the Nel group, in connection with agreements for the delivery of fueling equipment and services. Besides Nel, the defendants included entities that are now part of Cavendish Hydrogen ASA (Cavendish Hydrogen, OSE: CAVEN), as well as four individuals. Iwatani, Nel, and Cavendish Hydrogen have resolved their dispute, and related lawsuit, involving Iwatani’s hydrogen fueling stations in California. The dispute arose from technical and operational challenges in a developing industry and has been resolved amicably and in the best interests of all parties. With the issues now resolved to each party’s satisfaction, Iwatani, Nel, and Cavendish can confidently affirm each other’s continuing commitment to advancing the hydrogen fueling industry and remain open to future collaboration. The settlement amount for Nel ASA is USD 7.5 million. The settlement eliminates further legal costs and mitigates litigation risk in the US. ENDS  For additional information, please contact:Kjell Christian Bjørnsen, CFO, +47 917 02 097Wilhelm Flinder, Head of IR, Communications and Marketing, +47 936 11 350 About Nel ASA | www.nelhydrogen.comNel has a history tracing back to 1927 and is today a leading pure play hydrogen technology company with a global presence. The company specializes in PEM and Alkaline electrolyser technology for production of renewable hydrogen. Nel's product offerings are key enablers for a green hydrogen economy, making it possible to decarbonize various industries such as transportation, refining, steel, and ammonia. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act. This information was issued as inside information pursuant to the EU Market Abuse Regulation, and was published by Wilhelm Flinder, Head of Investor Relations, Communications and Marketing, at Nel ASA on the date and time provided.

Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT[®] in Aggressive Brain Cancer (Glioblastoma)

“The preliminary readout of our Phase 1 clinical trial with uTREAT[®] in glioblastoma is encouraging and supports the ability of our technology to safely deliver therapeutically relevant radiation doses to the tumor without reaching dose limits for healthy organs. With these data, we are confident in moving forward with the Phase 1 trial and the development program for uTREAT[®], with the ambition of developing a potentially game-changing radioligand therapy for patients with glioblastoma,” said Curasight’s CEO Ulrich Krasilnikoff. About the Phase 1 trial with uTREAT® in brain cancer The trial aims to investigate Curasight’s uTREAT[®] as a new targeted radioligand therapy for patients with glioblastoma. Participants in the trial are patients with newly diagnosed, verified or suspected GBM. uTREAT[®] is administered via a catheter directly into the vessels that feed the tumor (super SIACI). To enhance tumor targeting, the blood-brain barrier is transiently opened with the osmotic compound mannitol. The mode of administration is designed to achieve high binding of uTREAT[®] in tumors while minimizing radiation exposure to healthy organs. About Curasight’s uPAR theranostic platform Curasight’s uPAR theranostic platform combines two key technologies - uTRACE[®] and uTREAT[®] - both targeting uPAR. uTRACE[®] is designed to deliver sensitive imaging for diagnosis, while uTREAT[®] offers a targeted radiopharmaceutical therapy solution. Together, they form an integrated approach to improving the diagnosis and treatment of cancers that express uPAR. Curasight’s ambition is to develop both uTRACE[®] and uTREAT[®] to improve diagnosis and treatment of uPAR-expressing cancers. About high-grade glioma Treatment of glioblastoma and other high-grade gliomas (WHO grades 3 or 4) presents a significant unmet medical need, necessitating innovative and effective treatments. A total of approx. 65,000 patients are diagnosed with primary brain tumors, and more than 30,000 patients are diagnosed annually with the most aggressive form, glioblastoma, in the US and EU. Approximately 10% of patients with primary brain tumors are children. The prognosis for individuals with glioblastoma is very poor, as approximately 50% of patients die within 14 months, and after five years from diagnosis, only 5% are still alive. External beam radiation is a cornerstone in the therapy of brain cancers. uTREAT[®] could potentially complement current radiation strategies and reduce radiation exposure to healthy brain tissue due to more specific tumor tissue targeting.

Inside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care market

Terveystalo Plc INSIDE INFORMATION 8 June 2026 at 08:05 EEST Inside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care market Terveystalo Plc ("Terveystalo") and its subsidiary, Terveystalo Healthcare Oy, have today signed a share purchase agreement to acquire all shares in Silmäasema Oy ("Silmäasema") (the "Transaction") with Coronaria Oy ("Coronaria"), the institutional shareholders and certain management team members and other shareholders of Silmäasema (the "Main Sellers"). The purchase price, cash- and debt-free, is approx. EUR 574 million, consisting of an initial cash payment of EUR 275 million and 36.5 million new shares in Terveystalo valued at the closing share price of Terveystalo on 5 June 2026 of EUR 8.20 per share (the "Consideration Shares"). Subject to the completion of the Transaction, Coronaria will become the largest shareholder of Terveystalo with a holding of approximately 15.1% of outstanding shares and voting rights in Terveystalo. Subject to the completion of the Transaction, the Sellers (as defined below) will in aggregate hold approximately 22.4% of outstanding shares and voting rights in Terveystalo. · Silmäasema in brief: Silmäasema is the leading vision and eye health company in Finland in both private eye care and optical retail.[1] An important element of Silmäasema's strong growth and high profitability over the years has been its unique integrated operational model, which covers the entire eye health and vision care value chain and features multiple customer touchpoints across Silmäasema's optical retail, eye clinic and hospital network. The model facilitates seamless and integrated customer paths between the optical retail and ophthalmology businesses. · Creating a market leader in a growing market: The Transaction strengthens Terveystalo's position in the growing eye care market by adding material scale and forming a broader platform for faster growth and stronger profitability. The combined company will benefit from a highly complementary and diverse private customer base, creating significant cross-selling opportunities and broader value creation potential. The Transaction has a strong industrial logic as it combines two high-quality Finnish companies with strong cultural and operational compatibility. The combined company would serve a total of approximately two million customers with an even more versatile range of services and products, and would be well positioned to capitalise on attractive market opportunities, including internationally. · Strategic new owner: Due to the consideration structure, and subject to the completion of the Transaction, Coronaria will become Terveystalo’s largest shareholder and hence will remain invested in Terveystalo and aligned with its long-term value creation. Coronaria brings deep industry expertise and an excellent track record in value creation. The Terveystalo Board of Directors is looking forward to Coronaria’s strong participation and contribution in board work following the completion of the Transaction. · Material scale: On an illustrative basis for the 2025 financial year, the combined company would have approximately EUR 1.55 billion in annual revenue, and EUR 193 million in adjusted EBIT (excluding synergies). · Synergistic EPS-accretive Transaction: The Transaction is expected to create substantial value through estimated annual pre-tax run-rate synergies of approximately EUR 11–15 million. The full run-rate effect is expected by the end of year three following completion of the Transaction. In the estimate, the synergies are expected to arise primarily from cost synergies (estimated to be approximately 70% of the run-rate synergies), which are expected to be mainly realised within 18 months of the completion of the Transaction, and to a lesser extent from direct revenue synergies. One-off integration costs are expected to total EUR 7–9 million. The Transaction is expected to be adjusted earnings per share (EPS)[2] accretive in the first full year following the completion of the Transaction. · For customers and patients, the combined company will be a stronger partner, supported by Terveystalo's digital capabilities and comprehensive healthcare service offering, Silmäasema's vision care and eye health platform, and combined integrated care pathways and customer engagement. Silmäasema will continue under its current brand. · For the employees of both companies, the Transaction will offer broader opportunities for development across a larger and more diverse organisation, supported by developing career paths, access to a wider professional network and the long-term growth prospects of a combined company. · The initial cash payment is subject to certain adjustments, including post-closing adjustments for actual net debt and net working capital of the Silmäasema group, while the number of Consideration Shares is not subject to any adjustments. The consideration structure is designed to support shareholder value creation by maintaining Terveystalo's financial flexibility, while aligning the interests of Terveystalo and the Sellers (as defined below) through the share consideration component. · The Transaction values Silmäasema at an enterprise value / 2025 adjusted EBIT multiple of 11.5x[3], including the estimated full run-rate synergies at the midpoint of the estimate, reflecting the strong market position, growth profile and profitability of Silmäasema, as well as the expected value creation from the Transaction. Ville Iho, President and CEO of Terveystalo, said: "Terveystalo and Silmäasema will form a unique European combination with a compelling value proposition for an expanding customer base. I warmly welcome Silmäasema's employees and professionals, and I look forward to both teams embarking together on this exciting next phase as part of the new Terveystalo. I am convinced that, by working together, we can provide even better customer service and care, while creating an even more attractive work environment for vision care health professionals. This Transaction is highly compelling from both a strategic and financial perspective. Silmäasema strengthens Terveystalo's position in the attractive and growing eye care market, adds significant scale in a resilient private-pay business, and further diversifies Terveystalo's revenue mix. The Transaction offers a clear path to value creation, underpinned by meaningful long-term revenue growth potential, synergies, and expected accretion to adjusted earnings per share from the first full year following completion. Our cultures and operational model are well aligned, which supports disciplined integration and the delivery of the Transaction’s full value potential for customers, professionals and shareholders." Teppo Lindén, CEO of COR Group Oy, Coronaria and Silmäasema, said: "By joining forces with Terveystalo we can offer much broader health services to our customers and new career opportunities for our employees and professionals. We believe the Transaction brings together two high-quality companies with a strong strategic and operational fit, and creates an attractive platform for long-term value creation. As a significant shareholder in Terveystalo following completion, Coronaria intends to be an active, growth-oriented owner, supporting Terveystalo and its management in executing its strategy and capturing the value-creation opportunities of the Transaction. We see substantial opportunities in the combined company's strong market position, agile business mix and ability to drive profitable growth over time both domestically and internationally. We will support Terveystalo as a long-term Finnish shareholder in its next phase of development." Kari Kauniskangas, Chair of the Board of Directors of Terveystalo, said: "For Terveystalo, the acquisition of Silmäasema is based on solid industrial synergies and the Transaction establishes an attractive basis for clear value creation potential. I am delighted that Terveystalo's key shareholders support this milestone transaction for Terveystalo and have committed to voting in favour of the Board of Directors' proposal to authorise the share issue at the Extraordinary General Meeting. Upon the completion of the Transaction, we will welcome Coronaria as Terveystalo's largest shareholder. I am confident that Coronaria's extensive industry expertise will bring significant value to supporting Terveystalo's long-term growth." Silmäasema in brief Silmäasema is the leading company in Finland in both optical retail and private eye care.[4] In 2025, Silmäasema generated EUR 267 million in revenue and EUR 37 million in adjusted EBIT[5]. Silmäasema has demonstrated a strong and steady, above-market revenue growth of approximately 16% CAGR per annum between 2020 and 2025 during the ownership of Coronaria. Silmäasema uses its strong optical retail presence as an effective gateway to both eye health and surgical services. Silmäasema offers a complete range of services across the entire eye health value chain and seeks to effectively utilise the referral potential and customer flows between its optical retail and ophthalmology businesses. Silmäasema serves approximately 1 million customers each year. Silmäasema is Finland's most respected eye health provider and has the highest customer satisfaction in the industry.[6] Silmäasema's strong private-pay foundation has resulted in a strong market position and the leading brand in the industry. The company operates in a stable, non-cyclical environment supported by structural growth drivers and a demonstrated long-term growth track record. Silmäasema's unique business model combines self-reinforcing characteristics with digital capabilities, providing unique positioning at the intersection of healthcare services and optical retail with considerable earnings leverage. Silmäasema has a proven service concept with a strong execution track record, underpinning a low-risk company profile. In ophthalmology, Silmäasema is a leading private eye care provider in Finland[7] and holds approximately a 15% share of the public pay eye care market. Silmäasema has 20 private eye hospitals (of which 16 co-located with optical retail and 4 standalone) and 5 locations that serve public healthcare. These handle more than 320,000 eye doctor visits and operations each year, with a 90% out-of-pocket share. Silmäasema's locations employ around 350 eye doctors and more than 200 other professionals in eyesight and eye health. In optical retail, Silmäasema operates 155 stores in Finland and 10 in Estonia. Silmäasema sells approximately 360,000 pairs of eyeglasses each year from a network of around 50 major suppliers, with 97% of sales paid out-of-pocket. Of the 155 stores in Finland, 104 are optical retail stores, 35 combine optical retail and an ophthalmology clinic, and 16 combine optical retail and an eye hospital. Silmäasema holds approximately 7.3% of shares in Synsam AB (publ). The shares are not part of the Transaction. Strategic rationale: Making Terveystalo the market leader in the growing Finnish eye care market Silmäasema is expected to provide material scale to Terveystalo's eye care franchise in a growing market, making it the number one in Finland, and improve the growth and profitability outlook, reinforce the private-pay platform, and add a complementary customer mix with revenue derived mainly from out-of-pocket payments. The Transaction is significant, strategic, and enables synergies, supported by Silmäasema's proven service model, consistent growth in revenue and profitability, and scalable business structure. Upon completion of the Transaction, Terveystalo's current eye health units will be integrated into Silmäasema, and the resulting entity will be managed within the group structure as a new independent business segment. Silmäasema's brand will be retained in the Transaction. The integration is expected to proceed smoothly, supported by Silmäasema's extensive experience in bolt-on integrations and its management team's success in expanding eye health services profitably. The Transaction is synergistic and Silmäasema's business is "plug and play" in nature, offering Terveystalo future growth prospects and strategic flexibility, making this a highly compelling acquisition with strong value-creation potential. Terveystalo anticipates significant cost and revenue synergies and expects to grow sales through optical retail expansion, attract more customers, and improve customer referrals to eye health services. The Transaction enhances Terveystalo's strategic options for both organic and inorganic growth in Finland and internationally by increasing opportunities for synergistic bolt-on acquisitions in the eye care space and internationally by enabling larger platform acquisitions. Both companies have a strong customer-centric culture and high medical quality standards, and they focus on continuous improvement and operational excellence, providing a solid foundation for successful integration. The combined company will offer an even more attractive platform for healthcare professionals, combining scale, professional development opportunities, and even more robust capabilities to improve treatment outcomes through more integrated offering and care pathways. The ophthalmology and optical retail market[8] in the Nordics was estimated at approximately EUR 4.0 billion in 2024, of which optical retail accounted for EUR 2.1 billion and ophthalmology for EUR 1.9 billion. The market is expected to grow to approximately EUR 5 billion by 2029 (optical retail EUR 2.4 billion and ophthalmology EUR 2.5 billion), representing a compound annual growth rate (CAGR) of approximately 4%. Growth is supported by structural demand growth from demographic development and ageing, prevalence of certain eye conditions, privatisation and increasing demand for high-quality services and products. Silmäasema's historical financial performance and financial standing In 2025, Silmäasema generated EUR 267 million in revenue and EUR 37 million in adjusted EBIT[9], with approximately 43% of revenues (EUR 116 million) coming from ophthalmology and 57% (EUR 154 million) from optical retail[10]. Revenues of Silmäasema have grown steadily from EUR 60 million in 2012 to EUR 267 million in 2025, reflecting a strong long-term growth trajectory of approximately 12% CAGR per annum between 2012 and 2019 and approximately 16% CAGR per annum between 2020 and 2025, during the ownership of Coronaria, representing above-market growth. This financial track record is underpinned by strong profitability and cash flow generation, driven by clear and concrete operational drivers. Silmäasema has significant opportunities for continued growth and value creation by leveraging its platform, including further growth opportunities in Finland and internationally. Silmäasema's growth has been supported by significant strategic and operational actions, including the consolidation of eye care operations and businesses into Silmäasema, the introduction of the "Retail clinic" concept with increased integration of optical retail and ophthalmology, a three-year capital expenditure programme for diagnostics, digitalization and AI, acquisitions of selected franchise and independent stores, discontinuation of certain retail and ophthalmology units, and the start of new management as well as implementation of new management systems and key performance indicators (KPIs) across both businesses. At a segment level, Silmäasema's adjusted EBIT[11] margins have improved between 2021 and 2025, with ophthalmology margins consistently increasing from 6.7% to 11.5% and optical retail margins ranging between 15.3% and 17.8% over the same period. Further information on Silmäasema's historical financial performance and financial standing is presented in the Appendix to this release. Terveystalo and Silmäasema combined The following table provides certain illustrative financial information of Terveystalo and Silmäasema based on their respective audited consolidated financial statements for 2025 as prepared in accordance with IFRS(1). EUR million, except for Terveystalo Silmäasema Combined companypercentages, ratios and number ofprofessionalsRevenue 1,279 267 1,546Adjusted EBITDA 252 56 308Adjusted EBITDA-% 20% 21% 20%Adjusted EBIT 156 37 193Adjusted EBIT-% 12% 14% 13%Net debt (incl. IFRS 16 leases) 508 - 783(3)Net debt / EBITDA(2) (incl. IFRS 16 2.1x - Around 2.7x(3)leases)Number of professionals(4) Around Around Around 16,100 14,400 1,700 (1) Does not include impact from the acquisition of Hohde Group.(2) Unadjusted EBITDA.(3) Illustrative net debt calculated by adding the Transaction’s cash consideration of EUR 275 million to Terveystalo's net debt.(4) Includes employees and private practitioners. Terveystalo estimates that the Transaction would increase Terveystalo's adjusted earnings per share (EPS) in the first full year following completion of the Transaction. Considering the purchase price and estimated synergies, Terveystalo estimates that the Transaction would create value for shareholders of Terveystalo. Financial rationale and shareholder value creation: Synergistic EPS-accretive Transaction The Transaction supports profitable growth of the combined company and is expected to be adjusted earnings per share (EPS) accretive for Terveystalo in the first full year following the completion of the Transaction. The Transaction is expected to create substantial value through estimated annual pre-tax run-rate synergies of approximately EUR 11–15 million. The full run-rate effect is expected by the end of year three following the completion of the Transaction. In the estimate, the synergies are expected to arise primarily from cost synergies (estimated to be approximately 70% of the run-rate synergies), such as network optimisation, procurement efficiencies and savings in selling, general and administrative expenses and to a lesser extent from direct revenue synergies from cross-selling of Silmäasema's vision and eye health retail customers' product and service offering to Terveystalo's customer base. Cost synergies are expected to be mainly realised within 18 months of completion of the Transaction. The Transaction is also expected to deliver further material revenue upside through broader cross- and upselling opportunities, which are not included in the synergy estimate. One-off integration costs are expected to total EUR 7–9 million. Financing of the Transaction Terveystalo's current partner banks, Danske Bank A/S, Nordea Bank Abp, OP Corporate Bank plc and Skandinaviska Enskilda Banken AB (publ), have signed a firm commitment letter, subject to customary conditions, under which they have committed to arranging debt financing to finance the Transaction. The debt financing will be provided in the form of a term loan facility of up to EUR 350 million and the amounts borrowed under the facility will be used towards the payment of the purchase price of the Transaction and acquisition costs. The facility will have a tenor of four years, subject to two one-year extension options. Shareholder support: strong commitment from Terveystalo's key shareholders Terveystalo will publish a notice today to convene the Extraordinary General Meeting on 30 June 2026. Terveystalo's shareholders Rettig Investment AB, Varma Mutual Pension Insurance Company, OP Cooperative, Hartwall Capital (HC Holding Oy Ab), Ilmarinen Mutual Pension Insurance Company and Elo Mutual Pension Insurance Company, who in aggregate hold approximately 59.3% of all outstanding shares and votes (excluding treasury shares) in Terveystalo, have irrevocably undertaken, subject to certain customary conditions, to attend Terveystalo's Extraordinary General Meeting and vote in favour of the proposal of the Terveystalo Board of Directors for the share issue authorisation in respect of all the shares in Terveystalo held by such shareholders on the record date of the Extraordinary General Meeting. Timing and conditions The completion of the Transaction is subject to approval by the Finnish Competition and Consumer Authority and Terveystalo's Extraordinary General Meeting resolving to authorise the Terveystalo Board of Directors to issue the Consideration Shares, as well as other customary conditions. Terveystalo estimates that, subject to the above conditions being satisfied or waived, the Transaction will be completed by the end of 2026 or in the first quarter of 2027. The Sellers and lock-up The Main Sellers include Coronaria, Elo Mutual Pension Insurance Company, CapMan Growth Equity Fund II Ky, Varma Mutual Pension Insurance Company, Ilmarinen Mutual Pension Insurance Company, Valtion Eläkerahasto and Amos Andersons fond as institutional sellers and certain members of Silmäasema's board of directors and management team and certain other shareholders of Silmäasema, who together hold more than 95% of the shares on a fully diluted basis in Silmäasema. Certain minority shareholders of Silmäasema, holding less than 5% of the shares in Silmäasema on a fully diluted basis (the "Minority Sellers" and together with the Main Sellers, the "Sellers"), are expected to accede to the share purchase agreement prior to the completion of the Transaction. The Minority Sellers include Silmäasema's key persons, doctors working as private practitioners and other individuals directly or through their companies. Coronaria has agreed to a customary transfer restriction (lock-up) concerning the Consideration Shares for a period of 12 months from the completion of the Transaction, except for transferring the Consideration Shares to Coronaria's affiliates subject to certain conditions. The institutional sellers have agreed to a customary transfer restriction (lock-up) concerning the Consideration Shares for a period of 6 months from the completion of the Transaction, except for transferring the Consideration Shares to such institutional seller's affiliates subject to certain conditions. The Consideration Shares issued to the other Sellers are not subject to any transfer restrictions. Advisors SEB Corporate Finance is acting as financial advisor to Terveystalo. Krogerus Attorneys Ltd is acting as legal advisor to Terveystalo. Burson Finland Oy is acting as communications advisor to Terveystalo. DNB Carnegie is acting as financial advisor to Silmäasema. Roschier, Attorneys Ltd. is acting as legal advisor to Coronaria. Astrea Attorneys at Law Ltd is acting as legal advisor to Coronaria and Silmäasema. Briefing and webcast Terveystalo and Silmäasema will arrange a press conference on 8 June 2026 at 10:30 EEST in Helsinki, Studio Eliel, Sanomatalo (address: Töölönlahdenkatu 2, Helsinki). The event will be held in Finnish and will also be streamed live at https://terveystalo.events.inderes.com/2026-06-08-webcast. A briefing for investors and analysts will be held on 8 June 2026 at 12:00 noon EEST. The event will be held in English and streamed at https://terveystalo.events.inderes.com/2026-06-08-webcast-2. Conference call: https://events.inderes.com/terveystalo/2026-06-08-webcast-2/dial-in. The conference call can be accessed by registering through the link. After registration, the phone number and a conference ID will be provided. Recordings of the events and the presentation slides will be made available at https://www.terveystalo.com/terveystalo-silmaasema-en later on the same day. Terveystalo Plc Board of Directors More information: CFO Juuso PajunenTel. +358 40 584 9722 Vice President, Investor Relations & Sustainability, Kati KaksonenTel. +358 10 345 2034kati.kaksonen@terveystalo.com Distribution:Nasdaq Helsinki OyMain mediawww.terveystalo.com Terveystalo in brief Terveystalo is the largest private healthcare service provider in Finland in terms of revenue and one of the leading occupational health providers in both Finland and Sweden. We aim to create seamless, compassionate, and effective healthcare of the future. We offer comprehensive primary care, specialised care, and well-being services for corporate clients, insurance companies, consumers and public-sector customers. Terveystalo's digital appointments are available anytime, anywhere, 24/7. The Terveystalo app has around 2.7 million registered users. We provide services through our extensive network of clinics and hospitals across Finland. In Sweden, we offer preventive occupational health services through our subsidiary, Feelgood. In 2025, Terveystalo served approximately 1.2 million individual customers, and there were around 7.2 million customer visits in Finland. Terveystalo employs around 14,400 professionals in healthcare and other fields. Terveystalo is listed on Nasdaq Helsinki and has a strong Finnish ownership base. www.terveystalo.com Silmäasema in brief Silmäasema is the leading company in Finland in both optical retail and private eye care. We see the full picture from every customer interaction and treatment to the eye health of the Finnish people. Silmäasema's more than 1,700 vision and eye health professionals serve close to one million customers each year. Silmäasema operates 155 optical retail stores and eye clinics, 20 private eye hospitals and 5 public eye care units across Finland. Silmäasema generated EUR 267 million in revenue in 2025. In Estonia, Silmäasema operates 10 optical retail locations under the Eagle Vision brand. Coronaria in brief Coronaria is one of the top 5 private healthcare providers in Finland. We offer high-quality, impactful services in rehabilitation, oral health, and healthcare across the country. Silmäasema, a provider of eye care and optical services, is part of Coronaria. In 2025, our revenue was EUR 418.6 million, and we employ over 5,000 professionals and nurses. Coronaria is part of the Finnish Cor Group. IMPORTANT INFORMATION The information contained herein shall not constitute a notice of any general meeting, an offer document, a prospectus, an offer to sell or a solicitation of an offer to purchase or subscribe for any securities in any jurisdiction. Certain statements in this release are "forward-looking statements." Forward-looking statements include statements concerning the Transaction and its effects on Terveystalo, and Terveystalo's plans, assumptions, projections, objectives, targets, goals, strategies, future events, future revenues or performance, plans or intentions relating to acquisitions, Terveystalo's competitive strengths and weaknesses, plans or goals relating to financial position, future operations and development, its business strategy and the anticipated trends in the industry and the political and legal environment in which it operates and other information that is not historical information. In some instances, they can be identified by the use of forward-looking terminology, including the terms "believes", "anticipates", "would", "intends," "may," "will" or "should" or, in each case, their negative or variations on comparable terminology. Forward-looking statements in this release are based on assumptions. Forward-looking statements involve inherent risks, uncertainties and assumptions, both general and specific, and the risk exists that the predictions, forecasts, projections, plans and other forward-looking statements will not be achieved. Given these risks, uncertainties and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Any forward-looking statements contained herein speak only as at the date of this release. Save as required by law, Terveystalo does not intend to, and does not assume any obligation to, update or correct any forward-looking statement contained in this release. Appendix This appendix presents additional information on Silmäasema's financial figures. Silmäasema Group's revenue Silmäasema's revenue between 2012 and 2025. Silmäasema transitioned to consolidated financial statements prepared in accordance with IFRS standards on 1 January 2015. [][][]Year (IFRS, unless otherwise stated) Revenue (EUR million)2025 2672024 2492023 2312022 2032021 1732020 1302019 1312018 1232017 1182016 1012015 932014[(1)] 762013[(1)] 682012[(1)] 60 (1) Before the IFRS transition; prepared in accordance with Finnish accounting standards (FAS). Silmäasema Group’s per segment revenue, adjusted EBITDA, adjusted EBITDA-%, adjusted EBIT and adjusted EBIT-% for 2021–2025 Optical retail Year Revenue Adjusted Adjusted Adjusted EBIT Adjusted EBIT-%(IFRS) (EUR EBITDA (EUR EBITDA-% (EUR million) million) million)2025 154 37 24.3% 24 15.5%2024 140 34 24.3% 22 15.8%2023 131 34 25.9% 23 17.7%2022 116 27 23.6% 18 15.3%2021 104 27 25.9% 19 17.8% Ophthalmology Year Revenue Adjusted Adjusted Adjusted EBIT Adjusted EBIT-%(IFRS) (EUR EBITDA (EUR EBITDA-% (EUR million) million) million)2025 116 19 16.1% 13 11.5%2024 112 17 15.6% 12 10.6%2023 102 16 15.4% 10 9.9%2022 90 13 14.4% 8 9.0%2021 70 9 12.2% 5 6.7% [1] Silmäasema management estimate based on multiple sources, including an ophthalmology market study by a global management consultancy, industry statistics, NÄE ry, Terveyskirjasto and Statistics Finland Population Projection. [2] Adjusted EPS refers to EPS adjusted for amortisation of intangibles resulting from the Transaction and one-off transaction and integration costs. [3] Adjusted EBIT based on Silmäasema's audited consolidated financial statements for 2025. [4] Silmäasema management estimate based on multiple sources, including an ophthalmology market study by a global management consultancy, industry statistics, NÄE ry, Terveyskirjasto and Statistics Finland Population Projection. [5] Adjusting items are material items that deviate from ordinary business operations, such as advisory and other transaction costs related to acquisitions, exceptional advisory fees, and certain other non-recurring items. [6] Source: Taloustutkimus and Alma Media: Brändien arvostus 2025. [7] Silmäasema management estimate based on multiple sources, including an ophthalmology market study by a global management consultancy, industry statistics, NÄE ry, Terveyskirjasto and Statistics Finland Population Projection. [8] Estimates for 2024 and 2029 are based on Silmäasema management estimate using multiple sources, including an ophthalmology market study by a global management consultancy, industry statistics, NÄE ry, Terveyskirjasto and Statistics Finland Population Projection. [9] Adjusting items are material items that deviate from ordinary business operations, such as advisory and other transaction costs related to acquisitions, exceptional advisory fees, and certain other non-recurring items. [10] The presented revenue figures exclude internal and unallocated revenues. [11] Adjusting items are material items that deviate from ordinary business operations, such as advisory and other transaction costs related to acquisitions, exceptional advisory fees, and certain other non-recurring items.

Sinch appoints Jonas Dahlberg as acting CEO to lead next phase of execution and growth

As previously announced on May 7, Laurinda Pang has decided to step down as CEO of Sinch. Following continued discussions between the Board, Laurinda and Jonas, the Board determined that transitioning to an acting CEO is the right step to support Sinch’s next phase of execution and growth. “Over the past several years, Sinch has transformed into a more profitable business, with an integrated customer offering, poised for growth. The Board believes this leadership transition will build on and accelerate that momentum and we are fully aligned with both Laurinda and Jonas on the path forward,” said Erik Fröberg, Chairman of the Board. “Jonas has been deeply involved in the company’s transformation and strategy execution for the past year. He is an accomplished CEO with experience from leading large international organizations in tech enabled services. The Board has great confidence in his ability to lead Sinch during the next phase of development,” Erik Fröberg continued. Jonas Dahlberg joined Sinch as Chief Financial Officer (CFO) Apil 1, 2025. Prior to joining Sinch, he served as CEO and before that as CFO of Transcom, a global customer experience outsourcer. He also served in various executive positions at Sweco, the leading European Engineering Consultancy. Prior to Sweco, he was a consultant at McKinsey & Company. Jonas holds a M.Sc. degree in Applied Physics and B.Sc. in Business Administration. “During the last few years, Sinch has developed into a leading global cloud communications platform under the leadership of Laurinda. We are now well positioned to accelerate growth as the customer communication infrastructure for the AI economy. I’m excited to continue working with our talented teams to execute on our priorities: deliver value to our customers, drive innovation and create value for our shareholders,” said Jonas Dahlberg. “I’m incredibly proud of what we have accomplished as a team. We transformed from acquired stand-alone companies, into a more integrated company, strengthened profitability and reignited growth. Jonas is ideally positioned to lead Sinch into the future. I fully support this transition and the Board’s decision to accelerate the succession timeline as the company enters its next chapter,” said Laurinda Pang As previously communicated, Laurinda Pang will continue to support the company until a permanent successor is appointed, however no later than 31 December 2026. For further information, please contactFredrik HallstanDirector, Corporate CommunicationsMobile: +46761 15 38 30E-mail: fredrik.hallstan@sinch.com Mia NordlanderSVP Investor Relations & SustainabilityMobile: +46 73 511 53 95E-mail: mia.nordlander@sinch.com Note: This information is such that Sinch AB (publ) is required to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CEST on June 8, 2026 through the agency of the contact person set out above.

Stora Enso’s Shareholders’ Nomination Board composition

The Stora Enso Shareholders’ Nomination Board has been established to exist until otherwise decided. The Shareholders’ Nomination Board consists of the Chair of Stora Enso’s Board of Directors, the Vice Chair of the Board of Directors, and two members appointed by the two largest shareholders (one each) as of 31 May each year.Stora Enso’s two largest shareholders on 31 May 2026 were Solidium Oy and FAM AB.In accordance with the above, the members of the Shareholders’ Nomination Board are:Marcus Wallenberg (Chair of FAM AB’s Board of Directors)Matts Rosenberg (Chief Executive Officer of Solidium)Håkan Buskhe (Chair of Stora Enso’s Board of Directors)Jouko Karvinen (Vice Chair of Stora Enso’s Board of Directors)The Shareholders’ Nomination Board has elected Marcus Wallenberg as its Chair.The Shareholders’ Nomination Board annually prepares proposals for Stora Enso Oyj’s Annual General Meeting concerning the election and remuneration of members of the Stora Enso Board of Directors and Board committees, as well as the appointments of the Chair and the Vice Chair of the Board of DirectorsFor further information, please contact:Jutta MikkolaSVP Investor Relationstel. +358 50 544 6061Stora Enso is a global leader in renewable materials with a strong focus on packaging. Our purpose is to replace non-renewable materials with renewable solutions. Together with our customers, we design and deliver competitive, high-quality packaging materials and solutions, made from fresh and recycled fibers, accelerating the transition to a circular bioeconomy. Stora Enso has approximately 19,000 employees and our sales in 2025 were EUR 9.3 billion. Stora Enso's shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded on OTC Markets (OTCQX) in the USA as ADRs and ordinary shares (SEOAY, SEOFF, SEOJF). storaenso.com/investors STORA ENSO OYJ

Aspia Group acquires Quickinsight to expand advisory offering for business-critical decisions.

The acquisition adds specialist expertise in business-critical situations such as acquisitions, divestments and investments, and reinforces Aspia Group’s ambition to take a leading position in the evolving professional services market. Quickinsight supports investors, entrepreneurs and businesses with financial due diligence, data books, acquisition analysis and vendor assistance. Its services are tailored for SME transactions, where financial information needs to be structured, analysed and translated into clear business insight. By combining Quickinsight’s specialist expertise and tech-enabled ways of working with Aspia Group’s broader advisory platform, the acquisition strengthens Aspia’s ability to turn complexity into clarity for clients facing important business decisions. “Quickinsight brings specialist expertise that strengthens our advisory offering and our ability to support clients in complex business decisions. Together, we can help more clients understand risks, value drivers and opportunities with greater clarity, and move forward with confidence,” says Ola Gunnarsson, CEO of Aspia Group. Quickinsight will operate under the Aspia brand. About Quickinsight Quickinsight is a Swedish specialist firm within financial due diligence and advisory services for SME transactions. The company supports investors, entrepreneurs and businesses with financial due diligence, data books, acquisition analysis and vendor assistance related to acquisitions, divestments and investments. Quickinsight is characterised by senior project management, quality, speed, business acumen and tech-enabled ways of working. About Aspia Group Aspia Group is the premium business partner for tech-enabled business services across Northern Europe. We provide the financial clarity and trust required for over 30,000 customers to lead with confidence. By combining human expertise with smart technology, we help clients manage complexity, make better decisions and focus on their ambition. With 3,000 employees across more than 100 offices and an annual turnover of SEK 3.5 billion, the Group includes the brands Aspia, Accountor and Skeppsbron Skatt. Aspia. Dare to Grow. For further information, please contact:  Ola Gunnarsson CEO, Aspia Group ola.gunnarsson@aspia.se 

Gustav Segerberg appointed new CFO of EQT AB

Gustav Segerberg has been appointed as Chief Financial Officer (“CFO”) of EQT AB and will succeed Kim Henriksson, who has decided to step down following nearly eight years as CFO. The CFO transition is effective as of July 18, 2026. Henriksson will remain with EQT as a Senior Advisor, supporting an orderly transition and continuing to contribute his extensive experience to EQT and its portfolio companies.Segerberg has been instrumental to EQT’s growth, both as a member of the Executive Committee and most recently as Head of the CEO Office. Segerberg has overseen EQT AB’s transformative M&A activities – including the combinations with Baring Private Equity Asia, Exeter Property Group and, most recently, Coller Capital[1] – as well as organic growth initiatives like the expansion into private wealth.CEO Per Franzén said: "Having worked closely with Gustav for many years, I have the utmost confidence in his ability. His deep understanding of EQT's strategy, business model, and stakeholder relationships makes him exceptionally well placed to take on this role. Kim has been a deeply valued partner through one of the most transformative chapters in our firm's history. I want to extend my sincere gratitude to him for his outstanding contributions to EQT to-date and am pleased that he will continue as a Senior Advisor to the benefit of our portfolio companies, clients and shareholders."Commenting on his appointment, Segerberg said: "I am honoured to be appointed CFO of EQT and look forward to working with our exceptional team to continue delivering for our shareholders. EQT is a truly unique firm with a strong culture, a clear strategic vision, and substantial opportunities ahead. I am committed to building on the strong financial foundation Kim has established and driving EQT's continued growth."Under Henriksson’s leadership, EQT has established a highly professional finance function supporting the firm’s development into a leading global and transparent publicly listed private markets platform."It has been a privilege to serve as CFO of EQT since 2018 and to have been part of such an extraordinary growth journey. I am proud of what we have achieved together and confident that Gustav will be an outstanding CFO. I look forward to a smooth handover over the coming months and to thereafter work closely with EQT portfolio company boards, management teams and CFOs as a Senior Advisor, including supporting on IPO preparations and public company financial governance", added Henriksson. ContactOlof Svensson, Head of Shareholder Relations, +46 72 989 09 15EQT Press Office, press@eqtpartners.com, +46 8 506 55 334 [1]The transaction is subject to customary closing conditions, including regulatory approvals and certain Coller Capital fund investor consent approvals, and is expected to close in mid to late Q3 2026.

SAS and Garuda Indonesia expand global connectivity through new codeshare partnership

The partnership will offer seamless travel options to and from Jakarta (CGK) and Bali (DPS), as well as Copenhagen, Stockholm and Oslo, with convenient connections via Amsterdam, Tokyo Haneda and, from Winter 2026/2027, Bangkok. The agreement was signed during the IATA Annual General Meeting in Rio de Janeiro by Garuda Indonesia Director of Transformation, Neil Raymond Mills, and SAS President and CEO, Anko van der Werff. “Garuda Indonesia is a key partner for connecting Scandinavia with Indonesia and the wider region. Together, we are making travel simpler and more seamless for the many people, businesses and communities with ties between our countries. By bringing our networks closer together, we are creating more opportunities to connect Scandinavia with one of Asia's most dynamic markets,” said Van der Werff at SAS. The collaboration reflects the shared ambition of both airlines as SkyTeam members to enhance global connectivity and provide broader access between Europe and Southeast Asia. For Garuda Indonesia customers, the partnership opens access to SAS’ Scandinavian gateways, while SAS travelers gain new opportunities to reach Indonesia’s major destinations through Garuda’s network. “As part of Garuda Indonesia’s ongoing transformation journey, we are pleased to deepen our collaboration with Scandinavian Airlines to expand connectivity between Southeast Asia and Northern Europe, leveraging our complementary network strengths to provide customers with broader travel options and a more seamless journey experience. Beyond enhancing market access and presence for both airlines, this partnership will further support tourism, business, and cultural exchange, enabling more travelers from Europe to explore Indonesia’s diverse destinations while offering Indonesian travelers greater access to the unique attractions and cultures of the Scandinavian region,” said Garuda Indonesia’s Deputy CEO, Thomas Oentoro. Frequent flyer members will also benefit from the cooperation, with EuroBonus and GarudaMiles members able to earn and redeem points across the combined network. From 9 June 2026, passengers will be able to purchase itineraries covered by the codeshare agreement through the sales channels of both airlines, while first date of travel will be 15 June.

Saab to divest its Public Safety Solutions operations

Saab Public Safety Solutions is a leading provider of situational awareness for mission critical organisations including police, fire, airport and transport, to enable faster, more informed decision-making and support a more coordinated response. The divestment is in line with Saab’s strategy to increase its focus on core areas of its business and, upon closing, Saab will divest its product unit Public Safety Solutions, including software solutions, customer base, and 75 employees transferring to Omda. “As we strategically prioritize addressing the evolving needs of our defense customers, we anticipate that Public Safety Solutions will find even greater opportunities for growth and success within Omda. This decision is in line with our strategic objectives and aims to provide Public Safety Solutions with the optimal conditions to advance,” says Carl-Johan Bergholm, head of Saab’s business area Surveillance. “Integrating Saab’s advanced Situational Awareness technologies into our Emergency product portfolio strengthens our offering and market position,” says Omda’s CEO Sverre Flatby. “Current and new customers will gain access to a unique, integrated software suite that supports the entire value chain across healthcare, police, and fire services,” Flatby continues.Based in Hull, United Kingdom, and Gothenburg, Sweden, Public Safety Solutions is renowned for its high-quality, accurate products that perform reliably in the most challenging conditions. Saab is a leading defence and security company with an enduring purpose, to help nations keep their people and society safe. Empowered by its 28,000 talented people, Saab constantly pushes the boundaries of technology to create a safer and more sustainable world. Saab designs, manufactures and maintains advanced systems in aeronautics, weapons, command and control, sensors and underwater systems. Saab is headquartered in Sweden. It has major operations all over the world and is part of the domestic defence capability of several nations. Saab AB (publ)SE-581 88 LinköpingSweden 

ALL.SPACE Awards $8.2M Production Order to Sivers Semiconductors for Ka-Band Beamforming ICs

Kista, Sweden –June 9,2026–Sivers Semiconductors  AB (STO:SIVE), a global leader in photonics and wireless technologies,today announcedan $8.2M production order for 2027 from ALL.SPACE , the world's leading multi-orbit satellite communications company, for Sivers’ multi-beam Ka-band beamforming integrated circuits (BFICs). This purchase order underscores Sivers' growing momentum in the defense and commercial satellite communications market, as its BFICs play a critical role as a key enabler of next-generation multi-orbit satellite communications platforms. ALL.SPACE has recently demonstrated strong portfolio and pipeline momentum supporting U.S. Army and U.S. Navy customers, conducting trials with the Royal Canadian Navy, and rapidly adding support for a variety of satellite networks such as Telesat, SES, and Viasat. York Space Systems  (NYSE: YSS) has also entered into a definitive agreement (DA) to acquire ALL.SPACE, further cementing its position in the U.S. defense ecosystem. “This production order represents an important milestone in our partnership with ALL.SPACE as we move from development and initial production to scaled multi-year deployment,” said Vickram Vathulya, CEO of Sivers Semiconductors. “The successful market adoption validates both the differentiated performance of Sivers’ beamforming platform and the importance of ALL.SPACE next-generation terminals for future satellite communications infrastructure.” “Our continued partnership with Sivers Semiconductors has been instrumental in bringing our next-generation multi-orbit communications capabilities to market,” said Paul McCarter, CEO of ALL.SPACE. "This production order reflects the strong performance of the jointly developed Ka-band beamforming technology and supports growing demand from our customers worldwide.” Demand for multi-orbit satellite communications is accelerating as defense organizations and commercial operators increasingly seek resilient, always-on connectivity across LEO, MEO, and GEO satellite networks. As a result, advanced beamforming semiconductors and electronically steered antenna technologies are becoming critical enablers, helping deliver the flexibility, performance, and reliability required to seamlessly operate across multiple orbital constellations. For more information, please visit https://www.sivers-semiconductors.com/.  About Sivers Semiconductors Sivers Semiconductors is a critical enabler of a greener data economy with energy-efficient photonics & wireless solutions. Our differentiated high-precision laser and RF beamformer technologies help our customers in key markets such as AI Datacenters, SATCOM, Defense and Telecom solve essential performance challenges while enabling a much greener footprint. For additional information, please visit us at:www.sivers-semiconductors.com. (SIVE.ST) About All.Space All.Space was founded in 2013 with a vision to provide the solution to the challenges of multi-orbit communications. As the providers of the most advanced platforms for total communications convergence, ALL.SPACE is shaping the very future of defense operations with the world's first fully capable multi-link terminal, which connects seamlessly and simultaneously to all satellite and cellular networks. For more information, please visit: https://www.all.space/. ###

Inside information: Sitowise signs an agreement to sell its Swedish subsidiary

Sitowise Group Plc 9 June 2026   Inside Information   8.30 a.m. EEST Sitowise Group Plc has signed an agreement to sell the entire shareholding of its Swedish subsidiary Sitowise Sverige AB (the Sweden business area) to Sweco. The business to be divested, Sitowise Sverige AB, offers technical consulting services in Sweden with a focus on structural engineering and building services for commercial and residential buildings, infrastructure design, and project management. It generated net sales of EUR 26.3 million in 2025, employs about 265 people and was loss-making. The management has decisively executed a restructuring of the Swedish operations, delivering a material operational improvement that ultimately created the conditions for a divestment. The divestment allows Sitowise to focus on the highest impact for solid growth and strengthened profitability. Sitowise’s Swedish subsidiary Sitowise Digital Solutions AB (previously Infracontrol AB) continues to be a part of Sitowise's Digital Solutions business area. The parties have agreed on an enterprise value (EV) of approximately EUR 3.0 million. The parties have also agreed on an earn-out of up to approximately EUR 2.0 million related to long-term lease liabilities, which will be recognized in profit or loss in 2027–2029 if realized. “We are pleased that our Swedish business has attracted interest and we have reached this agreement with Sweco. We are confident that Sweco will be a good new home for our current Swedish experts,” says Jannis Mikkola, acting CEO of Sitowise Group Plc. “The transaction marks a new phase for Sitowise. Our three continuing businesses – Infra, Buildings and Digital Solutions – stand on solid foundations. We will focus on strengthening our competitiveness and market position, leveraging technological transformation, AI and automation to remain at the forefront of the industry. The transaction will improve Sitowise Group’s profitability and cash flows,” Mikkola continues. From here on, the priority is to grow ahead of the market across all three business areas. This will be driven by expansion in Sitowise’s strong client segments and selected growth areas, supported by deploying the best talent across the organization. In the medium term, growth will be complemented by selective M&A. Sitowise continues to move forward as a company built for sustainable growth and long-term value creation. Sitowise will classify the business to be divested as assets held for sale until completion of the transaction and present it as discontinued operations starting from the second quarter interim report of 2026. The assets and liabilities of the divestment are measured at fair value less costs to sell. Any resulting impairment is recognized as part of the result from discontinued operations. Sitowise will, therefore, publish restated Group financial information for 2025 and for January–March 2026 prior to the publication of the second quarter interim report on 12 August 2026. The financial impacts of the transaction are still to be confirmed, but for illustrative purposes, had the transaction taken place in 2025, it would have reduced the Group's net sales by EUR 26.3 million, while clearly improving the Group's adjusted EBITA margin. Sitowise expects to record a sales loss on the remaining book value of its shares in Sitowise Sverige AB in the Group parent company. The completion of the transaction is subject to customary closing conditions and regulatory approvals. The transaction is expected to be completed during the third quarter of 2026.   Further information:Jannis Mikkola, acting CEO, tel. +358 40 747 9670Sanna Sormaala, CFO, tel. +358 50 452 5498Media desk, mediadesk@sitowise.com, tel. +358 400 158 637 Distribution:Nasdaq Helsinki LtdKey mediawww.sitowise.com Sitowise in brief Sitowise is a Nordic expert in technical consulting and digital solutions. Our mission is to engineer the foundation of Nordic resilience. We design infrastructure, buildings and cities that stand the test of time and change. We enhance society’s operational reliability by developing critical infrastructure and ensure the sustainable use of the environment and natural resources. We operate in three business areas that are Infra, Buildings and Digital Solutions. The Group’s net sales in 2025 were EUR 189 million, and the company employs approximately 1,900 experts. Sitowise Group Plc is listed on the Nasdaq Helsinki stock exchange under the trading symbol SITOWS.

Sweco acquires building and infrastructure company in Sweden with approximately 250 experts

Sitowise Sverige AB is a subsidiary of the Finnish engineering and consulting group Sitowise Group Oyj  and delivers consulting services within structural engineering, building service systems, project management and transport infrastructure to the Swedish market, including in the pharma and life science segment. The company reported a turnover of approximately SEK 296 million in 2025. Sweco has 7 600 employees in Sweden and delivered a strong first quarter  in 2026. “I am excited to welcome the experts from Sitowise Sverige AB to join Sweco in Sweden. With this important addition, we strengthen our leading position as a technology advisor in buildings and infrastructure and increase our strong geographical footprint across Sweden. Together with our new colleagues from Sitowise, we will now focus on delivering client value and on continued profitable growth, says Fredrik Wallner, Business Area President for Sweco Sweden.The acquisition will be subject to approval by the Swedish Competition Authority (Konkurrensverket) and the Inspectorate of Strategic Products (ISP). Once that is completed, approximately 250 experts will be integrated into Sweco in Sweden as soon as possible. Press photos: · Sweco Sweden consultants, free use, please credit: Måns Berg · Sweco Sweden's Fredrik Wallner, free use, please credit: Anna W Thorbjörnsson About Sweco’s acquisition agenda This acquisition aligns with Sweco’s acquisition strategy to grow the business by adding key skills that complement Sweco’s 23,000 experts and expands the Group’s market position as Europe’s leading architecture and engineering consultancy. Sweco’s strategy is to grow through a combination of acquisitions and organic growth. The Group has completed close to 170 acquisitions over the past 20 years. In total, Sweco completed 13 acquisitions in 2025, adding approximately SEK 2.1 billion in annual net sales and more than 1,500 experts to Sweco. 

Extraordinary places to stay in Bremen: City adventures including a house boat, the harbour and a nature reserve

Staying on the water: from a houseboat to a historic hotel ship The houseboats and hotel ships along the Weser are a perfect invitation to get to know Bremen from a different perspective. On the strip of land between Neustädter Hafen and the Weser, the Hausboote am Lankenauer Höft  offer a relaxed break in a luxury holiday home, just a stone’s throw from restaurants and the beach. There is also some very special floating accommodation in the historic city centre. The traditional green-sailed ‘Alexander von Humboldt ’ on the famous Schlachte-Ufer is a chance to experience the maritime history of Bremen close up. The cosy cabins on the hotel ship are the perfect retreat for all those looking for a special alternative to a traditional hotel room. Innovative concept hotels reflect Bremen’s creative side At the same time, Bremen is showing off its creative side with concepts that reinterpret the character of converted marine and industrial spaces. In a novel twist, the HafenTraum IndoorHostelCamp  brings camping inside in the dry: indoor tiny houses and vintage caravans combine urban design with a feeling of adventure. Accommodation like Camp 28  also feeds the desire for freedom. The unspoilt lakeside campsite on the Stadtwaldsee is well connected to the city centre via cycle routes and public transport, so a relaxed camping holiday in the countryside can be combined with a city break. The Land of Green  is also evidence of how well sustainability and eco-conscious tourism can be combined with modern comfort and experiences on a trip to Bremen. To the south of the artists’ community of Worpswede, travellers can stay in unspoilt tiny houses or tree-houses, and enjoy the Teufelsmoor nature conservation area at any time of year. The forest resort also offers a range of wellness amenities and foodie treats. Perfect combination of countryside and city break The variety of accommodation makes Bremen ideal for all kinds of breaks, from a spontaneous weekend trip to a longer holiday with the family. With short connections and an excellent network of cycle paths and public transport, countryside bases also make the perfect starting point for exploring the city. The different accommodation options  in Bremen and the surrounding area reflect the maritime, creative, natural and relaxed character of the city. This is what makes it such a charming destination for those seeking a city full of atmosphere and charm.

New smart air valve integrates operational reliability and hygiene in drinking water networks

As demands for operational safety and drinking water quality in modern drinking water networks continue to rise, the role of traditional valves is undergoing a fundamental shift. Today, addressing individual functions in isolation is no longer sufficient. What is required are integrated solutions that combine hygiene safety and network monitoring into a single, holistic approach. To meet this need, the VAG DUOJET® @ON Smart Air Valve was developed and introduced as a production-ready solution at the IFAT trade fair in Munich in May 2026. It marks the next step in the evolution of a proven valve into an enhanced system component. The core approach is to combine hygiene protection and network monitoring in a single valve. The traditional venting and air-release function is combined with an automated, hygienically effective flushing strategy. This ensures that areas within the drinking water system that are prone to stagnation are regularly flushed, thereby maintaining drinking water quality at a defined level at all times. The flushing function is designed to run automatically at user-defined intervals – for example, every three months – and can be adapted to the specific system conditions. This helps ensure compliance with the hygiene requirements of DVGW W392-2 without requiring on-site service personnel to intervene. The manual flushing cycles that were previously required are no longer necessary. The process is repeatable and significantly reduces operational effort for work assignments. Timo Bugert, Product Manager for Global Engineering at VAG, explains from a technical perspective: “The automatic flushing system integrates seamlessly into the system and offers not only hygienic benefits but also advantages in terms of maintenance and network operation. This integration establishes a reliable foundation for consistently reliable hygiene safety throughout the entire network.” In addition to its integrated flushing function, the valve fulfills its core purpose as a single-chamber high-performance valve for the controlled venting and filling of piping systems. It combines three essential functions: venting during discharge, air release during filling, and continuous operational venting. The design enables the stable and efficient removal of both large volumes of air during dynamic operating phases and small amounts of air during continuous operation – even at air velocities approaching the speed of sound. In addition, the smart valve enables continuous monitoring of relevant operating conditions. The integrated sensors and system controls measure pressure conditions and valve positions. This data is not collected in isolation but rather enables a reliable assessment of the system’s condition. Upon request, operators receive both regular status updates and real-time alerts in the event of deviations from normal operation. The information gathered enables continuous monitoring of the condition of the pipelines and the manhole infrastructure. Pressure deviations, unusual operating conditions, or unauthorized access to the valve or the installation shaft can be detected early and transmitted to the network operator as status or warning messages. This advancement allows early detection of potential incidents, such as pipe breaks or critical operating conditions. The valve thus assumes a significantly enhanced role within the supply network. Security is also a top priority when it comes to data transmission. Communication is unidirectional and encrypted. Only status and warning messages are transmitted from the field to the operator; external access to the valve is prevented. This ensures a high level of IT security. The combination of a low-maintenance design – with operating periods designed for a minimum of three years without requiring on-site service – and integrated data capabilities supports compliance with the requirements of DVGW W392-2 and enables seamless integration into existing and future network structures. At the same time, it lays the groundwork for advanced applications such as condition-based maintenance or higher-level network analyses. This approach demonstrates that the future of water supply does not depend on the isolated digitization of individual components, but rather on the intelligent integration of function and information. Only when the valve itself becomes an active information carrier does measurable added value emerge – both in technical and economic terms. In this way, the valve becomes an integral part of a resilient and sustainable water supply network. To learn more about the VAG DUOJET® @ON Smart Air Valve and how it can enhance hygiene safety and operational efficiency in your network, visit vag-group.com  or contact our experts for a personalized consultation.

Norse Atlantic Airways appoints Frans Leenaars as Chief Commercial Officer

Arendal, Norway, 9 June – Norse Atlantic Airways today announced the appointment of Frans Leenaars as Chief Commercial Officer (CCO), effective immediately. Frans joins Norse with more than two decades of international leadership experience across aviation, travel and customer-focused businesses. Throughout his career, he has held senior commercial positions within Air France-KLM and Disney Parks & Resorts, as well as a range of executive leadership roles at TUI Group, one of the world's leading travel companies. As CCO, he will be responsible for leading Norse's global commercial strategy and technology developments, including continued network development, partnerships, customer experience, revenue management, sales, marketing and IT. "Frans brings a unique combination of aviation expertise, commercial leadership and customer-centric thinking," said Eivind Roald, Chief Executive Officer of Norse Atlantic Airways. "His extensive experience from both airlines and the broader travel industry will be highly valuable as we continue to evolve our commercial platform, strengthen strategic partnerships and optimize the deployment of our fleet across scheduled, charter and ACMI operations. Frans will play an important role in further enhancing the customer experience while supporting Norse's focus on profitability and value creation as an airline on demand." Commenting on his appointment, Frans Leenaars said: "Norse has established itself as a modern and innovative airline. I am impressed by what the team has accomplished in a relatively short period of time and look forward to working alongside colleagues across the company to further strengthen our commercial proposition, expand partnerships and deliver value to customers and owners". The appointment comes as Norse continues to build on its commercial and operational progress, supported by a balanced business model, a growing customer base and a strengthened financial foundation. Investor contact: Anders Hall Jomaas, CFO anders.jomaas@flynorse.com  About Norse Atlantic ASA Norse Atlantic Airways is an airline committed to offering affordable fares on direct, long-haul flights to popular destinations, along with specialized charter and ACMI services for tailored travel needs and extensive cargo operations. Norse Atlantic operates a modern fleet of 12 fuel-efficient Boeing 787 Dreamliners, serving a network of destinations across North America, Europe, Africa and Asia

New SAS–Aerolíneas Argentinas codeshare expands travel options

Under the agreement, Aerolíneas Argentinas will place its AR code on SAS‑operated flights between Madrid and Rome and the Scandinavian capitals of Copenhagen, Stockholm and Oslo. In turn, SAS will place its SK code on Aerolíneas Argentinas’ transatlantic services between Buenos Aires, Madrid and Rome, giving travelers in Northern Europe new one‑stop access to Argentina. The cooperation also enables unique long‑range itineraries across the SkyTeam network — including the possibility to travel from the world’s southernmost commercial airport in Ushuaia to the northernmost in Longyearbyen on a single, integrated journey. “This partnership marks an exciting step forward for SAS as we continue strengthening our global reach together with trusted SkyTeam partners. Aerolíneas Argentinas is a natural fit for us, and by linking our networks we are opening new and genuinely compelling opportunities for customers travelling between Scandinavia and South America. This cooperation not only creates smoother journeys and stronger connectivity — it also brings two regions with deep cultural and economic ties closer together. We are thrilled to offer our passengers an even broader world of destinations and look forward to welcoming more travelers onboard across our joint network,” said Paul Verhagen, Executive Vice President & Chief Commercial Officer, SAS. The agreement allows passengers to travel on a single ticket, complete one check‑in process and check baggage through to their final destination, significantly improving the travel experience and expanding connection options between Scandinavia and Argentina. "This agreement allows us to continue expanding our international connectivity network and offer our passengers new travel alternatives to Northern Europe through a strategic partner such as SAS,” said Fabián Lombardo, President of Aerolíneas Argentinas. As SkyTeam members, both airlines will also offer eligible customers access to SkyPriority services, while members of EuroBonus and Aerolíneas Plus will be able to earn and redeem points across the combined network. Implementation of the codeshare agreement is planned for the third quarter of 2026, subject to regulatory approvals.

Borr Drilling Limited – Early Tender Results for its Previously Announced Consent Solicitation and Tender Offer and Early Settlement Date

Hamilton, Bermuda, June 9, 2026 – Borr Drilling Limited (NYSE and OSE: BORR) (“Borr Drilling” or the “Company”) today announced the early tender results, as of 5:00 p.m., New York City time, on June 8, 2026 (the “Early Tender/Consent Deadline”), in respect of the previously announced offer by Borr IHC Limited, its wholly-owned subsidiary (the “Issuer”), to purchase for cash (the “Tender Offer”) (i) any and all of its outstanding 10.000% Senior Secured Notes due 2028 (the “2028 Notes”) and (ii) any and all of its outstanding 10.375% Senior Secured Notes Due 2030 (the “2030 Notes” and, together with the 2028 Notes, the “Notes”), and the related solicitation of consents (the “Consent Solicitation”) from Holders to vote in favor of certain proposed amendments (the “Proposed Amendments”) to the indenture dated November 7, 2023 (as amended or supplemented from time to time, the “Existing Indenture”), in each case pursuant to the terms and subject to the conditions set forth in the offer to purchase and consent solicitation statement dated May 26, 2026 (as amended or supplemented from time to time, the “Statement”). Capitalized terms used in this release but not otherwise defined have the meaning given in the Statement. On May 27, 2026, the Issuer priced an offering of $1,100,000,000 8.750% Senior Secured Notes due 2032 and $935,000,000 9.000% Senior Secured Notes due 2034 (together, the “New Notes Offering”) in connection with satisfaction of the Financing Condition. The closing of the New Notes Offering is expected to occur on June 10, 2026 and is subject to customary closing conditions. Early Tender ResultsThe Withdrawal/Revocation Time and the Early Tender/Consent Deadline passed at 5:00 p.m., New York City time, on June 8, 2026. The following table sets forth certain information regarding the Notes and the Tender Offer, including the aggregate principal amount of Notes (and related Consents) that were validly tendered and not validly withdrawn as of the Early Tender Time according to Global Bondholder Services Corporation, the Tender Agent and Information Agent for the Tender Offer: []Notes CUSIP / ISIN Original Outstanding Aggregate Numbers Principal Amount Principal Amount Original Issued Principal Amount Tendered [(1)]10.000% Rule 144A: 100018 AA8 $1,380,696,000.00 $1,128,129,659.88 $1,324,402,000Senior /US100018AA89RegulationSecured Notes S: G1467F AA1 Due / USG1467FAA15 202810.375% Rule 144A: 100018 AB6 $877,094,000.00 $770,650,554.20 $794,306,000Senior / US100018AB62Secured Regulation S: G1467F Notes AB9 / Due USG1467FAB97 2030 1. 1. As of May 22, 2026. For the 2030 Notes, this reflects the initial aggregate original principal amount of 2030 Notes adjusted to reflect amortization in respect thereof. For the 2028 Notes, this reflects the initial aggregate original principal amount of 2028 Notes adjusted to reflect amortization in respect thereof. The Company has received valid and unrevoked tenders (and related Consents) of Notes representing 95.92% of the aggregate original principal amount of the 2028 Notes outstanding and 90.56% of the aggregate original principal amount of the 2030 Notes outstanding, representing 93.84% of the aggregate original principal amount of the Notes outstanding. Holders can no longer validly withdraw tenders of Notes (and revoke related delivered Consents) as the Withdrawal/Revocation Time has passed. In addition, pursuant to the terms of the Existing Indenture, as Holders of more than 90% of the aggregate original principal amount of the outstanding 2028 Notes and Holders of more than 90% of the aggregate original principal amount of the outstanding 2030 Notes have validly tendered and not withdrawn Notes in the Tender Offer, the Issuer intends to redeem all remaining Notes of each such series that remain outstanding (after giving effect to the purchase of tendered Notes on the Early Settlement Date) at a redemption price equal to the price offered to each tendering Holder (excluding any early tender or incentive fee) plus, to the extent not included in the payment to tendering Holders, accrued and unpaid interest, if any, to, but excluding, the date of such redemption. The Issuer intends to issue a notice of redemption promptly on or after the Early Settlement Date with an anticipated redemption date of such remaining Notes on or promptly after the Final Settlement Date. However, there can be no assurance that any Notes will be so redeemed. Nothing contained herein shall constitute a notice of redemption for the Notes. Because the Company received consents of Holders representing 93.84% of the outstanding aggregate principal amount of the Notes, such Notes having been validly tendered (and not validly withdrawn), on June 8, 2026, the Issuer and BNY Mellon Corporate Trustee Services Limited, as trustee, and Wilmington Trust (London) Limited, as security agent, among others, executed supplemental indentures to the Existing Indenture (the “Supplemental Indentures”), which implement the Increased Offer Proposed Amendments. The Increased Offer Proposed Amendments will (i) remove substantially all of the covenants and other obligations under the Indenture that can be removed with the consent of Holders of a majority of the aggregate principal amount of the Notes then outstanding and (ii) release all Liens in the Collateral securing the Notes and disapply certain covenants relating to the Collateral. The Supplemental Indentures will only become operative upon the Early Settlement Date (as defined below) if the relevant settlement conditions (as described under the caption “Conditions to Consummation of the Tender Offer and the Consent Solicitation” contained in the Statement) are satisfied or waived. On the Early Settlement Date (as defined below), Holders who validly tendered their Notes (and related Consents) before the Early Tender/Consent Deadline are eligible to receive: i. for each $1,000 original principal amount of the 2028 Notes, an amount determined in the manner described in the Statement by reference to the Fixed Spread for the 2028 Notes specified on the front cover of the Statement over the applicable Reference Yield based on the bid-side price of the applicable Reference Security specified on the front cover of the Statement, andii. for each $1,000 original principal amount of the 2030 Notes, $1,060.00. Holders may continue to tender their Notes (and thereby deliver Consents) until 5:00 p.m., New York City time, on June 24, 2026, in respect of the Tender Offer and Consent Solicitation, unless extended or earlier terminated by the Issuer in its sole discretion, subject to applicable law (the “Expiration Time”). Holders who validly tender their Notes (and related Consents) after the Early Tender/Consent Deadline but at or prior to the Expiration Time will not be eligible to receive the Total Consideration, but will be eligible to receive the Tender Offer Consideration on the Final Settlement Date (as defined in the Statement). The Tender Offer Consideration or the Total Consideration, as applicable, will be multiplied by the applicable Factor (as defined in the Statement), which reflects the partial amortization of the Notes. Holders whose Notes are accepted for purchase pursuant to the Tender Offer will also receive accrued and unpaid interest, multiplied by the applicable Factor from the last interest payment date on such purchased Notes up to, but not including, the applicable Settlement Date. Important Dates and TimesPursuant to the terms and conditions of the Statement, the Issuer has elected to settle on June 10, 2026 the Notes tendered at or prior to the Early Tender/Consent Deadline (the “Early Settlement Date”). The final settlement date will occur promptly following the Expiration Time and is expected to be the second business day after the date on which the Expiration Time occurs (the “Final Settlement Date”). The Issuer reserves the right in its sole discretion, subject to applicable law, to (i) waive prior to the Expiration Time any and all conditions to the Tender Offer; (ii) extend the Expiration Time; (iii) amend the terms of the Tender Offer and Consent Solicitation in any respect; or (iv) terminate, withdraw or otherwise decide not to proceed with the Tender Offer and Consent Solicitation at any time prior to or at the Expiration Time and not accept for purchase or payment any Notes not theretofore accepted for purchase or payment. The Issuer’s obligations to accept for purchase and pay for Notes pursuant to the Tender Offer and the Consent Solicitation is subject to the satisfaction of, or where applicable, the Issuer’s waiver of, the conditions set forth under “Conditions to Consummation of the Tender Offer and the Consent Solicitation,” including the Financing Condition, the Supplemental Indenture Condition, and the General Conditions as described in the Statement. Information Relating to the Tender Offer and the Consent SolicitationThe Company has engaged Citigroup Global Markets Inc is acting as the dealer manager and solicitation agent for the Tender Offer and the Consent Solicitation (“Dealer Manager and Solicitation Agent”). Questions regarding the terms of the Tender Offers and Consent Solicitations may be directed to Citigroup Global Markets Inc. at +1 (212) 723-6106 (banks and brokers) or +1 (800) 558-3745 (toll-free) or via email at ny.liabilitymanagement@citi.com. Global Bondholder Services Corporation is acting as (i) the Information Agent for the Tender Offer and the Consent Solicitation, (ii) the Tender Agent for the Tender Offer and (iii) the Tabulation Agent for the Consent Solicitation. Requests for copies of the Statement should be directed to Global bondholder Services Corporation at +1 (212) 430- 3774 (banks and brokers) or +1 (855) 654-2014 (toll-free) or via email at contact@gbsc-usa.com. This press release is for information purposes only and does not constitute or form part of an offer to sell or the solicitation of an offer to purchase or subscribe for securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities referred to herein have not been and will not be registered under the Securities Act of 1933 or applicable state securities laws, and may not be offered or sold in the United States or to U.S. persons (other than distributors) unless such securities are registered under the Securities Act of 1933, or an exemption from the registration requirements of that act is available. About Borr Drilling LimitedBorr Drilling Limited is an international drilling contractor incorporated in Bermuda in 2016 and listed on the New York Stock Exchange since July 31, 2019 and on Euronext Oslo Børs since May 21, 2026 under the ticker “BORR.” The Company owns and operates jack-up rigs of modern and high specification designs and provides services focused on the shallow-water segment to the offshore oil and gas industry worldwide. Please visit our website at www.borrdrilling.com. Forward-Looking StatementsThis press release and related discussions include forward-looking statements made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements do not reflect historical facts and may be identified by words such as “anticipate”, “believe”, “continue”, “estimate”, “expect”, “intends”, “may”, “should”, “will”, “ensure”, “likely”, “aim”, “plan”, “guidance” and similar expressions and include statements regarding the Tender Offer and Consent Solicitation, including expected Early Settlement Date, the Financing Transaction and other non-historical statements. Such forward-looking statements are subject to risks, uncertainties, contingencies and other factors that could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein, including risks related to the Tender Offer and Consent Solicitation including risks relating to the terms and conditions of the Tender Offer and the Financing Transaction and other risks and uncertainties, including those described in our most recent annual report on Form 20-F for the year ended December 31, 2025 and our other filings with the Securities and Exchange Commission. Such risks, uncertainties, contingencies and other factors could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein. These forward-looking statements are made only as of the date of this release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. The Board of DirectorsBorr Drilling LimitedHamilton, Bermuda

Inside information: The business of Summa Defence’s subsidiary Summa Energy is sold

Summa Defence Plc       Company announcement, inside information        9 June 2026 at 6:00 p.m. EEST Summa Energy Oy has signed an agreement with Absolicon Solar Collector AB on the sale of its business. The transaction is part of Summa Defence's goal announced on 6 March 2026 to clarify the Group's structure and allocate resources to the company's focus areas. Summa Energy Oy is a supplier of large solar thermal plants. The company designs and delivers clean energy production systems for industry and district heating production as complete deliveries. In 2025, the company's net sales was EUR 8.6 million (EUR 9.7 million in 2024). Absolicon Solar Collector AB is a Swedish company that develops, manufactures and sells solar energy systems that generate renewable energy. Absolicon’s share is traded on the Spotlight marketplace (XSAT). “The divestment of Summa Energy’s business is part of the strategic review and evaluation of strategic alternatives for some of our subsidiaries. The objective of this review is to support Summa Defence’s long-term strategy, strengthen our capital structure and accelerate growth in our core businesses in the defence sector,” says Robert Blumberg, CEO of Summa Defence. Summa Energy's sales price is EUR 393,000, of which EUR 175,000 is cash and EUR 218,000 is Absolicon Solar Collector AB’s shares. The transaction will be recorded in the first half of 2026. The review and evaluation of strategic alternatives regarding the other subsidiaries is ongoing. The evaluation is part of Summa Defence’s normal strategic development work and may not necessarily result in any arrangements or transactions. SUMMA DEFENCE PLC More information:Robert Blumberg, CEOPhone: +358 40 839 7408E-mail: robert.blumberg@summadefence.com Summa Defence in brief Summa Defence Plc is a Finnish defence and security technology group whose mission is to create a strong industrial foundation of innovative defence and dual use SMEs for strengthening the comprehensive security of society. Summa Defence aims for both organic and inorganic growth across three focus areas: maritime technologies, land technologies and new technologies. The company’s vision is to be a forerunner in comprehensive security industry. The shares of Summa Defence Plc are listed on the Nasdaq First North Growth Market in Sweden (SUMMAS) and Finland (SUMMA).www.summadefence.fi/en/ The company’s Certified Adviser is Augment Partners AB, info@augment.se, tel. +46 8 604 22 55.

Borr Drilling Limited – Pricing Terms for its Previously Announced Consent Solicitation and Tender Offer for its Senior Secured Notes due 2028

Hamilton, Bermuda, June 9, 2026 – Borr Drilling Limited (NYSE and OSE: BORR) (“Borr Drilling” or the “Company”) today announced the pricing terms of its previously announced offer by Borr IHC Limited, its wholly-owned subsidiary (the “Issuer”), to purchase for cash (the “Tender Offer”) (i) any and all of its outstanding 10.000% Senior Secured Notes due 2028 (the “2028 Notes”) and (ii) any and all of its outstanding 10.375% Senior Secured Notes Due 2030 (together with the 2028 Notes, the “Notes”), and the related solicitation of consents (the “Consent Solicitation”), in each case pursuant to the terms and subject to the conditions set forth in the offer to purchase and consent solicitation statement dated May 26, 2026 (as amended or supplemented from time to time, the “Statement”). Capitalized terms used in this release but not otherwise defined have the meaning given in the Statement.  The table below indicates, among other things, the Total Consideration for each $1,000 original principal amount of the 2028 Notes validly tendered at or prior to 5:00 p.m., New York City time, on June 8, 2026, as calculated at 10:00 a.m. (New York City time) today, June 9, 2026 (the “Price Determination Date”) in accordance with the terms of the Statement: [][][][]Notes CUSIP / ISIN Original Outstanding Factor U.S. Blomberg Fixed Total Numbers Principal Amount Principal Amount Treasury Reference Spread Consideration Issued Reference Page Security [(1)] [(2)] [(2)(3)(4)]10.000% Rule 144A: 100018 AA8 $1,380,696,000.00 $1,128,129,659.88 0.81707317 2.000% FIT3 +50 $1,048.36[(5)] Senior / UST dueSecured US100018AA89Regulation NovemberNotesDue S: G1467F AA1 15, 2028 / USG1467FAA15 2026 1. As of May 22, 2026. This reflects an aggregate original principal amount of 2028 Notes adjusted to reflect amortization in respect thereof. 2. The factor is a number that represents a fraction (expressed as a decimal rounded to 8 decimal digits) the numerator of which represents the unpaid principal amount of such series of securities and the denominator which represents the initial principal amount outstanding of such series of securities (the “Factor”). The Total Consideration will be the amount set forth in the table above multiplied by the applicable Factor, which reflects the partial amortization of the 2028 Notes. 3. For each $1,000 original principal amount of 2028 Notes validly tendered and accepted for purchase and with respect to which the applicable Holder has provided its Consent. The Early Tender Payment includes a Consent Payment of $2.50 for each $1,000 original principal amount of 2028 Notes. Holders that validly tender their 2028 Notes and thereby deliver their Consents at or prior to the Early Tender/Consent Deadline (and do not validly withdraw such 2028 Notes and therefore do not validly revoke the related Consents) will be eligible to receive the Consent Payment of $2.50 per $1,000 original principal amount of 2028 Notes in respect of such 2028 Notes. 4. Excludes Accrued Interest, which will be paid in addition to the Total Consideration. 5. The Total Consideration for the 2028 Notes validly tendered has been determined in the manner described in the Statement by reference to the fixed spread (the “Fixed Spread”) specified above plus the yield (the “Reference Yield”) based on the bid-side price of the U.S. Treasury Reference Security specified above (the “Reference Security”) as quoted on the Bloomberg Bond Trader FIT3 series of pages (the “Reference Page”) as of the Price Determination Date, which includes the Early Tender Payment (including the Consent Payment). Holders may continue to tender their Notes (and thereby deliver Consents) until 5:00 p.m., New York City time, on June 24, 2026, in respect of the Tender Offer and Consent Solicitation, unless extended or earlier terminated by the Issuer in its sole discretion, subject to applicable law (the “Expiration Time”). The Issuer reserves the right in its sole discretion, subject to applicable law, to (i) waive prior to the Expiration Time any and all conditions to the Tender Offer; (ii) extend the Expiration Time; (iii) amend the terms of the Tender Offer and Consent Solicitation in any respect; or (iv) terminate, withdraw or otherwise decide not to proceed with the Tender Offer and Consent Solicitation at any time prior to or at the Expiration Time and not accept for purchase or payment any Notes not theretofore accepted for purchase or payment. The Issuer’s obligations to accept for purchase and pay for Notes pursuant to the Tender Offer and the Consent Solicitation is subject to the satisfaction of, or where applicable, the Issuer’s waiver of, the conditions set forth under “Conditions to Consummation of the Tender Offer and the Consent Solicitation,” including the Financing Condition, the Supplemental Indenture Condition, and the General Conditions as described in the Statement. Information Relating to the Tender Offer and the Consent SolicitationThe Company has engaged Citigroup Global Markets Inc is acting as the dealer manager and solicitation agent for the Tender Offer and the Consent Solicitation (“Dealer Manager and Solicitation Agent”). Questions regarding the terms of the Tender Offers and Consent Solicitations may be directed to Citigroup Global Markets Inc. at +1 (212) 723-6106 (banks and brokers) or +1 (800) 558-3745 (toll-free) or via email at ny.liabilitymanagement@citi.com. Global Bondholder Services Corporation is acting as (i) the Information Agent for the Tender Offer and the Consent Solicitation, (ii) the Tender Agent for the Tender Offer and (iii) the Tabulation Agent for the Consent Solicitation. Requests for copies of the Statement should be directed to Global bondholder Services Corporation at +1 (212) 430- 3774 (banks and brokers) or +1 (855) 654-2014 (toll-free) or via email at contact@gbsc-usa.com. This press release is for information purposes only and does not constitute or form part of an offer to sell or the solicitation of an offer to purchase or subscribe for securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities referred to herein have not been and will not be registered under the Securities Act of 1933 or applicable state securities laws, and may not be offered or sold in the United States or to U.S. persons (other than distributors) unless such securities are registered under the Securities Act of 1933, or an exemption from the registration requirements of that act is available. About Borr Drilling LimitedBorr Drilling Limited is an international drilling contractor incorporated in Bermuda in 2016 and listed on the New York Stock Exchange since July 31, 2019 and on Euronext Oslo Børs since May 21, 2026 under the ticker “BORR.” The Company owns and operates jack-up rigs of modern and high specification designs and provides services focused on the shallow-water segment to the offshore oil and gas industry worldwide. Please visit our website at www.borrdrilling.com. Forward-Looking StatementsThis press release and related discussions include forward-looking statements made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements do not reflect historical facts and may be identified by words such as “anticipate”, “believe”, “continue”, “estimate”, “expect”, “intends”, “may”, “should”, “will”, “ensure”, “likely”, “aim”, “plan”, “guidance” and similar expressions and include statements regarding the Tender Offer and Consent Solicitation, including expected settlement dates, the Financing Transaction and other non-historical statements. Such forward-looking statements are subject to risks, uncertainties, contingencies and other factors that could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein, including risks related to the Tender Offer and Consent Solicitation and other risks and uncertainties, including those described in our most recent annual report on Form 20-F for the year ended December 31, 2025 and our other filings with the Securities and Exchange Commission. Such risks, uncertainties, contingencies and other factors could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein. These forward-looking statements are made only as of the date of this release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. The Board of DirectorsBorr Drilling LimitedHamilton, Bermuda